Design, characterization, and reinforcement of mineralized collagen-glycosaminoglycan scaffolds for orthopedic wound repair by Weisgerber, Daniel W
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 Daniel W. Weisgerber  
  
 
 
 
 
 
 
DESIGN, CHARACTERIZATION, AND REINFORCEMENT OF MINERALIZED COLLAGEN-
GLYCOSAMINOGLYCAN SCAFFOLDS FOR ORTHOPEDIC WOUND REPAIR 
 
 
 
 
 
 
 
BY 
 
DANIEL W. WEISGERBER 
 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Materials Science and Engineering 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2015 
 
 
 
 
Urbana, Illinois 
 
 
Doctoral Committee: 
 Professor Brendan Harley, Chair and Director of Research 
 Professor Paul Braun 
 Professor Jianjun Cheng 
 Assistant Professor Cecilia Leal  
ii 
 
ABSTRACT 
The treatment of craniofacial orthopedic defects remains a challenge due to the large size, complex 
geometry, and load bearing aspects that often accompany such defects. The typical treatment or correction 
of craniofacial defects employed during surgical intervention of such injuries often necessitates the use of 
either autologous or allogenic bone grafts for orthopedic implants as the gold standard. However, this 
standard of treatment has been plagued with concerns over the size, geometry, donor site morbidity, 
disease transmission, and availability. To address these concerns, the development of an alternative 
orthopedic implant biomaterial capable of: (1) flexible design for meeting bone, defect, and patient 
specific treatment criteria; (2) guiding and supporting cellular specific repair specific to orthopedic 
defects; (3) demonstrate mechanical competence for surgical implantation and subsequent loading during 
function. This work outlines the development of a collagen-glycosaminoglycan platform that satisfies 
these requirements for the treatment of craniofacial defects. Chapter 2 details the fabrication and 
characterization of the collagen-glycosaminoglycan scaffold biochemical and biophysical properties 
important for the bioactivity and interaction with target cellular populations. The chapter 3 evaluates the 
in vitro cellular response and subsequent remodeling of a relevant cell population, mesenchymal stem 
cells, within the collagen-glycosaminoglycan scaffold. Chapter 4 addresses the necessary mechanical 
reinforcement and subsequent characterization of a multi-scale polycaprolactone-collagen-
glycosaminoglycan composite biomaterial for in vivo implantation and culture. In chapter 5 the 
polycaprolactone-collagen-glycosaminoglycan composite was then implanted in a subcritical mandibular 
ramus defect to affirm the composites in vivo efficacy. Finally, chapter 6 evaluated possible alterations in 
the collagen-glycosaminoglycan scaffold design for enhancing cellular behavior, while chapter 7 
expanded upon the multi-compartment collagen-glycosaminoglycan scaffold design for the treatment of 
craniofacial defects and associated entheses.  
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CHAPTER 1  
INTRODUCTION AND BACKGROUND TO ORTHOPEDIC 
BIOMATERIALS 
 
1.1  Introduction to the Anatomy of Bone 
The human body is 15 wt% bone with a total of 206 bones subdivided into the appendicular skeleton, 
pertaining to both the legs and arms containing 126 bones, the axial skeleton, which includes the spine, 
rib cage, and skull containing 74 bones, and the auditory ossicles, the 6 bones within the ears responsible 
for transmitting sound [1]. Between these subdivisions of bones, each bone can be classified as a long 
bone, short bone, flat bone, and irregular bone based upon their geometry and function [1]. There are a 
total of 90 long bones which are typically illustrated by the femur and tibiae, the largest bones in the legs 
extending from the hip to the knee and the knee to the ankle respectively, or the phalanges, 3 of which 
comprise each finger with 2 in the case of the thumb. Of the 30 short bones, common examples include 
the 8 carpal bones comprising the wrist as well as the 7 tarsal bones that together make up the hind and 
mid-foot. The skull and rib cage are both comprised of multiple flat bones each of which are 
representative of the 29 flat bones found in the human body. Finally, the 57 irregular bones are typically 
depicted as the vertebrae or mandible due to their irregular shape. The sesamoid bones such as the patella 
in the knee are small independent bones embedded in tendon or muscle, and are typically excluded from 
the total bone count within the human body.  
 
The two most overt roles bone provides is the protection of our vital organs in the case of the skull and rib 
cage, and the structural support necessary for locomotion provided by the aptly named musculoskeletal 
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system. However, bones also serves essential roles in maintaining homeostasis within the body. Aside 
from adapting and repairing bone, bone resorption and deposition also controls the release and storage of 
essential ions stored in the bone, including calcium and phosphate. The regulation of these ions remains 
governed by osteogenic cells, and plays an essential roles in balancing physiological pH in the body as 
well as other cell processes, such as action potential propagation in neurons via the release of neural 
transmitters following the influx of calcium via voltage gated ion channels in the axon terminal. 
Additionally, the bone marrow serves as the site of hematopoiesis, the generation of blood and immune 
cells within the body.  
 
Each bone is typically comprised of two anatomically distinct types of osseous tissues, an outer cortical 
bone shell with an inner cancellous bone core. Cortical or compact bone is the denser of the two (<5% 
porosity) and comprises approximately 80% of all bone mass [1]. The anatomical subunit comprising the 
cortical bone is the osteon which consists of concentric mineralized collagen lamellae centered on the 
harversian canal (circa 60 µm in diameter)[2], enclosing the blood vessels and nerves within these canals. 
Osteogenic cells are embedded within these lamellae in pockets known as lacunae and both communicate 
with other cells and exchange waste for nutrients from the Harversian canal via channels called canaliculi. 
In contrast, cancellous bone, also known as trabecular or soft bone, comprises the remaining 20% of all 
bone mass [1] of all bone and is softer (>30-90% porosity) compared to cortical bone. In the case of 
cancellous bone, the anatomical osteon subunit is less clear, but has been described as a series of parallel 
lamellae (circa 500 µm thick) of varying length described as a plate [3]. The ratio of cortical to cancellous 
is dependent on the bone, such as 1:3 in vertebrae as well as location in that bone 1:1 in the femoral head 
and 19:1 in the radial diaphysis [1]. 
 
The bone extracellular matrix, or the local micro-environment that cells reside in, consists of organic 
protein constituents, an inorganic mineral phase, and lipids. Of the organic protein constituents in bone, 
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85-90% consists of the matrix protein collagen type I [1]. The remaining organic protein constituents can 
be divided into proteins derived exogenously that help guide cellular behavior, such as growth factors and 
serum-proteins, and a wide range of osteoblast secreted proteins, which include proteoglycans, 
glycosylated proteins, and osteonectin [1]. Hydroxyapatite calcium phosphate mineral phase and other 
smaller compounds, such as carbonate and magnesium, account for 35-70% of bone as the inorganic 
mineral phase of bone. 
 
1.2  In Utero and Ex Utero Bone Development 
During development, new bone formation, also known as osteogenesis, occurs through either 
intramembranous ossification or endochondral ossification processes [4]. In the case of intramembranous 
ossification, the mesenchymal tissue is converted to bone, while endochondral ossification involves the 
conversion of a cartilage intermediate tissue into bone [4]. 
 
1.2.1 Intramembranous Ossification 
The process of intramembranous ossification, primarily responsible for the development of many of the 
craniofacial and flat bones found in the skull, first begins with the formation of compact nodules 
comprised of mesenchymal cells [4]. The bone morphogenetic protein family and the Cbfa1 gene in 
mesenchymal cells has been implicated in the differentiation of mesenchymal cells into osteoblasts [4]. 
Within these nodules, these mesenchymal cells will then expand into capillaries or osteogenic roles, 
where the latter is responsible for the deposition of an osteoid matrix that binds calcium salts [4]. As the 
deposition and calcification of osteoid proceeds in needle like projections called spicules, the periosteum 
membrane is formed by the compact mesenchymal cells surrounding the new bony spicules [4]. 
Osteoblasts that are trapped within the newly formed bone either undergo apoptosis or differentiate into 
osteoclasts, while mesenchymal cells bordering the bony spicules and the forming periosteum membrane 
become osteoblasts to contribute to new bone formation [4]. 
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1.2.2 Endochondral Ossification 
In contrast, endochondral ossification is implemented in the formation of the long bones within the body 
through a series of five stages [4]. In the first stage, mesenchymal cells that are to form a compact nodule 
are committed to become cartilage cells through paracrine signaling inducing Pax1 and Scleraxis 
transcription factors, which activate cartilage-specific genes [4]. The subsequent condensation of these 
cells into a compart nodule and differentiation into chondrocytes, with N-cadherin and N-CAM proteins, 
and the SOX9 gene having been identified as having an with important role in this stage of endochondral 
ossification [4]. The third and fourth stages involves the proliferation of the chondrocytes and their 
secretion of a cartilage extracellular matrix model before becoming hypertrophic chondrocytes, wherein 
proliferation is concluded and cellular size increases [4]. Within the fourth stage, these hypertrophic 
chondrocytes augment the previously secreted cartilage extracellular matrix model with collagen type X, 
which enables mineralization via calcium carbonate [4]. The fifth and final stage of endochondral 
ossification involves the blood vessel infiltration, apoptosis of the hypertrophic chondrocytes, and the 
differentiation of surrounding cellular bodies into osteoblasts with the subsequent deposition of bone by 
these osteoblasts on the now partially degraded cartilage extracellular matrix [4]. In the case of long 
bones, this process of endochondral ossification beings at the center of the cartilage extracellular matrix 
model and expands longitudinally [4]. In order to preserve the potential for new bone formation, the 
chondrocytes near the end of the cartilage extracellular matrix model proliferate prior to hypertrophy, 
extending the cartilaginous region [4]. These new cartilaginous regions are referred to as the epiphyseal 
growth plates, and contain distinct regions of chondrocyte proliferation, chondrocyte maturation, and 
hypertrophic chondrocytes [4]. The epiphyseal growth plates continue to provide the cartilage 
extracellular matrix model for new bone formation through this process of endochondral ossification for 
as long as they are capable of chondrocyte proliferation [4]. 
 
 5 
 
1.3  Physiological Aspects of Bone Remodeling and Defect Repair 
While bone is capable of providing support during locomotion and biochemical homeostasis, one of the 
most profound yet often overlooked characteristic is the unique ability of bone to adapt and repair itself in 
response to its environment using modeling and remodeling processes. The maintenance of bone 
homeostasis via remodeling is performed to repair damage accumulated at a micron level during 
physiological function (Figure 1.1) [5]. This remodeling process is achieved through a resorption and 
deposition cycle lasting 6-7 months. In a similar manner, the repair of small sub-critically sized defects 
involves bone remodeling following the inflammatory response and stabilization of the defect over a 
period of months to years [1]. 
 
1.3.1 Maintenance of Bone Homeostatic via Remodeling 
This cyclic process has been documented with 4 stages consisting of activation, resorption, reversal, and 
formation. Activation involves the recruitment of monocyte-macrophage osteoclast precursor cells, which 
proceed to fuse into multi-nucleated preosteoclasts that bind to the organic bone phase creating resorption 
pockets [1]. During resorption, resorbing osteoclasts release hydrogen ions to mobilize the bone mineral 
phase and a myriad of matrix degradation proteins dissolving the bone over a period of 2-4 weeks [1]. 
Following the apoptosis of the multi-nucleated osteoclasts and subsequent completion of resorption, the 
reversal phase or the transition from resorption to formation is triggered by a series of matrix derived 
biomolecules and changes in the local strain environment brought about by resorption [1]. Matrix 
deposition during the formation stage of remodeling occupies the remaining 4-6 months and involves the 
presence of osteoblasts depositing and mineralizing the bone matrix [1]. During this period of time 
osteoblasts deposit an unorganized and unmineralized collagen protein matrix, often referred to as woven 
bone, before being organized and mineralized into the osteon subunit [1]. Following formation, 50-70% 
of the remaining osteoblasts then either undergo apoptosis, or, if buried within the bone, differentiate into 
osteocytes joining the canalicular network [1].  
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Approximately 2-3% of cortical bone is remodeled each year [1]. In a functionally identical process, 
trabecular bone experiences a higher degree of remodeling, implicating it as the primary source of mineral 
homeostasis in the body. Changes in bone thickness with age has been attributed to differences in the rate 
of remodeling in the periosteal or outside surface compared to the endosteal or inside surface of bone [1]. 
The process of bone repair, commonly referred to as a union, following injury is also similar, but 
possesses notably different stages related to injury and stabilization. Indirect fracture healing, or the 
natural physiological healing process in non-operative healing, progresses as the inflammatory response, 
recruitment of stem cells, generation of a bony callus, revascularization of the callus, callus 
mineralization and resorption, and finally remodeling [6, 7]. 
 
1.3.2 Physiological Repair of Defects 
Following the initial trauma, the acute inflammatory response takes place during the first 7 days with the 
generation and coagulation of hematoma or blood clot at the fracture ends and medulla acting as a 
template for repair [6]. During this period, inflammatory cells stimulate revascularization and secrete 
numerous growth factors, such as tumor necrosis factor-α (TNF-α), that regulate cell recruitment and 
osteogenic differentiation [6]. The recruitment of cells, specifically mesenchymal stem cells (MSCs), to 
the site and subsequent differentiation is then mediated with a cascade of collagen type I and II matrix 
production with growth factor signaling, including the transforming growth factor-β (TGF-β) and bone 
morphoprogenic proteins (BMPs) [6]. Then 7-9 days after injury, a fibrin-rich soft cartilaginous callus is 
formed between the fracture ends, with sub-periosteal ossification adjacent, to provide a degree of 
structural support [6]. The subsequent revascularization and neoangiogenesis of the injury site, necessary 
to provide the nutrients essential for repair, is accomplished through surrounding matrix degradation and 
the activation of both vascular endothelial growth factor (VEGF) and angiopoietin-dependent cellular 
pathways [6]. By 14 days after injury, calcification of the previously soft cartilaginous callus occurs as the 
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responsible chondrocytes become hypertrophic before TNF-α initiates the cascade resulting in its 
resorption followed by the deposition of woven bone by osteoclasts and osteogenic cells [6]. Finally, after 
21-28 days, natural bone formation is achieved through the resorption of the woven bone, instigated by 
TNF-α, IL-1, and BMPs, by osteoclasts and the deposition of new lamellar bone via osteoblasts in a 
process similar to remodeling over a period of years [6]. 
 
In the case of direct fracture healing of small sub-critical sized defects, surgical intervention is necessary 
to achieve both anatomical reduction, correction of bone alignment, and stable fixation of the injury to 
allow either contact or gap healing to restore the function over a period of months to years [6]. Contact 
healing progresses when the gap between bones is less than 0.01 mm and involves cutting cones headed 
by osteoblasts that bridge the gap and create cavities that are then filled by bridging osteons [6]. Gap 
healing occurs within the range of 0.8-1 mm and results in deposition of bone lamella perpendicular to the 
bone axis, which must undergo additional remodeling into the osteon subunit [6]. It has been observed 
that strain and loading, Wolff’s law, of the injury site can be beneficial to healing kinetics, however, 
excessive strain or loading can result in delayed union or nonunion [6]. Due to the absence of a fibrous 
scar at its conclusion, the physiological bone healing processes has been identified as nearly regenerative 
in nature [6]. However, a plethora of complications have been identified as causing delayed union and 
nonunion between the fracture ends [7, 8]. Such complications include the age, the existence of co-
morbidities such as diabetes, prescribed and non-prescribed drugs in the case of non-steroidal anti-
inflammatory drugs and smoking respectively, methods of treatment including anti-coagulation 
treatments, as well as the critical roles of gap size and reduction in bone fracture [8].  
 
Beyond this critical size limitation, the addition of orthopedic implants during surgical intervention is 
necessary to promote the union of bones. However, in the case of severe orthopedic trauma involving a 
large degree of bone loss or complex geometries limitations in the applications of orthopedic implants 
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remain significant considerations. As such regenerative medicine and tissue engineering solutions have 
garnered attention as alternatives to the current orthopedic treatments to overcome these limitations. 
 
1.4  A Brief History of Orthopedics 
The origin of the word orthopedics can be traced to the word orthopedia original coined by Nicholas 
Andry at the University of Paris for the treatment of deformities in children in 1741 [9]. It has since 
evolved into the specialization of treating skeletal deformities in today’s medical community. However, 
the treatment and study of skeletal and musculoskeletal deformities predates 1741 by several centuries. 
Some of the earliest written accounts addressing the treatment of defects emphasized the significance of 
reduction or alignment and immobilization by Hippocrates [9]. Later work by historical figures such as 
Guy de Chauliac (1300-1368) and Leonardo de Vinci (1452-1519) addressed the use of traction for 
anatomical reduction in treating orthopedic defects by the mechanical leverage of muscle and bone 
respectively, the latter additionally addressed by Galileo’s pupil and physicist Alphonso Giovannni 
Borelli (1608-1679) [9]. Later, the anatomical structure of bone was introduced with the first known 
account of bone vascularization, the Harversian canal, by Clopton Havers (1657-1702), and cellular role 
of osteoblasts in the formation of the osteoid tissue by John Goodsir (1814-1867) [9]. 
 
1.5  Treatment Approach for Orthopedic Defects: Reduction, Fixation, and Bone Grafts 
Since the 1990s, between 60% and 70% of all injuries involve to the musculoskeletal system, an increase 
from 23.4 million in the 1990s to 24.8 million today [10]. With even this increase in occurrence, 
ambulatory visits and prescription drugs for the treatment of musculoskeletal injuries has risen by 85% 
and 97% respectively [11]. As of 2011, individuals over the age of 65 represent more than half of all 
musculoskeletal injuries, while these individuals represent only 13% of the total population, with the 
proportion of the people over 65 projected to increase to 20% by 2030 [11]. While only a subset of the 
larger musculoskeletal defects, craniofacial defects represent an important target of treatment for 
 9 
 
orthopedic surgeons. Craniofacial repair addresses a wide range of defects resulting from birth 
deformities, such as the cleft lip or cleft palate afflicting 0.17% of all newborns [12, 13], or acute 
maxillofacial trauma, as in the case of sport activities and traffic accidents that representing 54.4% of 
such injuries [14].  
  
While orthopedic methods are heavily dependent on the specific injury, the overall orthopedic approach 
for treating direct fractures remains: anatomical reduction and stable fixation. In the case of fractures, 
traction, or the anatomical positioning of the fracture ends mechanically, is followed by either open or 
closed reduction [15]. Stable fixation can occur either internally, in the case of open reduction, with plates 
and screws or externally, typically in the case of closed reduction, with casts.  
 
Especially pertaining to craniofacial defects, more complicated defects involving geometrically complex 
bone loss or requiring the addition of bone volume for functional restoration requires a more proactive 
treatment. In the case of the five most common orthopedic training techniques for craniofacial repair, the 
cranial or iliac bone to the nasal dorsum, perialar rim graft, lateral canthopexy with full canthal tendon 
release/mobilization and fixation to orbital rim, osseous genioplasty, and bone graft harvest for orbital 
floor defects, involve the harvest, placement, alignment, and fixation of the bone graft to fix the targeted 
defect [16]. While the same treatment principles of traction, reduction, and fixation still hold, addressing 
such critically sized defects, or defects unable to heal without intervention requires the addition of an 
orthopedic implant to promote union. Such orthopedic implants can be classified into two general 
categories, the relatively biologically inert and non-degradable implant, such as titanium or silicon, or the 
more common gold standard of an autologous or an allogenic bone graft. The autologous bone graft 
consists of bone harvested from a secondary site within the patient, while the allogenic bone graft 
involves the implantation of a similarly identical donor bone graft that has been treated to remove any 
residual cell populations and possible contagions. In both cases limited availability has remained a 
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constant concern, with autologous bone grafts limited in the amount of bone that can be safely harvested, 
and allogenic bone grafts limited by donor availability. Additionally, concerns over secondary wound site 
morbidity from autologous harvesting and allogenic disease transmission remain prominent for these gold 
standards of orthopedic treatment. As such, regenerative medicine and tissue engineering approaches 
utilizing a bioactive orthopedic biomaterial implant has garnered attention as an alternative to the use of 
the autologous and allogenic bone grafts. 
 
1.6  Introduction to Alternative Orthopedic Implant Materials 
A majority of orthopedic interventions involve the use of orthopedic implant materials, either biologically 
inert materials, or more commonly, harvested bone to either replace bone loss or correct defects [16-20]. 
Even non-osseous related treatments such as ACL reconstruction can employ the use of implant materials 
or bone harvest for fixation in place of or augmenting interference screws. However, in the case of large 
defects, harvesting sufficient autologous bone remains impractical requiring the use of allografts to 
achieve a functional outcome. To avoid autologous bone grafts with associated donor site morbidity and 
impaired function, allogenic bone grafts have been employed (Figure 1.2). But concerns of allogenic 
supply and disease transmission still remain prevalent for such allogenic bone grafts. These concerns and 
limitations over autologous and allogenic bone grafts has spurred the development of biomaterials to 
replace current implant materials. However, such biomaterials developed as alternatives to the current 
orthopedic implant, regardless of their classification, must fundamentally be capable of both enabling and 
enhancing the physiological process in the fields of regenerative medicine and tissue engineering [21]. To 
accomplish these goals, the regenerative medicine and tissue engineering fields leverage the biochemical, 
biophysical, and biomolecular material design variables, such as  degradation rate, pore size, stiffness, 
growth factor incorporation, biological motifs, and composition. 
 
 11 
 
Biomaterials designed to replace implant materials can be divided into several categories based upon their 
role in the physiological process and their composition, these categories generally include biologically 
inert versus active, degradable or resorbable versus non-degradable, and synthetic versus organic, with 
growing favor in  regenerative medicine and tissue engineering for biologically active and degradable 
biomaterials capable of influencing the native physiological response as opposed to biologically inert 
implants. With the development of tissue engineering the significance of both chemical and physical 
biomaterial properties as well as degradability in guiding the biological response both locally and 
systemically has been established [22, 23]. Degradable biomaterials designed with such criteria in mind 
can generally be divided into two broad categories: inorganic and organic biomaterials. Inorganic 
biomaterials used in tissue engineering can be further categorized into synthetic polymeric biomaterials 
and ceramic biomaterials. Synthetic biomaterials, with prime examples such as polyethylene glycol (PEG) 
and poly(lactic acid) (PLA), are flexible in their chemical modification. Ceramics, like tricalcium 
phosphate and hydroxyapatite, are more commonly used in orthopedic applications due to their physical 
properties. Organic biomaterials are commonly comprised of both physiologically relevant and naturally 
occurring proteins and biomolecules, examples ranging from collagen and proteoglycans to silk fibers. 
 
Synthetic biomaterials employed in orthopedic applications are highly favored for the definitive control 
over the wide range and flexibility of both chemical and physical properties that may be present upon 
implantation. Outside the fields of regenerative medicine and tissue engineering, synthetic biomaterials, 
such as poly(L-lactide acid), mixtures of poly(propylene fumarate) and poly(propylene fumarate)-
diacrylate, and poly(glycolic acid), have been used to provide viable biodegradable alternatives to metal 
orthopedic implants, as in the case of interference screws, fixative plates, and FDA approved sutures [24-
26]. Within the fields of regenerative medicine and tissue engineering, synthetic biomaterials have been 
capable of meeting the various design criteria for application across multiple tissues by modulating their 
stiffness from 10 Pa to 100 kPa [27, 28], variations in microstructure pore size, density, and surface 
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roughness [29, 30], and the incorporations of different chemistries invoking stimuli dependent responses. 
The most notable limitation of synthetic biomaterials was their inferior capacity to directly influence 
cellular behavior and function within regenerative medicine and tissue engineering applications compared 
to organic biomaterials [31]. However, advances in biology and the biomaterial design has allowed the 
incorporation of biological motifs and components to increase the inherent bioactivity of these materials 
without concerns of pathogen transmission and immunogenicity [31]. Examples of the expansive range of 
biological motifs included in polymeric biomaterial design include the addition of the adhesion promoting 
RGD (Arg-Gly-Asp amino acid) domain [32], the incorporation of a nano-hydroxiapatite mineral phase in 
poly(L-lactic acid) composites to better mimic the anatomic bone micro-environment [33], and the 
inclusion of biomolecules such as growth factors ranging from BMP for bone to VEGF for 
vascularization [34].  
 
Ceramic biomaterials or bioceramics, almost exclusively calcium phosphate ceramics (CPCs), have been 
employed in conjunction with orthopedic applications for their excellent resistance to deformation and 
osteoinductive properties. Numerous calcium based ceramics for the treatment of bone defects are 
represented most commonly by beta-tricalcium phosphate (Ca3(PO4)2; β-TCP) and calcium 
hydroxyapatite (Ca10(PO4)6(OH)2; HA), while others include calcium aluminate (CaO.Al2O3), beta-
calcium pyrophosphate (Ca2P2O7), biphasic calcium phosphate (a mixture of HA and β-TCP), calcium 
carbonate (CaCO3), and amorphous calcium phosphates (Ca3(PO4)2) [35-40]. At the micron and 
nanoscale, the surface roughness, surface charge, crystallinity, grain size, and solubility of ceramic 
biomaterials are all tunable properties that affect the protein adsorption, subsequent cell adhesion, and 
ultimately cellular differentiation [39]. At the tissue level, the mechanical properties such as the 
compressive modulus of ceramic biomaterials are comparable or exceeding cortical bone in the 10 GPa 
range, with TCP ranges from 20 to 80 GPa depending on the sintering temperature [41]. However, 
concerns over the inherent pore size, degradation, low ductility, and wear debris represents some of the 
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difficulties ceramic biomaterials face. Recent work impregnating a β-TCP ceramic with polycaprolactone 
has shown an improvement in mechanical tolerances [42]. 
 
Unlike synthetic and ceramic biomaterials, degradable organic biomaterials have been defined by their 
native interaction with the physiological environment, with the ability to facilitate cellular processes in 
regenerative medicine and tissue engineering applications. Examples of naturally derived biomaterials 
commonly employed in orthopedic applications of regenerative medicine and tissue engineering include 
chitosan, silk, alginate, fibrin, elastin, laminin, proteoglycans, and collagen based materials and 
composites [43-46]. The ability of natural polymers to interact with cells, their inherent biocompatible 
with biocompatible degradation products and low immunogenicity, and ability to closely simulate the 
native extracellular matrix especially in the case of physiologically relevant matrix proteins such as 
collagen and fibrin make natural polymers an attractive application [46]. However, in the case of 
orthopedic implants especially, some natural polymeric biomaterials, with moduli ranging anywhere from 
1 kPa to 200 kPa [28, 47, 48], lack the mechanical competence of the target tissue, typically in the 2 MPa 
to 20 GPa range [49, 50], creating problems during instances of load bearing. 
 
In addition to leveraging the biochemical and biophysical design variables of synthetic, ceramic, and 
organic biomaterials as a more bioactive treatment approach, the incorporation of biomolecular design 
considerations has also demonstrated enhanced bioactivity. While such biomolecular components include 
biological motifs [32], a major avenue of design includes the incorporation and release of proteins, 
particularly growth factors, into the wound environment to enhance treatment. In particular, growth 
factors belonging to the bone morphogenetic protein (BMP) family, especially BMP-2, play essential 
roles in the development, growth, and repair of the skeleton during embryogenesis and extending 
throughout adulthood [51]. Utilization of growth factors belonging to the BMP family in in vitro, in vivo, 
and clinical work has demonstrated bone formation [52-55]. However, complications arising from the use 
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of growth factors, particularly of the BMP family, have included heterotopic ossification, osteolysis, 
neurological deficits, and cancer [56-58]. As such, additional work investigating the controlled delivery 
and release of such biomolecular components is required for safe incorporation in regenerative medicine 
and tissue engineering biomaterial design. 
 
1.7  Multi-Scale Biomaterial Composites Design: a Solution to a Problem 
While all biomaterials possess inherent qualities, a common method for addressing specific deficiencies 
or augmenting desirable biophysical and biochemical properties is the fabrication of a multi-component 
multi-scale biomaterial composite. In the case of calcium phosphate ceramics and other bioceramics used 
in orthopedic applications, the incorporation of natural and synthetic polymeric biomaterials has 
demonstrated improved protein adsorption and tunable degradation as in chitosan/β-1,3-glucan/calcium 
phosphate ceramic composite and cellulose/apatite composites [59, 60]. In the case of synthetic and 
organic biomaterials, the inclusion of a calcium phosphate mineral component like the hydroxyapatite 
mineralization of silk fibroin hydrogels and agarose gels loaded with either hydroxyapatite or calcium 
carbonate, greatly increases the osteogenic capacity of the material [40, 61]. Most biomaterial composites 
are composed of similar scale components typically as polymer-polymer composite biomaterials, as in the 
case of the collagen-polycaprolactone biomaterial composite developed for controlled insulin release, or 
more commonly, polymers coated with a nano-crystal hydroxyapatite, such as the chitosan-nano-
hydroxyapatite scaffold for osteoblast and mesenchymal stem cell culture [62] [63]. A second approach to 
composite biomaterial design involves a multi-scale component approach with examples such as a 
millimeter scale macroporous polycaprolactone construct loaded with growth factors, bone 
morphoprogenic protein 2 (BMP2) and erythropoietin (EPO) to assist in bioactivity at the cellular level, 
or a beta-tricalcium phosphate (β-TCP) ceramic with polycaprolactone (PCL) impregnated into the 
microstructure to improve mechanical ductility [42, 64]. 
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1.8  Collagen-Glycosaminoglycan Scaffolds 
Of the natural polymeric biomaterials the collagen and gelatin based scaffold design has shown particular 
promise for the treatment of a wide range of tissues due to its inherent biophysical properties and 
immunogenicity. These applications cover a scope of chemically and physically different tissues ranging 
from soft neural tissue for the treatment of brain and nerve defects in the case of silk-collagen protein 
constructs [65, 66], to the treatment of cartilage defects [67-69], to muscle tissue [70-72], and to hard 
bone tissue for the treatment of orthopedic defects [73-75].  Collagen protein is ubiquitous and is found 
throughout the body in different tissues.The collagen protein family comprises approximately 30% of all 
protein found in the human body, making it an ideal candidate for extracellular matrix mimetic scaffold 
design [76, 77]. The collagen-glycosaminoglycan based scaffold design pioneered by Yannas et al in 
1989 for the treatment of skin defects has served as a successful template for a range of regenerative 
medicine and tissue engineering applications [78, 79]. FDA approved, the collagen-glycosaminoglycan 
scaffold demonstrated a defined chemical composition, tunable pore structure, controlled degradation, and 
non-angiogenic properties, and was successful in disrupting wound contraction by inhibiting 
myofibroblast differentiation and activity [78, 80-82]. Additionally, the collagen-glycosaminoglycan 
scaffold design was later utilized for peripheral nerve regeneration treating a 10 mm gap defect in the rat 
sciatic nerve and achieving functional repair approaching that of the autograft [83-85]. This scaffold 
design has since been applied to both osteochondral and orthopedic regenerative medicine and tissue 
engineering applications [86-90]. 
 
As a successful application in both regenerative medicine and tissue engineering, there has been an 
explosion of studies investigating both the biophysical and biochemical related properties of the collagen-
glycosaminoglycan scaffold and their effects on the physiological environment for regenerative medicine 
and tissue engineering applications. More recent studies performed on this variation of collagen-
glycosaminoglycan scaffold design has evaluated the biophysical properties including effect of 
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lyophilization conditions on pore size [91], the effect of pore size on cell attachment and permeability [92, 
93], the mechanical properties and contractile forces exerted by cells [94, 95], and microstructure 
anisotropy [96, 97]. Similarly, the biochemical properties of collagen-glycosaminoglycan scaffolds 
pertaining to degradability [98], antigenicity, and immunogenicity [99] have been investigated. Work 
within this lab has expanded upon this foundation to investigate the application of collagen-
glycosaminoglycan scaffolds for cardiatric applications [100] and tendon repair [97, 101], as well as 
biomolecule incorporation [102, 103], angiogenic processes [104, 105], and variation in proteoglycan 
composition [106]. 
 
1.9  Mineralized Collagen-Glycosaminoglycan Scaffolds 
The modification of Yannas et al collagen-glycosaminoglycan scaffold design for orthopedic regenerative 
medicine and tissue engineering applications has been accomplished with the incorporation of a calcium 
phosphate mineral phase during fabrication. Studies indicated that it was possible to incorporate a 
biologically relevant mineral phase by the controlled addition of calcium nitrate tetrahydrate and calcium 
hydroxide to produce a brushite mineral phase with control over the reaction mass yield via concurrent 
mapping techniques in the absence of titrants [87, 107]. Using subsequently time dependent and pH 
controlled hydrolysis steps, it was shown that the brushite mineral phase could be converted from brushite 
(CaHPO4) to octacalcium phosphate (Ca8H2(PO4)6) to hydroxyapatite [88]. The triple coprecipitation of 
collagen, glycosaminoglycans, and calcium phosphate has been shown to produce collagen-
glycosaminoglycan scaffolds with 0 to 80 wt% mineral phases encompassing the 30 to 70 wt% 
hydroxyapatite mineral phase often observed in bone [87, 88, 108-112].  
 
Alternative methods of collagen-glycosaminoglycan scaffold mineralization have also included soaking in 
mineral suspensions such as ammonium sodium phosphate dibasic (NaNH4HPO4) followed by calcium 
chloride (CaCl2) or alternatively in simulated body fluid, or the direct addition of calcium phosphate 
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particles to the collagen-glycosaminoglycan scaffold precursor to incorporate a calcium phosphate 
mineral phase [113-115]. With various work investigating the effect of mineralization on scaffold 
biophysical and biochemical properties including facilitation of gene transfection [116-118], growth 
factor delivery [119-121], mechanics, porosity and pore microstructure, pore size, and matrix production 
[115]. Additional work has utilized this mineralized collagen-glycosaminoglycan scaffold design for the 
treatment of osteochondral defects through the development of a multi-compartment scaffold biomaterial 
[89].  
 
1.10  Overview of Thesis: Motivation, Hypothesis, and Chapter Outline 
While bone possesses the remarkable quality of repairing itself to a to such a degree it is considered 
regenerative, injuries beyond a critical size still result in wounds incapable of physiological repair. 
Beyond this critical size, surgical intervention employing the gold standard of autologous or allogenic 
bone grafts is required for functional recovery of the defect. With the growing number of orthopedic 
interventions compounded by patient specific, complex geometrical constraints, concerns over donor site 
morbidity in the case of autologous grafts, and allogenic supply and disease transmission in the case of 
allogenic grafts, has highlighted the need for alternative orthopedic biomaterials. The goal of this work 
has been the development of one such orthopedic biomaterial for the treatment of complex mandibular 
and craniofacial defects. 
 
In order to provide a viable alternative to autograft and allografts in the field of orthopedics, a more active 
biomaterial design capable of facilitating and furthermore instigating the physiological repair processes 
through biochemical, biophysical, and biomolecular properties, as opposed to the biologically inert 
materials currently employed. Such active biomaterial design via stimulation and direction of the cellular 
response through biochemical, biophysical, and biomolecular properties has been the focus of 
regenerative medicine and tissue engineering efforts. However, supplying the necessary supra-
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physiological doses of growth factors to achieve biomolecular stimulation remains a challenge with 
careful modulation and sustained release of such large dosages. This goal of an orthopedic biomaterial 
approach will emphasize a biochemical and biophysical material property guided cellular response in the 
absence of exogenous biomolecule supplementation. 
 
To achieve the treatment of complex mandibular and craniofacial defects in the absence of exogenous 
biomolecule supplementation, the further development and characterization of the mineralized collagen-
glycosaminoglycan design originally developed by Yannas et al and expanded upon by Harley et al was 
performed. Here we hypothesize that the calcium phosphate mineralized collagen-glycosaminoglycan 
scaffold is capable of inducing osteogenic cell behavior and mineral deposition through material 
properties, in the absence of osteogenic supplementation. Furthermore, we hypothesize that the 
mechanical properties of the mineralized collagen-glycosaminoglycan scaffold can be enhanced for in 
vivo implantation with the incorporation of a polycaprolactone support structure while preserving the 
innate aforementioned osteogenic potential. 
 
Chapter 2 highlights the flexibility of the mineralized collagen-glycosaminoglycan scaffold in its 
biophysical and biochemical properties for the treatment of a diverse range of orthopedic defects and 
patient specific considerations [48]. Here the biochemical and biophysical properties attributed to 
influencing cellular behavior were evaluated. These biochemical and biophysical properties included the 
compositional variation in mineral content, the average pore size, elastic modulus in compression, and the 
permeability. 
 
Chapter 3 investigates the influence of the mineralized collagen-glycosaminoglycan scaffold on a 
physiologically relevant cell population behavior, specifically evaluating an osteogenic-like phenotype 
towards the treatment of orthopedic defects [122]. Here mesenchymal stem cells were cultured in vitro 
 19 
 
over 56 days, with the influence of calcium phosphate mineral content within the collagen-
glycosaminoglycan scaffold compared to bone morphogenetic protein 2 and osteogenic media 
supplemented variations. The metabolic activity, osteogenic gene expression, and matrix remodeling were 
evaluated on within the collagen-glycosaminoglycan scaffolds. 
 
Chapter 4 evaluates the mechanical reinforcement of previous scaffolds with the fabrication of a multi-
scale mineral polycaprolactone-collagen-glycosaminoglycan composite biomaterial for the treatment of 
load bearing craniofacial orthopedic defects [123]. Here a mechanically competent macro-porous 
polycaprolactone support construct was impregnated with highly bioactive micro-porous mineralized 
collagen-glycosaminoglycan matrix. Initial cell attachment was evaluated after 24 h of in vitro porcine 
adipose derived stem cells culture, while differences the bulk elastic moduli and micron-scale pore 
architecture determined the biophysical properties. 
 
Chapter 5 confirms the in vivo efficacy of the multi-scale polycaprolactone-collagen-glycosaminoglycan 
composite through implantation into a sub-critical mandibular ramus defect within a porcine animal 
model [124]. Following a 6 week in vivo culture, new bone formation in the composite was investigated 
and compared to the mineralized collagen-glycosaminoglycan scaffold and the polycaprolactone support 
construct alone. Healing was evaluated through the quantity and relative density of new bone formation. 
 
Chapter 6 investigates compositional alterations to the original mineralized collagen-glycosaminoglycan 
scaffold with a substitution of heparin as the glycosaminoglycan [125]. Enhancements in bioactivity were 
evaluated through an in vitro culture with porcine adipose derived stem cells over a period of 28 days, 
with cellular metabolic activity, mineral deposition, and changes in elastic moduli measured as criteria of 
cellular bioactivity within scaffold variants. 
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Chapter 7 continues the evaluation of the versatility of the collagen-glycosaminoglycan scaffold through 
the expansion of the previously developed multi-compartment collagen-glycosaminoglycan scaffold 
design towards the treatment of entheses within a craniofacial defect [48]. Biochemical and biophysical 
properties, including pore size, elastic moduli in compression, and permeability, were evaluated within a 
multi-compartment scaffold containing distinct non-mineral and mineral regions with a gradient interface 
between. 
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1.11  Figures 
 
Figure 1.1 Presence of microcracks in bone. 
Presence microcracks (identified by right arrows) stained with calcein identified in previous literature [5]. 
A drill hole was used as a reference point in the right image. The present scale bars were 200 um (left 
image) and 100 um (right image). 
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Figure 1.2 Severe craniofacial trauma treated with allograft from a donor. 
(A) Severe craniofacial trauma caused by gunshot wound and (B) reconstruction after 3 months [126].  
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CHAPTER 2  
FABRICATION AND CHRACTERIZATION OF THE 
COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLD: 
FLEXIBILITY OF BIOPHYSICAL AND BIOCHEMICAL 
MATERIAL PROPERTIES AND DESIGN1 
2.1  Overview 
The incorporation of a mineral phase within biomaterials for orthopedic applications has been shown to 
enhance the osteogenic bioactivity of these minerals scaffolds. Here the incorporation of a calcium 
phosphate mineral phase into collagen-glycosaminoglycan scaffold design is verified with the resulting 
alterations in biochemical and biophysical properties being investigated. This chapter investigated two 
degrees of mineralization (40 wt% and 80 wt%) via a triple co-precipitation and lyophilization method 
spanning the physiological range of bone mineral (30-75wt%). The hydroxyproline and 1,9-
dimethylmehylene blue (DMMB) chemical assays were used to quantify the amount of collagen and 
glycosaminoglycans, respectively, within the mineralized scaffolds with the remaining mass fraction 
determining the mineral phase percentage. In both degrees of mineralization, powder x-ray diffraction 
was used to identify the mineral phase. Additionally, the effect of mineralization on the mechanical 
                                                     
1 This work is a partial adaption from the study 48. Weisgerber, D.W., et al., The impact of discrete 
compartments of a multi-compartment collagen-GAG scaffold on overall construct biophysical 
properties. Journal of the mechanical behavior of biomedical materials, 2013. 28: p. 26-36.. The work 
presented in Chapter 7 concludes this adaptation from the study 48. Ibid. 
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properties and microstructure was investigated via the compressive modulus, average pore size, and 
permeability of the scaffold. 
 
2.2  Introduction 
Orthopedic defects remain challenges in regenerative medicine and tissue engineering research due to 
their large size, complex geometries, and load bearing function. The standard clinical treatment for such 
critically sized orthopedic defects involves the use of an orthopedic implant, namely an autologous or 
allogenic bone graft [17, 18, 127]. However, concerns over defect size and volume as well as the donor 
site pain and morbidity remain for autologous bone grafts, while concerns over disease transmission as 
well as donor availability for allogenic bone grafts are also predominate [128-131]. These concerns along 
with the growing prevalence of orthopedic defects resulting from the growing and aging population have 
sparked the regenerative medicine and tissue engineering communities to investigate orthopedic 
biomaterial alternatives. Previous orthopedic implants employed clinically are physiologically inert and 
non-degradable serving only to provide mechanical support with limited osteoconductivity. Prime 
examples are the titanium hip implant, poly insert, and silicone implants [16]. While these implants 
support mechanical restoration for load bearing applications they do not support the physiological aspects, 
such as ion homeostasis and hematopoiesis. However, the lack of physiological function and concerns 
over loosening, termed aseptic loosening, of the cement failure and resulting wear debris and wear debris 
have warranted an additional approach to biomaterial design [132-134]. Current regenerative medicine 
and tissue engineering approaches have taken a more active approach in guiding the physiological wound 
healing processes through biophysical, biochemical, and biomolecular material properties [21].  
 
This growing paradigm shift toward evaluating tissue engineering biomaterials that actively enhance the 
physiological wound healing process for a physiologically relevant treatment outcome has prompted 
biomaterials are evaluated on the biophysical and biochemical properties that influence cellular behavior 
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[22, 23]. These properties have included material stiffness, necessary in providing support but also the 
materials influence on cell fate [28], microstructure and surface area as influencing cell attachment, on 
nutrient and waste exchange [92], and composition especially in the case of orthopedic implants where 
the role of calcium phosphate minerals has been demonstrated to influence cellular behavior [87].  
 
Within regenerative medicine, biomaterials designed on simulating the extracellular matrix environment, 
particularly collagen based scaffolds, have shown particular promise [78, 79]. The collagen-
glycosaminoglycan scaffold originally crafted for dermal regeneration for burn victims represent one of 
the many successful applications [78]. Additional studies have evaluated the collagen-glycosaminoglycan 
scaffold for nerve regeneration [83-85], tendon regeneration [97], and osteochondral regeneration [89]. 
Additionally, the literature has demonstrated the incorporation of a calcium phosphate mineral phase into 
the collagen-glycosaminoglycan scaffold for the treatment of orthopedic defects [87, 88]. 
 
This work evaluates the fabrication of one such mineralized collagen-glycosaminoglycan scaffold 
fabricated by the lyophilization of a mineralized collagen-glycosaminoglycan precursor suspension [88]. 
The lyophilized mineralized collagen-glycosaminoglycan precursor suspension was first fabricated 
through the controlled triple co-precipitation of collagen, glycosaminoglycan, and calcium phosphate 
precursor components using a rotor-stator homogenization setup and concurrent mapping techniques to 
control the calcium phosphate mineral mass yield [87, 107]. The composition with mineral percentage 
was then evaluated to verify previous work [87, 88, 108, 135]. Then the effect of mineral content and 
final freezing temperature during lyophilization on the biophysical and biochemical material properties 
was evaluating including microstructural and mechanical material properties implicated in the bioactivity 
of orthopedic implants. 
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2.3  Overview of the Rotor-Stator Homogenization Process 
The fabrication of the non-mineralized collagen-glycosaminoglycan (CG) and mineralized collagen-
glycosaminoglycan (CGCaP) precursor suspensions was accomplished via the homogenization of 
collagen, glycosaminoglycans, and mineral components with a rotor-stator. Rotor-stator tissue 
homogenizers consist of a motor and a probe or generator, which is composed of two parts: the rotor and 
stator. Here the rotor rotates within the stator between 3,000-60,000 rpm, with the tissue being drawn into 
the probe through the stator via holes or gaps within the teeth [136]. Larger particulates are then 
homogenized by mechanical shear and extreme turbulence generated by the rotor-stator. At the micron 
level, homogenization within the rotor-stator is achieved again by extreme turbulence, but also by the 
collapse of low-pressure vapor cavities, termed cavitation, and the shear forces generated from the rotor 
passing the stator [136]. The degree of homogenization and resulting particle size is dictated by the rotor 
speed and gap between rotor and stator, with smaller particle sizes achieved at faster speeds and smaller 
gaps. The inherent flexibility of this system allows for the homogenization of various proteins or 
chemicals into one precursor suspension that can be later used for scaffold fabrication.  
 
2.4  Fabrication of Non-Mineral CG Suspension 
The non-mineralized collagen-glycosaminoglycan (CG) suspension was achieved by the homogenization 
of collagen and glycosaminoglycans via a rotor-stator setup. This was accomplished by homogenization 
of 0.5% w/v type-I fibrillar collagen isolated from bovine Achilles tendon (Sigma-Aldrich, St. Louis, 
MO) in 0.05M acetic acid. Then at a ratio of 11.25 collagen:1 glycosaminoglycan, 0.044% w/v 
chondroitin sulfate isolated from shark cartilage (Sigma-Aldrich, St. Louis, MO) was solubilized in 
0.05M acetic acid and added to the homogenized collagen suspension. Following homogenization, the 
resulting CG suspension was stored at 4°C prior to lyophilization. 
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2.5  Fabrication of Mineral CGCaP Suspension 
Similarly, the mineralized collagen-glycosaminoglycan (CGCaP) suspension was achieved by the triple 
co-precipitation of collagen, glycosaminoglycan, with a calcium phosphate mineral. The preparation of 
the precursor suspension proceeded with the homogenization of type-I fibrillar collagen from bovine 
Achilles tendon (Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate isolated from shark cartilage 
(Sigma-Aldrich, St. Louis, MO) in the presence of calcium hydroxide (Ca(OH)2; Sigma-Aldrich, St. 
Louis, MO) and phosphoric acid. The subsequent addition and homogenization of calcium hydroxide and 
calcium nitrate tetra-hydrate (Ca(NO3)2 4H2O; Sigma-Aldrich, St. Louis, MO) concluded the triple co-
precipitation. The resulting CGCaP suspension was stored at 4°C prior to lyophilization. 
 
The controlled precipitation of the calcium phosphate mineral phase was achieved by a concurrent 
mapping method previously established [87, 107]. Briefly, control over the mass yield of the calcium 
phosphate mineral phase was achieved by independently varying the calcium hydroxide to calcium nitrate 
tetra-hydrate molar ratio and the molarity of the phosphoric acid. In this study, two variations (low and 
high mineral content) of the molar ratio of the calcium ingredients and the molarity of the phosphoric acid 
used was derived from the previous work utilizing this triple co-precipitation methodology [87, 88, 108, 
135].  
 
2.6  Overview of the Lyophilization Process 
Following the fabrication of the precursor suspensions, subsequent lyophilization achieved the 3-
dimensional scaffold microstructure employed in this study and throughout all remaining work evaluating 
the mineralized collagen-glycosaminoglycan scaffold. Lyophilization or freeze drying is the process by 
which water is removed via freezing and sublimation. Lyophilization represents one of the most common 
processes for the long term preservation of proteins and accounts for the formulation of approximately 
50% of all pharmaceuticals [137]. In the case of biomaterials, lyophilization provides a straightforward 
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process by which most synthetic and organic polymers can be organized into a 3-dimensional pore 
structure. Briefly, the biomaterial precursor suspension is cooled until ice crystal nucleation begins with 
subsequent freezing leading to the growth of the nucleated ice crystals [137]. As the ice crystals grow, the 
suspension solutes and solid material components of the biomaterials are concentrated at the ice crystal 
periphery in what is termed “cryoconcentration” [137]. Continued cooling of the precursor solution 
results in either the eutectic crystallization or vivification of the concentrated solutes [137]. At a 
temperature below the freezing point of water, the pressure is then reduced by pulling vacuum on the 
system; if performed correctly, increasing the temperature at a low pressure results in sublimation, the 
phase transition of water from solid (ice) to vapor (air) avoiding the liquid (water) phase altogether. 
Removal of the ice crystals results in voids or pores within the resulting matrix, or cake when referring to 
lyophilization.  
 
For biomaterial fabrication via lyophilization it is essential to note that with various techniques and 
careful manipulation, ice crystal nucleation and ice crystal growth can be decoupled. This allows for 
independent control over the pore microstructure via nucleation and pore size via growth kinetics. For the 
design of biomaterials, and in the particular case of collagen-glycosaminoglycan scaffolds, this allows for 
the flexible design of unique isotropic or anisotropic pore structures with tunable pore sizes. Examples of 
such include the alignment of pores in collagen-glycosaminoglycan scaffolds for the treatment of tendon 
defects [97].  
 
2.7  Non-Mineral and Mineralized Collagen-Glycosaminoglycan Scaffold Fabrication 
In the present study, 1 mL of the non-mineral (CG) and mineral (CGCaP) precursor suspensions was 
pipetted into each of the 6 cylindrical wells (12 mm deep, 13 mm diameter, 1.5 mm thick base) present in 
a custom polysulfone array mold. Lyophilization was then preformed using a Genesis freeze-dryer 
(VirTis, Gardener, NY). Briefly, the scaffold precursor suspensions were cooled at a constant rate of 
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1°C/min to a final freezing temperature of -10°C or -40°C and held at that final freezing temperature for 
175 minutes. Sublimation then proceeded at 0°C and 200 mTorr. In the case of the non-mineral CG 
scaffold a secondary dehydrothermal (DHT) crosslinking step was performed at 105°C and <25 Torr for 
24 h in a vacuum oven (Welch, Niles, IL) as previously established [138]. The resulting scaffolds were 12 
mm in diameter and 10 mm in height. Subsequent compositional, microstructural, and mechanical 
analysis was performed on these scaffold specimens. 
 
2.8  Compositional Analysis of the Mineralized Collagen-Glycosaminoglycan Scaffold 
In order to demonstrate control over the incorporation of the calcium phosphate mineral phase into the 
mineralized CGCaP scaffolds, two CGCaP scaffold variations were produce with a high and low mineral 
wt%. Compositional analysis was achieved using a hydroxyproline assay to measure the concentration of 
collagen present [139], a 1,9-dimethylmethylene blue (DMMB) assay to determine the amount of sulfated 
glycosaminoglycan content present [140], and mass subtraction to determine the remaining calcium 
phosphate mineral phase fraction [87, 88].  Briefly, following lyophilization the dry mass of all samples 
was measured (n = 4). Subsequent measurement of the collagen content within the scaffold was 
accomplished by the colorimetric detection and quantification, via a flourometer (Tecan, Männedorf, 
Switzerland) and comparison to a prepared hydroxyproline standard respectively, of hydroxyproline 
present within the scaffold digest, digested with 6 M HCl (Sigma-Aldrich, St. Louis, MO) at 110°C for 24 
h. Hydroxyproline is derived from the hydroxylation of the amino acid proline and occurs at regular 
intervals in the collagen amino acid sequence. As such, the total amount of collagen present in each 
scaffold was determined by a known scaling of the mass of hydroxyproline present within the 
corresponding digest. The amount of glycosaminoglycan (GAG) present within each scaffold was 
determined by the formation and isolation, via centrifugation, of the sulfated glycosaminoglycan (GAG)-
1,9-dimethylmethylene blue (DMMB) complex (GAG-DMMB) by addition of DMMB to the scaffold 
digest, digested via proteinase K (Sigma-Aldrich, St. Louis, MO) at 56°C overnight. After removing the 
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supernatant following centrifugation, the GAG-DMMB complex is re-suspended and colormetrically 
detected using a flourometer (Tecan, Männedorf, Switzerland) with the resulting quantification and 
comparison to a prepared chondroitin sulfate standard determining the total amount of GAG present 
within the scaffold digest and subsequently the scaffold. Because the mineral CGCaP scaffolds were 
fabricated through the homogenization and lyophilization of only collagen, glycosaminoglycans, and 
calcium phosphate additives, the remaining fraction of calcium phosphate was determined via mass 
subtraction: CaP wt% = (total mass – collagen mass – GAG mass)/(total mass) (Figure 2.1). 
 
Visualization of microstructural differences due to the high and low mineral wt% was identified using a 
JEOL JSM-6060LV Low Vacuum Scanning Electron Microscope (JEOL USA, Peabody, MA).  
Determination of the calcium phosphate mineral phase was accomplished via powdered x-ray diffraction. 
Briefly, samples were placed inside a Siemens/Bruker D-5000 diffractometer (Bruker AXS, Madison, 
WI) with a Cu Kα source and scanned from 2.5° 2θ to 50° 2θ at a rate of 1°/min and an increment of 0.1° 
2θ. The mineral phase was then determined from the analysis of the resulting spectra using MDI Jade 
analysis software (Materials Data Inc., Livermore, CA). 
 
The low mineralized CGCaP scaffold variation was found be composed of 37.8 ± 1.1 wt% collagen, 19.7 
± 0.4 wt% GAG, and 42.6 ± 1.2 wt% CaP mineral (Figure), and are henceforth referred to as the 40 wt% 
CGCaP scaffold. Similarly, the high mineralized CGCaP scaffold variation was found to be composed of 
18.6 ± 3.0 wt% collagen (Figure), 2.9 ± 0.2 wt% GAG, and 78.5 ± 3.0 wt% CaP mineral, and are 
henceforth referred to as the 80 wt% CGCaP scaffold. In both cases, the composition coincides with the 
previously described concurrent mapping method and procedures previously outlined [87, 88, 108, 135]. 
The variation in precursor suspension reflected by the resulting composition of the mineral scaffold 
highlights ability to produce scaffolds with a defined mineral content spanning the native physiological 
range of bone, 30-70 wt% [109-112]. This variation in the mineral content was visually observed via 
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scanning electron microscopy (Figure 2.2). Additionally, the calcium phosphate mineral phase in both 40 
wt% and 80 wt% CGCaP scaffolds was found to consist of only brushite (CaHPO4) in agreement with 
previous work (Figure 2.3), with variation in the peak intensity corresponding to the difference in the 
quantity of brushite[87, 88]. Additional studies evaluating the calcium phosphate mineral phase in 
collagen-glycosaminoglycan scaffolds have modification of the brushite phase to octacalcium phosphate 
to apatite via hydrolysis[87, 88]. 
 
2.9  Effect of Composition and Lyophilization Temperature on Pore Microstructure 
Changes in the pore structure due to the presence of the calcium phosphate mineral phase was 
investigated by the comparison of the average pore size at two different final freezing temperatures, -
10°C and -40°C. In order to determine the average pore size scaffolds were embedded, sectioned, and 
stained in accordance to previous work evaluating the pore structure within collagen-glycosaminoglycan 
scaffolds [91]. Briefly, 6 mm cores of the non-mineral CG and mineral 80 wt% CGCaP scaffolds biopsied 
(Integra Miltex, York, PA) from their monolithic (12 mm diameter, 10 mm height) counterparts were 
section in the transverse and longitudinal plane. Both transverse and longitudinal sections were then 
embedded in glycomethacrylate using a previously described method [91]. Samples were then further 
sectioned into 5 µm slices, stained with aniline blue (Thermo Fisher Scientific Inc, Waltham, Ma) for 
collagen, and imaged using an optical microscope (Leica Microsystems, Wetzlar, Germany). A linear 
intercept macro in Scion Image was then used to calculate both the average pore size and average aspect 
ratio within each scaffold. 
 
Comparing the non-mineral CG scaffold and mineral CGCaP scaffold exhibited no significant difference 
in average pore size in the range of 150-160 um. Between the non-mineral CG and mineral CGCaP 
scaffold, a non-significant average pore size in the range of 150-160 µm was observed (Figure 2.4, Table 
2.1). The lack of variation in average pore size between the non-mineral CG and mineral CGCaP 
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scaffolds is informative and suggests that during lyophilization the concentration of precursor solute, or 
cryoconcentration during ice crystal growth, did not saturate. Such saturation would force significantly 
larger struts resulting in a significantly smaller average pore size. This suggests that further alterations in 
density, through additional protein or calcium phosphate mineral, may be achieved without significant 
impact to the pore microstructure. Additionally, comparing the non-mineral CG scaffolds between -10°C 
and -40°C, and the mineral CGCaP scaffolds between -10°C and -40°C also yielded no significant effect 
of final freezing temperature on average pore size (Figure 2.4, Table 2.1). This is contrary to previous 
work evaluating the microstructure of collagen-glycosaminoglycan scaffolds [92, 141]. However, the lack 
of disparity in pore size due to freezing temperature is attributed to the low thermal conductivity of 
polysulfone, which in effect blunted the difference in freezing kinetics between the two temperatures. 
Previous studies have already established the significance of freezing kinetics due to cooling rate, 
freezing temperature, and mold conductivity on pore size [91-93, 141], while this work demonstrates the 
non-significant impact of calcium phosphate mineral on pore size. As such it is concluded that further 
manipulation of the freezing kinetics during the fabrication will highlight the flexibility of the 
lyophilization approach in controlling pore microstructure for mineral scaffold fabrication. 
 
2.10  Effect of Composition on Scaffold Mechanical Characteristics 
The effect of the calcium phosphate mineral on the mechanical properties of the collagen-
glycosaminoglycan scaffold design was evaluated by the comparison of the non-mineral CG scaffold to 
the mineral CGCaP scaffold during compression testing. Here scaffolds were compressed to 75% of their 
total height, 0.75 strain, using a MTS Insight Electromechanical load frame (MTS, Eden Prairie, MN) 
with a 250 N load cell. In all cases, scaffold height and diameter was recorded using calipers prior to 
testing. The resulting load vs displacement plots were converted to stress (≡ σ = load/area) vs strain (≡ ε = 
displacement/height) with the elastic modulus (E), collapse stress (σel), and collapse strain (εel) determined 
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from the linear elastic regime (ε: 0.02-0.12) and the intersection of the linear regression from the elastic 
regime and collapse plateau respectively (Figure 2.5). 
 
At both final freezing temperatures, -10°C and -40°C, a significant increase (p < 0.05) in elastic modulus 
of the mineral CGCaP scaffold compared to the non-mineral CG scaffolds was observed (Figure 2.6, 
Table 2.1). Only mineralized scaffold exhibited a significant (p < 0.05) change in modulus between the 
final freezing temperatures, -10°C and -40°C (Figure 2.6, Table 2.1). Here the incorporation of a mineral 
phase resulted in a two orders of magnitude increase in modulus, however, the relative difference between 
the mineral CGCaP scaffold and the physiological range of bone (90 MPa – 230 MPa) excludes the 
current biomaterial from load bearing orthopedic defects [49]. Additionally, both the stress-strain 
behavior of the non-mineral CG and mineral CGCaP scaffold exhibited the linear elastic, the collapse 
plateau, and densification regimes characteristic of low-density open-cell foams described by cellular 
solids theory described in the literature [142].  Because these scaffolds behave as low-density open-cell 
foams, cellular solids theory can also be used to model the modulus of the material [94, 142]. The 
collapse strain evaluated for all non-mineral CG and mineral CGCaP scaffolds was approximately 0.1, 
ranging from 0.07 to 0.14, consistent with previous observations for low-density open-cell foams [94, 
142]. The adaptation of the mineral CGCaP scaffold for physiologically relevant orthopedic defects will 
be addressed through the formation of a biomaterial composite discussed later. 
  
2.11  Effect of Composition on Scaffold Permeability 
Finally, as a measure of potential cellular and bimolecular penetration into the scaffold as well as the 
exchange of cellular waste for nutrients the permeability of the mineral CGCaP scaffold was investigated 
and compared to that of the non-mineral CG scaffold. In this study the permeability of the scaffold was 
investigated at various degrees of compression using the constant-head permeability apparatus (Figure 
2.7). Briefly, the constant-head permeability apparatus works by measuring the flow of fluid through a 
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sample under constant pressure, this method is commonly employed in geological studies of soil or rock 
permeability. In this work, a custom polycarbonate permeability rig was fabricated with variable spacers 
representing predefined degrees of compression, ε: 0, 0.10, 0.40, and 0.65 (Figure 2.7). The hydrated non-
mineral CG or mineral CGCaP scaffold was then placed between two T316 stainless steel mesh discs (0 
.0075” wire diameter, 0.009” gaps, TWP Inc, Berkley, CA) with an appropriately sized gasket or 
grommet preventing leakage. A variable pressure head, ∆P: 1.2”, 3.0”, or 7”dependent on scaffold variant 
and degree of compression, was applied. The resulting fluid volume (v, mL) was measured in small 
volumes with a graduated cylinder against time (t, sec), determining the fluid flow rate (Q = v/t). Using 
the fluid viscosity (µ), sample thickness (l) and cross-sectional area (A), the permeability (K) of the 
scaffolds was calculated using Darcy’s law [93]: 
 
𝐾𝐾 =  𝑄𝑄 ∙ 𝑙𝑙 ∙ 𝜇𝜇
∆𝑃𝑃 ∙ 𝐴𝐴
 
 
In order to identify changes in scaffold permeability due to the presence of a calcium phosphate mineral 
phase, compression, final freezing temperature, and cellular solids predictions of the permeability of each 
scaffold (ε: 0, 0.10, 0.40) was normalized to the identical scaffold unstrained (ε: 0) (Figure 2.8). Between 
the non-mineral CG and mineral CGCaP scaffold, the mineral scaffold possessed a significantly (p < 
0.05) higher permeability. This observation was counter to the results predicted by cellular solids theory, 
which predicted a decrease in permeability with increasing density [142]. Suggesting that the increased 
fluid flow in the mineral CGCaP scaffold may be due to the inherent mechanical competence and 
resistance to deformation preserving the highly porous scaffold architecture compared to the non-mineral 
CG scaffold. Additionally, a significant (p < 0.05) decrease in permeability was also observed with the 
decrease in final freezing temperature, -10°C to -40°C (Figure 2.8), suggesting sensitivity to changes in 
the average pore size, even the non-significant changes observed (Figure 2.4, Table 2.1). When strained, 
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the permeability significantly decreased in both the non-mineral CG and mineral CGCaP scaffold 
corresponding to pore collapse and an increased resistance to fluid flow due to densification, in agreement 
with cellular solids theory predictions (Figure 2.8) [142]. 
 
2.12  Conclusions  
This work has evaluated the incorporation of a mineral phase into the collagen-glycosaminoglycan 
scaffold and the resulting effects on the biophysical material properties encompassing microstructure, 
mechanics, and permeability (Table 2.1). A variable amount of brushite calcium phosphate mineral 
ranging from 40 wt% to 80 wt% was incorporated into the collagen-glycosaminoglycan scaffold via a 
triple co-precipitation and concurrent mapping methods. A non-significant difference in average pore 
size, circa 160 µm, was observed between the non-mineral CG and mineral CGCaP. Additionally, a non-
significant trend in average pore size was observed due to final freezing temperature, this contrast to 
previous literature is attributed to the mold thermal conductivity blunting the freezing kinetics during 
lyophilization. A significant increase in the modulus of the collagen-glycosaminoglycan scaffold was 
observed with the addition of the calcium phosphate mineral phase in accordance to an increase in density 
predicted by cellular solids theory. Finally, a significant increase in permeability was observed in the 
mineral CGCaP scaffold compared to the non-mineral CG scaffold, this observation was counter to an 
increase in density and predictions from cellular solids theory and was attributed to the mechanical 
competence and resistance to deformation.  
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2.13  Figures and Tables 
 
 
Figure 2.1 The composition of the low (40 wt%) and high (80 wt%) mineralized scaffolds.  
Composition was determined via assays evaluating collagen (hydroxyproline assay), glycosaminoglycans 
(1,9-dimethylmethylene blue), and calcium phosphate (CaP; mass subtraction: CaP wt% = [total mass – 
collagen mass – glycosaminoglycan mass] / total mass).  
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Figure 2.2 SEM visualization of low (40 wt%) and high (80wt%) mineralized scaffolds. 
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Figure 2.3 The diffraction patterns of scaffolds identifying mineral phase.  
Diffraction patterns associated with (A) the non-mineral CG scaffold, (B) the low (40 wt%) mineral 
CGCaP scaffold, and (C) the high (80 wt%) mineral CGCaP scaffold were determined from powder x-ray 
diffraction. Analysis of diffraction patterns identified brushite as the calcium phosphate mineral phase. 
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Figure 2.4 The average pore size determined of non-mineral and mineral scaffolds.  
Pore size was determined via aniline blue staining of histological sectioning of the non-mineral CG and 
mineral CGCaP scaffolds that were fabricated at -10°C and -40°C. 
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Figure 2.5 The stress-strain behavior of the mineral and non-mineral scaffolds. 
As determined in unconfined compression, the stress-strain behavior of the (blue) mineral CGCaP 
scaffold and the (red) non-mineral CG scaffold. These included the linear elastic (circa 0-0.1 strain), 
collapse plateau (circa 0.1-0.3 strain), and densification (0.3-0.75 strain) regimes characteristic of low 
density open cell foams were observed. 
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Figure 2.6 The elastic modulus of the non-mineralized collagen-glycosaminoglycan scaffold  
(red) non-mineral CG scaffold and the (blue) mineral CGCaP scaffolds fabricated via lyophilization with 
a final freezing temperature of -10°C and -40°C. A significant (*: p <0.05) increase in modulus was 
observed in the (blue) mineral CGCaP scaffold compared to the (red) non-mineral CG scaffold. 
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Figure 2.7 Constant head permeability apparatus used to measure permeability. 
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Figure 2.8 Normalized permeability of the mineral and non-mineral scaffolds. 
The normalized permeability of non-mineral CG and mineral CGCaP scaffolds fabricated at -10°C and -
40°C as measured by a constant head permeability test with cellular solids theory predictions. 
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Table 2.1 Values of scaffolds measuring microstructure, mechanics, and permeability. 
 Scaffold Non-mineral CG scaffold Mineral CGCaP scaffold 
 Final Freezing 
Temperature 
-10°C -40°C -10°C -40°C 
Microstructure Average pore 
size (µm) 
163 ± 14 166 ± 56 152 ± 24 156 ± 6 
Average pore 
aspect ratio 
0.92 ± 0.03 0.92 ± 0.03 0.94 ± 0.02 0.95 ± 0.01 
Mechanical 
properties 
Elastic modulus 
(E; kPa) 
8.8 ± 1.1 8.1 ± 0.4 159.0 ± 18.3 123.4 ± 11.3 
Collapse strain 
(ε*el) 
0.09 ± 0.06 0.14 ± 0.04 0.09 ± 0.05 0.07 ± 0.03 
Collapse stress 
(σ*el; kPa) 
0.7 ± 0.4 0.9 ± 0.3 11.2 ± 2.5 7.5 ± 2.0 
Permeability Permeability 
(m2) 
2.4 ± 0.5 x10-8  1.6 ± 0.1 x10-8  6.1 ± 1.4 x10-7 3.7 ± 0.4 x10-7  
Mean pore size and aspect ratios of single compartment CG and 80 wt% CGCaP, and 80 wt% multi-
compartment CG-CGCaP (CG, interface, CGCaP regions). Results reported as mean ± STD with 
histology sections taken from n = 4. Linear elastic moduli (E*) as well as collapse strain (ε*el) and stress 
(σ*el) of CG and 80 wt% CGCaP. Results reported as a function of final freezing temperature with mean ± 
STD, n = 6. Permeability of the single-compartment CG and 80 wt% CGCaP scaffolds (ε: 0% strain), 
mean ± STD, n = 3.   
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CHAPTER 3  
DETERMINATION OF MIENRALIZED COLLAGEN-
GLYCOSAMINOGLYCAN SCAFFOLD BIOACTIVITY: 
ASSESSMENT OF IN VITRO CELLULAR BEHAVIOR AND 
MATRIX DEPOSITION2 
3.1  Overview 
The incorporation of the calcium phosphate mineral phase to the collagen-glycosaminoglycan scaffold 
design improved the biochemical and biophysical properties of the resulting mineralized collagen-
glycosaminoglycan scaffold while maintaining the inherent flexibility in scaffold design. However, in 
order to assess the effect these biochemical and biophysical properties have on the osteogenic bioactivity 
of the collagen-glycosaminoglycan scaffold, in vitro culture of an appropriate cell population was 
performed both with and without biomolecule supplementation. During the physiological bone healing 
process, the recruitment and differentiation of mesenchymal stems cells has been implemented as the 
major cell population contributing to both bone resorption and deposition [6]. Here human mesenchymal 
stems cells were seeded onto both non-mineral and mineralized collagen-glycosaminoglycan scaffolds for 
in vitro culture. Bioactivity of the collagen-glycosaminoglycan scaffolds was then assessed via cellular 
behavior and matrix remodeling metrics. For cellular behavior the metabolic activity and the relative 
                                                     
2 This work is adapted from the study 122. Weisgerber, D.W., S.R. Caliari, and B.A. Harley, 
Mineralized collagen scaffolds induce hMSC osteogenesis and matrix remodeling. Biomaterials science, 
2015. 3(3): p. 533-42. 
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mRNA levels associated with osteogenic genes in cells was assessed, while matrix deposition was 
determined by mineral deposition and changes in scaffold mechanical properties during in vitro culture.  
 
3.2  Introduction 
As a result of either acute trauma or resection during surgery, orthopedic defects remain particularly 
challenging targets of regenerative medicine and tissue engineering due to their inherently complex 
geometry, typically large size, and load bearing function [128-131]. The current standard clinical practice 
in treating such large critically sized orthopedic defects is the use of either autologous or allogenic bone 
grafts, however, concerns over the necessary bone volume and shape in addition to the pain and morbidity 
of the secondary wound site for autologous grafts, as well as the risk of disease transmission and donor 
availability for allogenic grafts remain a concern for this standard of treatment [143-145]. With the 
growing population and with more than two million orthopedic surgeries requiring autologous or 
autogenic bone grafts, the need for regenerative medicine and tissue engineering biomaterial alternatives 
is growing [146, 147]. However, biomaterials treating the large, geometrically complex, load bearing 
orthopedic defects must correctly balance biophysical, biochemical, and biomolecular design criteria with 
the bioactivity of a clinically relevant cell population necessary to produce a physiologically relevant 
defect repair [148-151]. 
 
With the growing need of regenerative medicine and tissue engineering orthopedic biomaterial 
alternatives a variety of design approaches have been explored, including calcium phosphate mineral 
constructs [152, 153], synthetic or natural polymeric scaffolds [154, 155], or the polymeric calcium 
phosphate mineral composites [114, 147, 156, 157]. Due to the inherently variable nature of orthopedic 
defects dependent on cause, location, and age, orthopedic biomaterials offer a wider degree of tunability 
allowing for patient specific treatment of such defects. This inherent biomaterial tunability spans 
biophysical, biochemical, and biomolecular include: morphology, such as fiber alignment [97]; topology, 
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such as surface roughness [158]; substrate stiffness [28, 159]; inclusion of growth factors such as the bone 
morphogenetic protein family [160, 161]; full-biomolecule supplementation strategies such as osteogenic 
media [86, 152, 162]. In the case of media and soluble biomolecular supplementation, the relatively short 
half-life and diffusive losses of biomolecule supplementation requires repeated supra-physiological 
supplementation which represents both expensive and complicated clinical treatments with safety 
concerns arising over the quantity of biomolecules used [147, 163]. 
 
Both previous work and literature has evaluated the development of collagen-glycosaminoglycan 
scaffolds with a range of tunable biophysical and biochemical properties [48, 97, 101] with combinatorial 
biomolecular supplementation for proliferation and phenotype stability [164, 165]. Particularly, previous 
work has evaluated a mineralized collagen-glycosaminoglycan scaffold variant for the treatment of 
orthopedic defects and demonstrated control over the calcium phosphate mineral phase incorporation with 
defined biophysical and biochemical properties relevant for regenerative medicine and tissue engineering 
applications. 
 
This work continues the evaluation of the previously described mineralized collagen-glycosaminoglycan 
scaffold variant for the treatment of orthopedic defects [48], here the in vitro efficacy and osteogenic 
bioactivity is evaluated with both a physiologically and clinically relevant cell population. Here the in 
vitro osteogenic bioactivity of the non-mineral and mineralized collagen-glycosaminoglycan scaffolds 
with human mesenchymal stem cells was evaluated via metabolic activity, osteogenic gene expression, 
and matrix deposition metrics both with and without biomolecule supplementation. Specifically, in vitro 
culture was performed in the presence of standard unsupplemented complete mesenchymal stem cell 
growth media and in the presence of bone morphogenetic protein 2 (BMP2) supplemented complete 
mesenchymal stem cell growth media and osteogenic media. This approach allowed the separate 
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evaluation of osteogenic bioactivity contribution due to the calcium phosphate mineral content and the 
benefits of soluble biomolecule supplementation. 
 
3.3  Materials and Methods 
3.3.1 Scaffold Fabrication 
In this study both non-mineralized collagen-glycosaminoglycan (CG) and calcium phosphate mineralized 
collagen-glycosaminoglycan (CGCaP) scaffolds were fabricated from the lyophilization of precursor 
suspension as previously described. Briefly, the non-mineral CG precursor suspension was fabricated 
from the homogenization of 0.5% w/v collagen type-I from bovine Achilles tendon (Sigma-Aldrich, St. 
Louis, MO) and 0.044% w/v chondroitin sulfate from shark cartilage (Sigma-Aldrich, St. Louis, MO) in 
0.05M acetic acid. The previously established 40 wt% mineral CGCaP precursor suspension was prepared 
by homogenizing 1.9% w/v collagen type-I from bovine Achilles tendon (Sigma-Aldrich, St. Louis, MO), 
0.044% w/v chondroitin sulfate from shark cartilage (Sigma-Aldrich, St. Louis, MO), calcium hydroxide 
(Ca(OH)2), and calcium nitrate tetra-hydrate (Ca(NO3)2∙4H2O) in phosphoric acid. Both precursor 
suspensions were stored at 4°C and degassed prior to use. A custom polysulfone tray (76.2 mm by 76.2 
mm, 1.5 mm thick base) was used as a mold with each lyophilized sheet consisting of 23 mL of the 
appropriate precursor suspension. The lyophilization was performed using a Genesis freeze-dryer (VirTis, 
Gardener, NY). The precursor suspensions were cooled to a final freezing temperature of -10°C at a 
constant rate of 1°C/min and held at -10°C for 175 minutes, with sublimation then occurring at 0°C and 
200 mTorr. From the resulting 72.6 mm x 72.6 mm non-mineral CG and mineral CGCaP scaffold sheets, 
individual scaffolds (8 mm diameter, 4 mm thick) were obtained via biopsy punches. 
 
3.3.2 Scaffold Crosslinking 
Following lyophilization the non-mineral scaffold underwent a separate dehydrothermal (DHT) 
crosslinking step, while both non-mineral CG and mineral CGCaP scaffolds were treated with an EDC 
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crosslinking step. This post fabrication crosslinking steps have been previously demonstrated to influence 
collagen-glycosaminoglycan scaffold degradation and mechanical properties [94]. As before, the 
dehydrothermal (DHT) crosslinking was performed at 105°C and <25 Torr for 24 h in a vacuum oven 
(Welch, Niles, IL). Both non-mineral CG and mineral CGCaP scaffold variants were dehydrated in 100% 
ethanol and stepwise hydrated in PBS following lyophilization. Hydrated scaffolds were then chemically 
crosslinked using a 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC; Sigma-
Aldrich, St. Louis, MO) and N-hydroxysulfosuccinimide (NHS; Sigma-Aldrich, St. Louis, MO). EDC 
and NHS were added in 5:2 molar ratio to moles of carboxylic acid (COOH) side groups present (5:2:1; 
EDC:NHS:COOH) in the collagen component of the non-mineral CG and mineral CGCaP scaffold [94].  
 
3.3.3 Human Mesenchymal Stem Cell Culture 
Human mesenchymal stem cells (hMSCs) were obtained from Lonza (Basel, Switzerland) and cultured in 
standard T75 flasks at 37°C and 5% CO2 with complete mesenchymal stem cell growth media comprised 
of low glucose Dulbecco’s modified eagle medium (DMEM), 10% mesenchymal stem cell fetal bovine 
serum (MSC FBS; Invitrogen, Carlsbad, CA), 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA), and 
1% L-glutamine (Invitrogen, Carlsbad, CA). Following expansion, hMSCs were seeded onto the non-
mineral CG and mineral CGCaP (8 mm diameter, 4 mm thick) scaffolds using a previously established 
static seeding method [92]. Briefly, excess liquid from hydrated non-mineral CG and mineral CGCaP 
scaffolds was blotted away using Kimwipes (Invitrogen, Carlsbad, CA). Then 3.75 x104 cells were seeded 
onto one side of the scaffold. After an allowed 15 min for initial cell attachment, scaffolds were flipped 
over and an additional 3.75 x104 cells were seeding on the remaining side. The cell laden scaffold was 
then incubated for 2 h to allow for cell attachment before being submerged into the appropriate cell 
culture media. Non-mineral CG and mineral CGCaP scaffold in vitro hMSC cell culture then proceeded 
for 56 days at 37°C and 5% CO2. 
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3.3.4 Biomolecule Supplementation and Ca / P Ion Release 
In order to determine the effect of mineralization on the collagen-glycosaminoglycan scaffold, non-
mineral CG and mineral CGCaP scaffolds were seeded with hMSCs and cultured in vitro for 56 days with 
complete mesenchymal growth media. Additionally, enhancement of the mineral CGCaP scaffold 
osteogenic bioactivity via soluble supplementation was investigated by the in vitro culture of hMSCs on 
mineral CGCaP scaffolds in the presence of either 100 ng/mL bone morphogenetic protein 2 (BMP2; 
ProSpec, Israel) supplemented complete mesenchymal growth media, or osteogenic media consisting of 
50 µM ascorbic acid, 0.1 µM dexamethasone, and 10mM β-glycerophosphate added to complete 
mesenchymal growth media (Figure 3.1). 
 
Because the presence of calcium and phosphate within the surrounding medium has been documented to 
influence the behavior of mesenchymal stem cells during in vitro culture, the previously undocumented 
solubilization and subsequent release of calcium and phosphate from the acellular mineral CGCaP 
scaffold and acellular non-mineral CG scaffold was quantified using colorimetric assays over a period of 
56 days in complete mesenchymal growth media at 37°C and 5% CO2. Briefly, ion release profiles were 
determined via Calcium Colorimetric and Phosphate Colorimetric Assay Kits (BioVision, Milpitas, CA). 
Following the exchange of fresh complete mesenchymal growth media, the removed media was (n = 4 per 
time point) was stored at 4°C such that all colorimetric analysis was performed together. The colorimetric 
change in media aliquots was then determined via a Tecan M200 fluorometer (Tecan, Männedorf, 
Switzerland). The resulting intensity was compared to an appropriate calcium or phosphate standards to 
determine the total calcium and phosphate ion released.  
 
3.3.5 Measurement of Mesenchymal Stem Cell Metabolic Activity 
Cell metabolic activity, specifically the mitochondrial metabolic activity, was assessed using the non-
destructive AlamarBlue® assay. The AlamarBlue® assay measures the metabolic activity by the 
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introduction and uptake of resazurin with the subsequent reduction into the fluorescent byproduct 
resorufin. A comparison to a prepared cell standard allows the quantification of metabolic activity within 
the sample. Briefly, all scaffold variants (n = 6) were washed in phosphate buffered saline (PBS) to clear 
any dead or unattached cells from the scaffold before immersion into 1 mL of the AlamarBlue® assay 
solution. Scaffolds were cultured in the AlamarBlue® solution for 105 min at 37°C and 5% CO2 under 
mild agitation to promote fluid exchange. After incubation in the AlamarBlue® solution, scaffolds were 
removed and the fluorescent resorufin measured via a F200 spectrophotometer (Tecan) at 
540(52)/580(20) nm (excitation/emission). Comparison to an hMSC AlamarBlue® standard was 
performed with the resulting cellular metabolic activity normalized to that of the initial seeded cell 
metabolic activity. 
 
3.3.6 Evaluation of Gene Expression within Collagen-Glycosaminoglycan Scaffolds 
In order to better determine the effect of mineralization and supplementation on the collagen-
glycosaminoglycan scaffold on cell behavior, the gene expression was inferred by the relative expression 
of messenger ribonucleic acid and, by proxy, the respective gene via real time polymerase chain reaction. 
In summary, real time polymerase chain reaction, or more commonly qPCR, involves the isolation of 
messenger ribonucleic acid (mRNA) and its subsequent conversion into complementary deoxyribonucleic 
acid (cDNA) by the incorporation of reverse transcriptase. Both detection and amplification of the 
osteogenic genes of interest were accomplished with specific primers. This work utilized the qPCR 
technique to identify the expression of genes that are associated with: bone sialoprotein (BSP); 
osteopontin (OPN); run-related transcription factor 2 (RUNX2); collagen type I (COL1A1) for the 
production of type I collagen; glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the house keeping 
gene for normalizing results. Briefly, samples were harvested after 14, 28, and 56 days of in vitro culture 
using a 1% β-mercaptoethanol lysis solution RNA was isolated from the scaffolds and subsequently 
purified using an RNeasy Plant Mini Kit (Qiagen, Valencia, CA). The resultant mRNA was transcribed 
 52 
 
into cDNA via QuantiTect Reverse Transcription Kit (Qiagen, Valencia, CA) and a Bio-Rad S1000 
thermal cycler (BioRad, Hercules, CA). Finally, using a QuantiTect SYBR Green PCR Kit (Qiagen, 
Valencia, CA) and the primer sequences for BSP, OPN, RUNX2, COL1A1, and GAPDH, chosen from 
the literature and synthesized by Integrated DNA Technologies (Coraville, IA) (Table 3.1), the gene 
markers were quantified. Results were analyzed using the delta-delta Ct method via Sequence Detection 
Systems software v2.4 (Applied Biosystems, Carlsbad, CA). 
 
3.3.7 Determination of Mineral Deposition within Collagen-Glycosaminoglycan Scaffolds 
Mineral deposition was evaluated through the use of alizarin red histological staining and micro-
computed tomography (uCT). Histological deposition of calcium phosphate was performed after 14, 28, 
and 56 days in culture with day 0 as a control. Briefly, Scaffolds were fixed in 10% formalin (Polyscience 
Inc, Warrington, PA), processed and embedded in paraffin, before paraffin sectioning which resulted in 5 
µm thick transverse sections. Alizarin Red (Sigma-Aldrich, St. Louis, MO) histological staining was then 
preformed electrostatically staining the calcium phosphate mineral phase red. For non-mineral CG and 
mineral CGCaP scaffolds with and without supplementation, representative sections of each scaffold were 
taken with an optical microscope (Leica; Buffalo Grove, IL) with histograms of pixel intensity 
constructed via Matlab. In the addition to alizarin red histological staining, micro-computed tomography 
(uCT) was used to assess changes in mineral content of the scaffolds. Briefly, after 14, 28, and 56 days in 
vitro culture, specimens were fixed in 10% formalin (Polyscience Inc, Warrington, PA), washed in de-
ionized water, and lyophilized to remove any liquid from the scaffold. An Xradia MicroXCT-400 was 
then used to image the 3-dimensional mineral distribution within the scaffold at 25 kEv and 5 watts with 
793 projections and a voxel size of 20 µm. The outputted image z-stack was then analyzed via a custom 
Matlab program via a defined image processing sequence (Figure 3.6) with results reported as mean 
mineral content as a function of radial position for the entire scaffold. 
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3.3.8 Changes in Matrix Mechanical Properties within Collagen-Glycosaminoglycan Scaffolds 
Finally, the effect of mineralization and biomolecule supplementation on the mechanical properties of 
collagen-glycosaminoglycan scaffolds in vitro over a period of 56 days was evaluated via compression 
testing. Briefly, using a TA.XTplus Texture Analyzer (StableMicro Systems Ltd., Surrey, UK), the elastic 
modulus in hydrated unconfined compression of human mesenchymal stem cells (hMSCs)-seeded non-
mineral CG and mineral CGCaP scaffolds was evaluated after 14, 28, and 56 days of in vitro culture. In 
order to avoid the strain rate dependent effect of fluid flow within the highly porous collagen-
glycosaminoglycan scaffolds, both non-mineral CG and mineral CGCaP scaffolds were compressed at a 
strain rate of 0.00005 per sec to 0.5 total strain. The elastic modulus was identified from the linear elastic 
regime of the stress-strain curve as collagen-glycosaminoglycan scaffolds have previously been 
demonstrated to behave as low-density open cell foams [48, 94, 142]. In addition to the elastic modulus, 
an estimation of the relative densification (ρcellular,scaffold /ρacellular,scaffold) of the scaffold due to cellular 
remodeling was also determined using the established cellular solids theory relationship describing the 
elastic modulus: 
 
ρ𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠
ρ𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠  =  � 𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠 
𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠
𝐸𝐸𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠𝑠𝑠,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠  ∝  �ρ𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠ρ𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠𝑠𝑠,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠 �2 
𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠
𝐸𝐸𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠𝑠𝑠,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠  ∝  �ρ𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠ρ𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠𝑠𝑠,𝑠𝑠𝑐𝑐𝑐𝑐𝑠𝑠𝑠𝑠𝑠𝑠𝑐𝑐𝑠𝑠 �2 
 
Where ρcellular,scaffold and ρacellular,scaffold are the densities of the hMSC seeded and unseeded scaffolds 
respectively, while Ecellular,scaffold and Eacellular,scaffold are their respective elastic moduli. The associated 
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Esolid,scaffold and ρsolid,scaffold, modulus and density respectively, of the solid scaffold and scaling constants as 
described in cellular solids theory cancelled for the relative densification [94, 135, 142]. 
 
3.3.9 Statistical Analysis 
Statistical analysis was performed via two-way analysis of variance (ANOVA) tests after which a Tukey-
HSD post-hoc test was used. Independent factors included time, scaffold type (CG vs. CGCaP), and 
treatment (growth media, osteogenic media, BMP-2 supplemented growth media). Mechanical 
characterization and gene expression experiments used at least n = 3 scaffolds per group while metabolic 
activity and scaffold compositional analyses used n = 6 scaffolds per group. Significance was set at p < 
0.5. Error bars are reported as standard deviation unless otherwise noted. 
 
3.4  Results and Discussion 
The resulting ion release profile identified a significant increase in calcium and phosphate ion content 
within the cell culture media, as early as day 2 for phosphate and day 5 for calcium (Figure 3.2). After 14 
days in vitro culture, the release of calcium and phosphate reached an asymptote. Based upon the 
cumulative calcium and phosphate released, the total mineral solubilized corresponded to approximately 
80% of the calcium phosphate incorporated during fabrication. An additional evaluation investigating the 
effect of the mineral CGCaP scaffold chemical crosslinking indicated a burst release of calcium and 
phosphate during the extensive washing steps, but no change in mineral release rate (Figure 3.3).  
 
A significant increase in metabolic activity by day 56 was observed for the non-mineral CG and mineral 
CGCaP scaffolds in mesenchymal stem cell growth media, as well as for mineral CGCaP scaffolds 
supplemented with bone morphogenetic protein 2 (BMP2) and osteogenic media (Figure 3.4). This 
verified that both the non-mineral CG and mineral CGCaP scaffolds were capable of supporting 
metabolically activity cell growth regardless of treatment. While the mineral CGCaP scaffolds in 
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mesenchymal stem cell growth media exhibited a lower initial metabolic activity than those in the non-
mineral CG scaffolds, by day 28 the mineral CGCaP scaffolds expressed higher metabolic activity similar 
metabolic activity that was not significantly different (Figure 3.4). This initial difference in metabolic 
activity was attributed to the differences in permeability measured previously [48]. Additionally, the 
osteogenic supplementation in the mineral CGCaP scaffold was observed to have a negative effect on 
cellular metabolic activity compared to the unsupplemented and bone morphogenetic protein 2 
supplemented mesenchymal stem cell growth media. Here it is hypothesized that the comparatively 
stunted metabolic activity of the mineral CGCaP scaffold supplemented with osteogenic media is due to 
the early differentiation of the mesenchymal stem cells limiting their metabolic activity and proliferation. 
This observation is in agreement with previous literature highlighting the tradeoff between cell 
proliferation and cell phenotype [164, 166-168]. 
 
All genes across all scaffolds and treatments were found to increase, with a significant (p < 0.05) increase 
in BSP expression, after 56 days of in vitro culture (Figure 3.5). Mineral CGCaP scaffolds supplemented 
with bone morphogenetic protein 2 exhibited an earlier significant increase in BSP compared to other 
scaffolds suggesting earlier signs of osteogenic like behavior within the cell population (Figure 3.5). 
Additionally, a relatively higher expression of BSP and osteopontin was observed in mineral CGCaP 
scaffolds relative to non-mineral CG scaffolds (Figure 3.5). Besides the earlier expression of BSP in the 
mineral CGCaP scaffold supplemented with BMP2, mineralized CGCaP scaffolds exhibited little 
difference in gene expression profiles (Figure 3.5). This suggested that the mineral CGCaP scaffold itself, 
independent of supplementation, dictates osteogenic cell behavior. The higher expression of COL1A1 
may also suggest an increase inclination for collagen deposition within the non-mineral CG and 
unsupplemented mineral CGCaP scaffolds (Figure 3.5).  
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Alizarin red histological analysis identified no distinction between mineral CGCaP scaffold treatments, 
unsupplemented, BMP2 supplemented, and osteogenic supplemented, at all-time points during in vitro 
culture (Figure 3.7, Table 3.2). However, stark differences in mineral content was observed between non-
mineral CG and mineral CGCaP scaffolds, with no mineralization observed in the non-mineral CG 
scaffolds, throughout the course of the study (Figure 3.7, Table 3.2). The more quantitative analysis via 
micro-computed tomography (µCT) similarly revealed a significantly (p < 0.0005) higher degree of 
mineralization in all hMSC seeded mineral CGCaP scaffold treatment groups compared to the hMSC 
seeded non-mineral CG scaffolds (Figure 3.8, Figure 3.9, Table 3.2). This suggests that the calcium 
phosphate mineral content within the mineral CGCaP scaffold plays an important role in the osteogenic 
potential and subsequent mineral deposition within the collagen-glycosaminoglycan scaffold design. 
Additionally, within hMSC seeded mineral CGCaP scaffolds, a significant increase in mineral content 
with culture time was observed within the unsupplemented complete mesenchymal stem cell growth 
media (day 14 vs 28/56) and the bone morphogenetic protein 2 supplemented complete mesenchymal 
stem cell growth media (day 14 vs 28 vs 56), while the osteogenic supplemented mineral CGCaP scaffold 
experienced a significant change in mineral deposition (Figure 3.8, Figure 3.9). The distinct increase or 
lack of a decrease within the mineral CGCaP scaffolds is counter to the calcium and phosphate release 
profiles previously investigated. This suggests that the mineral CGCaP scaffold possesses the correct 
biophysical and biochemical properties to incite osteogenic activity from the mesenchymal stem cell 
population resulting in scaffold remodeling in the absence of additional physiological cues. Furthermore, 
the increase in mineral deposition was observed in the absence of supplementation, suggesting that 
mineral deposition was potentially hampered in the presence of osteogenic supplementation (Figure 3.8, 
Figure 3.9). In fact, the unsupplemented hMSC seeded mineral CGCaP scaffold exhibited the highest 
degree of mineralization within the first 28 days, while the BMP-2 supplemented mineral CGCaP 
scaffolds demonstrated a higher degree of mineral deposition at later time points (Figure 3.8, Figure 3.9). 
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Again, this identified the mineral CGCaP scaffold without supplementation as capable of the same degree 
of mineralization as the equivalent biomolecule supplemented mineral CGCaP scaffolds. 
 
An additional radial analysis of the µCT results provided novel information regarding the in vitro spatial 
deposition of new mineral content, and, by proxy, the cell distribution and ingrowth within the mineral 
CGCaP scaffolds (Figure 3.10). Within all the mineral CGCaP scaffold treatments, new mineral content 
was located within 1.5 mm of the edge of the 4 mm radial discs (Figure 3.10), while within non-mineral 
CG scaffolds, no radial variation in mineral content was observed. This is in agreement with the bulk 
average mineral content assessed previously (Figure 3.10, Figure 3.9 respectively). Under the assumption 
of uniform solubilization of the calcium phosphate mineral phase within the mineral CGCaP scaffold, the 
radial differences in mineralization assert a non-uniform matrix remodeling, further emphasizing the need 
for a biomaterial scaffold design capable of flexible microstructural properties to balance cell penetration 
and metabolic support via diffusive transport with other biophysical properties such as mechanical 
robustness. While this work has emphasized the innate osteogenic bioactivity of the mineral CGCaP 
scaffold in the absence of supplementation, this also provides the unique opportunity for the incorporation 
of biomolecule supplementation modulating the non-osteogenic aspects of orthopedic defect treatment, 
such as angiogenesis via vascular endothelial growth factor (VEGF) supplementation. Additionally, the 
modulation of osteogenic bioactivity through biomaterial properties, as in the case of the mineral CGCaP 
scaffolds, provides the foundation for the development of a spatially distinct biomaterial design capable 
of modulating multi-lineage cell specificity via biophysical and biochemical material properties. 
 
The investigation of human mesenchymal stem cells (hMSCs) in vitro remodeling in the presence of the 
non-mineral CG and mineral CGCaP scaffold was expanded upon via the changes in mechanical 
properties, providing insight into protein and mineral deposition. A significant (p < 0.05) difference in 
modulus between hMSC-seeded non-mineral scaffolds and all hMSC-seeded mineral CGCaP scaffold 
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treatments was observed after 14, 28, and 56 days in vitro culture, while the modulus of all hMSC-seeded 
mineral CGCaP scaffolds was observed to significantly (p < 0.05) increase with time (Figure 3.11, Table 
3.2). These observations, between non-mineral and mineral scaffolds with time, mirrors differences in the 
mineral deposition previously examined (Figure 3.9), which is hypothesized to contribute to the change in 
mechanical properties. Likewise, no changes in modulus was observed within the non-mineral CG 
scaffold, suggesting that cellular remodeling did not result in additional extracellular matrix deposition. 
Additionally, the moduli of control acellular non-mineral CG and mineral CGCaP scaffolds remained 
unchanged throughout the duration of the in vitro culture, demonstrating that crosslinked scaffold 
mechanical properties were not compromised over this time frame due to degradation (Figure 3.11). A 
significant (p < 0.05) increase in modulus was observed in the mineral CGCaP scaffold supplemented 
with osteogenic media compared to the unsupplemented mineral CGCaP equivalent (Figure 3.11). This 
constant increase in modulus in osteogenic media-supplemented mineral CGCaP scaffolds is again 
evidence of the phenotype vs proliferation trade-off observed in the metabolic activity.  
 
3.5  Influence of Mineralization and Suggested Cellular Cause 
In a collaborative effort headed by Justine C. Lee, M.D., Ph.D., Xiaoyan Ren, Ph.D., and Timothy A. 
Miller, M.D. FACS, at the University of California at Los Angeles (UCLA), additional work has outlined 
the underlying cellular mechanism involved in the mineral CGCaP scaffolds’ inherent osteogenic 
bioactivity. In this series of studies, non-mineral CG and mineral CGCaP scaffolds were cultured in vitro 
with human mesenchymal stem cells (hMSCs) in the presence of bone morphogenetic protein 2 and, later, 
osteogenic media to evaluate the effect of mineral content and subsequently crosslinking on the 
osteogenesis of hMSCs. The resulting biophysical and biochemical properties were determined via 
quantitative real time polymerase chain reaction (qPCR), western blot analysis of protein activation, 
histology and immunohistochemistry, and micro-computed tomography (µCT). Initial work via µCT, 
histology, and immunohistochemistry identified that mineral CGCaP scaffolds were able to promote 
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osteogenic gene expression and mineralization of hMSCs in the absence of BMP supplementation [169]. 
Additionally, western blot analysis of the canonical BMP receptor Smad1/5 was consistently 
phosphorylated in mineral CGCaP scaffolds both with and without BMP2 supplementation, while 
Smad1/5 phosphorylation in non-mineral CG scaffolds only occurred in the presence of BMP2 
supplementation at the periphery of the scaffold [169]. That, coupled with the inverse behavior of 
ERK1/2, was observed with an increased phosphorylation at day 14 in non-mineral CG scaffolds 
compared to mineral CGCaP scaffolds, while decreased ERK1/2 phosphorylation was observed at days 
14 and 24 in both non-mineral CG and mineral CGCaP scaffolds due to BMP2 stimulation [169]. This 
suggests that the mineral CGCaP scaffold influences the endogenous production of BMP2 which activates 
the canonical BMP signaling receptor pathway. An additional study also investigated the hMSC response 
in mineral CGCaP scaffolds during in vitro culture in osteogenic media due to chemical crosslinking via 
the previously described 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride and N-
hydroxysulfosuccinimide with carboxylic acid groups present on collagen [170]. Cell mediated scaffold 
contraction was observed to result in a significant (p < 0.05) degree of contraction compared to their 
crosslinked counter parts, while the presence of mineralization significantly (p < 0.05) decreased 
contraction to a lesser degree [170]. Interestingly, it was observed via qPCR and µCT that increased 
contraction in both non-mineral CG and mineral CGCaP scaffolds induced a higher degree of 
mineralization and osteogenic gene expression [170]. 
 
3.6  Conclusions 
Biomaterials for bone tissue engineering must be able to instruct cell behavior in the presence of the 
complex biophysical and biomolecular environments encountered in vivo. While osteogenic media or 
exogenous BMP-2 supplementation are often used as an essential element of many bone regeneration 
studies, diffusive loss and rapid degradation are primary concerns of efforts requiring exogenous 
supplementation. Using a series of collagen-glycosaminoglycan scaffolds, the incorporation of a transient 
 60 
 
CaP mineral content was sufficient to enhance hMSC osteogenic differentiation and matrix remodeling in 
the absence of lineages-specific media supplementation. While osteogenic media and BMP-2 
supplementation may enhance the speed or long-term intensity of the response, mineralized CG scaffolds 
were able to support extensive hMSC osteogenesis, matrix remodeling, and new mineral formation in the 
absence of lineage specific media.  
 61 
 
3.7  Figures and Tables 
 
 
Figure 3.1 The scaffolds and supplementary treatments groups evaluated in vitro culture. 
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Figure 3.2 Cumulative release of calcium and phosphate from the mineral scaffold. 
The cumulative calcium (A) and phosphate (B) ion release profiles for acellular non-mineral CG and 
mineral CGCaP blank controls under in vitro culture conditions for a period of 56 days. Significance (*: p 
< 0.05) between the mineral CGCaP blank and the non-mineral CG blank at the same time point was 
indicated 
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Figure 3.3 Comparison of calcium and phosphate release during crosslinking. 
Calcium and phosphate ion release from the mineral scaffolds with and without EDC crosslinking to 
determine the effect of crosslinking on ion release profiles. Significance (*: p < 0.05) between the mineral 
CGCaP blank and the non-mineral CG blank at the same time point was indicated 
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Figure 3.4 The metabolic activity of hMSCs cultured in vitro.  
The metabolic activity measured during the in vitro culture over a period of 56 days. Evaluating 
differences between (A) the non-mineral CG and mineral CGCaP scaffold cultured with complete 
mesenchymal stem cell growth media, and (B) the mineral CGCaP scaffold treated with complete stem 
cell growth media, complete stem cell growth media supplemented with BMP2, and osteogenic media. 
Significance (*: p < 0.05) between indicated groups and significance (^: p < 0.05) between all other 
groups at that time point were identified. 
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Figure 3.5 Osteogenic genes expressed within mineral and non-mineral scaffolds. 
Profiles were obtained via quantitative PCR from in vitro culture of human mesenchymal stem cells on 
non-mineral CG and mineral CGCaP scaffolds with and without supplementation. Significance (*: p < 
0.05) between indicated groups was identified. 
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Figure 3.6 Procedure of micro-computed tomographic analysis of mineral deposition. 
A step by step procedure indicating the procedure performed in Matlab to analyze the mineral deposition 
within scaffolds cultured in vitro as measured by micro-computed tomography (uCT). Procedure analysis 
was performed as: (1) selection of a start and end uCT z-stack slice; (2) selection of the entire scaffold 
and surrounding air; (3) subtraction of the background not selected in step 2; (4) a selection of only the 
scaffold region; (5) division of the scaffold into radial partitions; (6) analysis of the voxels contained 
within each radial partition; (7) repeat of this analysis throughout the z-stack, or the uCT volume.  
 67 
 
 
Figure 3.7 Histological staining for mineral content within the scaffolds cultured in vitro. 
Representative images from the histological alizarin red staining performed on non-mineral CG and 
mineral CGCaP scaffold cultured in vitro with human mesenchymal stem cells to identify any changes 
within the mineral content. 
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Figure 3.8 Mineral content via micro-computed tomography within scaffolds. 
The mineral deposition within the mineral CGCaP and non-mineral CG scaffolds by human mesenchymal 
stem cells in vitro as measured via micro-computed tomography. The non-mineral CG scaffolds were 
outlined to provide their position in the image. 
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Figure 3.9 The average mineral content within each scaffold as measured via uCT. 
Average mineral content was determined via micro-computed tomography. Significance (*: p < 0.05) 
between indicated groups, significance (^: p < 0.05) between all other groups at a time point, and 
significance (§: p < 0.05) compared to mineralized CGCaP scaffold variants were identified.  
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Figure 3.10 A radial analysis of mineral deposition as measured via uCT. 
Radial distribution of mineral content as detected via micro-computed tomography in non-mineral CG 
and mineral CGCaP with and without supplementation during in vitro culture of human mesenchymal 
stem cells. An increase in mineral deposition was associated with both the cellular infiltration and nutrient 
exchange within the scaffold. 
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Figure 3.11 Elastic modulus of the mineral and non-mineral scaffolds during in vitro culture. 
The elastic modulus from non-mineral CG and mineral CGCaP scaffolds with and without 
supplementation cultured in vitro with human mesenchymal stem cells via unconfined hydrated 
compression. Significant differences compared to the acellular control within scaffold groups at each time 
point (*: p < 0.05) and significant differences compared to all other scaffolds at that time point (**: P < 
0.05) were observed. 
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Table 3.1 Primer sequences used in qPCR for gene expression. 
Name Forward Reverse 
COL1A1 CAG CCG CTT CAC CTA CAG C TTT TGT ATT CAA TCA CTG TCT TGC C 
OPN GCG AGG AGT TGA ATG GTG CTT GTG GCT GTG GGT TTC 
RUNX2 GGTTAATCTCCGCAGGTCACT CACTGTGCTGAAGAGGCTGTT 
BSP TGCCTTGAGCCTGCTTCC GCAAAATTAAAGCAGTCTTCATTTTG 
GAPDH CCATGAGAAGTATGACAACAGCC CCTTCCACGATACCAAAGTTG 
Primer sequences used in qPCR for gene expression. Sources were as follows: COL1A1 [171]; OPN 
[171]; RUNX2 [172]; BSP [173]; GAPDH [174]. 
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Table 3.2 Elastic modulus and estimated denfication of scaffolds as measured during in 
vitro culture. 
 Day 14 Day 28 Day 56 
Sample Moduli, kPa Est. Dens. Moduli, kPa Est. Dens. Moduli, kPa Est. Dens. 
CG (acellular) 1.83 ± 0.48 --- 1.71 ± 0.43 1.00 1.24 ± 0.21 1.00 
CG Growth 1.57 ± 0.43 0.93 1.11 ± 0.30 0.81 1.51 ± 0.13 1.10 
CGCaP (acellular) 23.00 ± 0.59 --- 19.84 ± 1.42 1.00 23.44 ± 3.34 1.00 
CGCaP Growth 34.71 ± 4.40 1.23 37.73 ± 3.32 1.38 58.69 ± 3.71 1.58 
CGCaP BMP2 33.70 ± 2.73 1.21 45.02 ± 7.72 1.51 62.67 ± 7.27 1.63 
CGCaP Osteo 44.16 ± 5.59 1.39 48.00 ± 10.53 1.56 76.95 ± 9.19 1.81 
Elastic moduli of non-mineral CG and mineral CGCaP scaffolds both acellular and hMSC seeded without 
(Growth) and with (bone morphogenetic protein 2: BMP2; osteogenic media: Osteo) supplementation. 
Estimated densification due to cellular contraction and matrix densification was calculated based on 
cellular solids theory and the changes in modulus compared to acellular scaffold variants. 
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CHAPTER 4  
ADAPTATION OF THE MINERALIZED COLLAGEN-
GLYCOSAMINOGLYCAN SCAFFOLD FOR IN VIVO 
IMPLANTATION: FORMATION OF A MULTI-SCALE 
BIOMATERIAL COMPOSITE3 
4.1  Overview 
A particular challenge in biomaterial development for treating orthopedic injuries stems from the need to 
balance bioactive design criteria with the mechanical and geometric constraints governed by the 
physiological wound environment. Such trade-offs are of particular importance in large craniofacial bone 
defects which arise from both acute trauma and chronic conditions. Ongoing efforts in our laboratory 
have demonstrated a mineralized collagen biomaterial that can promote human MSC osteogenesis in the 
absence of osteogenic media but that possesses suboptimal mechanical properties in regards to use in 
loaded wound sites. Here we demonstrate a multi-scale composite consisting of a highly bioactive 
mineralized collage-glycosaminoglycan scaffold with micron-scale porosity and a polycaprolactone 
support frame (PCL) with millimeter-scale porosity. Fabrication of the composite was performed by 
impregnating the PCL support frame with the mineral scaffold precursor suspension prior to 
lyophilization. Here we evaluate the mechanical properties, permeability, and bioactivity of the resulting 
                                                     
3 This work is adapted from the study 123. Weisgerber, D.W., K. Erning, C. Flanagan, S. Hollister, 
B.A.C. Harley, Adaptation of the mineralized collagen-glycosaminoglycan scaffold for in vivo 
implantation: formation of a multi-scale biomaterial composite. In preparation, 2015. 
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composite. Results indicated that the PCL support frame dominates the bulk mechanical response of the 
composite resulting in a 6000-fold increase in modulus compared to the mineral scaffold alone. Similarly, 
the incorporation of the mineral scaffold matrix into the composite resulted in a higher specific surface 
area compared to the PCL support frame alone. The increase in specific surface area within in the 
collagen-PCL composite also promoted increased initial attachment of porcine adipose derived stem cells 
versus the PCL construct alone. 
 
 
4.2  Introduction 
Surgical intervention in large and geometrically complex craniofacial defects often necessitates either 
autologous or allogenic grafts to augment the natural wound healing process. Biomaterial approaches 
offer an alternative to the autologous implant with the potential to avoid donor site morbidity, alleviate 
concerns of allogenic supply and disease transmission, and allow real-time production of patient-specific 
implant geometries [175]. However, to promote physiological repair processes, such biomaterials must 
maintain their geometry and mechanical competence [176, 177] particularly in the case of load bearing 
orthopedic injuries [178, 179]. Many injuries, including craniofacial defects, necessitate biomaterials 
capable of fitting non-trivial geometries to conform to an injury site, but also demonstrate mechanical 
stability under loading during implantation and routine physiological activity [180]. In all cases, these 
biomaterials must remain bioactive supporting cellular infiltration, attachment, proliferation, and matrix 
synthesis. 
  
Recently a range of biodegradable biomaterials have been described that promote pro-osteogenic 
processes within both the in vitro and in vivo environments. Here, the combination of organic and 
naturally derived polymers, such as in the case calcium phosphate mineralized chitosan biomaterials [60, 
181-183], have become a commonplace choice due to their ability to mimic the native composition of 
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bone. While such biomaterials have demonstrated potential to promote osteogenic repair, concerns over 
ensuring geometric structure and mechanical competence under loading remain at the forefront. In that 
same spirit, previous and ongoing work within our group has evaluated the efficacy of a calcium 
phosphate mineralized collagen-glycosaminoglycan scaffold for the treatment of orthopedic injuries. 
Studies have highlighted the versatility in fabrication of these scaffolds with varied geometric, 
mechanical, and microstructural properties via freeze drying techniques [48, 97]. In vitro studies have 
likewise demonstrated the ability of the mineralized collagen-glycosaminoglycan scaffold to promote 
mesenchymal stem cell osteogenic differentiation in the absence of osteogenic media or additional 
biomolecule supplementation [122]. Interestingly, recent results suggest this mineralized collagen 
scaffold promotes MSC osteogenesis via activation of endogenous BMP pathways [169, 184]. However, 
while this effort has demonstrated that the mineralized collagen-glycosaminoglycan matrix can promote 
pro-osteogenic activities, it has also highlighted the need for identifying strategies to increase the 
mechanical competence of these implants to meet the needs of in vivo applications [48]. And while 
increasing the relative density of these scaffolds can increase strength, it does so at the cost of reduced 
nutrient transport and cell penetration within the scaffold [185].  
 
With a critical need in orthopedics for mechanically robust implants that can also be developed to fit 
patient and injury specific geometries, a variety of three-dimensional printing approaches have recently 
begun to garner significant attention. Early work by Wagoner Johnson et al., demonstrated the use of 3D-
printed hydroxyapatite ceramic scaffolds able to enhance bone ingrowth and healing in vivo [186]. 
Ongoing efforts by Hollister et al. have demonstrated the use of polycaprolactone (PCL) constructs as 
well as additional control over incorporation of bioactive agents to enhancing biomolecule absorption and 
release [187, 188], gene transfer [189], and resultant in vivo treatment of both cartilage and bone defects 
[190, 191]. The nature of the PCL construct allows rapid patient customization. After the 3D defect 
volume is computationally defined, a porous architecture can be designed by iterative addition of a well-
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defined unit cell structure to fill the desired shape [192, 193]. Applying principles of mechanics, the 
deformation and failure modes of the resultant structure can be calculated and refined in order to meet 
functional requirements. However, the fabrication process and biomechanical stability considerations 
often limit the porosity of these materials to pores/channels larger than 1mm (3.5mm dia. channels in 
current PCL constructs for a mandibular repair), resulting in low specific surface areas (surface 
area/volume) for cell attachment as well as pore sizes well above the 100 – 500 µm range largely believed 
to be optimal for bone tissue engineering [194, 195]. So while 3D printed biomaterials offer mechanically 
robust, customizable implants, limits in printed feature size and low specific surface area represent critical 
dilemmas that must be addressed [196]. 
 
This manuscript describes development of a multi-scale biomaterial composite for the treatment of 
critically sized defects in bone that integrates mineralized collagen scaffolds with high osteogenic 
potential but suboptimal mechanical properties into 3D-printed PCL constructs with high strength. Multi-
scale composites offer unique potential to satisfy multiple, disparate design criteria. Many mechanically 
efficient structures in nature (e.g., plant stems, porcupine quills, bones) employ multi-scale designs to 
satisfy mechanical and biological constraints [197]multi-scale , suggesting such designs offer unique 
advantages for biomaterial design. Here we hypothesize that the combination of a bioactive collagen 
scaffold with micro-scale porosity with a strong PCL composite with mm-scale porosity will generate a 
composite with enhanced specific surface area and mechanical properties. We evaluate the average pore 
size, elastic modulus, permeability, and initial attachment of porcine adipose derived stem cells in multi-
scale mineralized polycaprolactone-collagen-glycosaminoglycan (PCL-CGCaP) composite, comparing 
results to the individual polycaprolactone construct and the mineralized collagen-glycosaminoglycan 
scaffold alone. 
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4.3  Materials and Methods 
4.3.1 Fabrication of Mineralized Collagen-Glycosaminoglycan Scaffold Precursor Suspension 
CGCaP scaffolds were fabricated by lyophilization of a CGCaP precursor suspension as previously 
described [48, 88]. Briefly, mineralized CGCaP precursor suspension was prepared by homogenizing (1.9 
w/v %) bovine type I collagen (Collagen Matrix, Oakland, NJ) and (0.84 w/v %) chondroitin-6-sulfate 
(Sigma-Aldrich, St. Louis, MO) with calcium salts (Ca(OH)2, Ca(NO3)2∙4H2O, Sigma-Aldrich, St. Louis, 
MO) in phosphoric acid (Sigma-Aldrich, St. Louis, MO). This CGCaP precursor suspension was stored at 
4°C and degassed prior to use. A Genesis freeze-dryer (VisTis, Gardener, NY) was used to lyophilize the 
precursor suspension in a custom 6 well (11.9 mm diameter, 10 mm height) polysulfone mold. Briefly, 
the lyophilization consisted of cooling from 20°C to -10°C at a constant rate of 1°C/min with a 2 h hold at 
-10°C prior to sublimation at 0°C and 200 mTorr. 
 
4.3.2 Fabrication of Polycaprolactone Support Construct 
PCL frames were fabricated by selective laser sintering (SLS) of a powder precursor consisting of 
polycaprolactone and 4 wt% hydroxyapatite. The PCL support frames were 10 mm in height and 11 mm 
in diameter, the architecture of the frame was defined using a 67% porous 5mm unit cell with 3.5 mm 
cylindrical pores through each axis (Figure 4.1). Specimen geometry was specified using a custom 
Interactive Data Language program (IDL, Research Systems, Inc.) with design criteria being stored as a 
.STL file for fabrication.  
 
4.3.3 Fabrication of Mineralized Collagen-Glycosaminoglycan Scaffold and Mineralized 
Collagen-Glycosaminoglycan-Polycaprolactone Composite 
PCL-CGCaP composites were fabricated by first soaking the PCL frames in the CGCaP precursor 
suspension for 15 min. Excess CGCaP precursor suspension was removed from the PCL frames via 
blotting with Kimwipes (Kimberly-Clark, Roswell, GA). Following the degassing of both the wetted PCL 
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frames and additional CGCaP precursor suspension the two were combined by placing the PCL frame 
into the previously described custom 6 well polysulfone mold and injecting 1 ml CGCaP precursor 
suspension into the frame. Composites were fabricated using an identical process conditions as described 
for creating CGCaP scaffold.  
 
4.3.4 Sterilization and Crosslinking of Specimens for In Vitro Culture  
All constructs used in the in vitro cell cultures underwent an ethanol sterilization with mineral scaffolds 
and composites undergoing additional cross-linking steps [94, 198]. Briefly, all constructs sterilized by a 
24 h soaked in ethanol overnight before being hydrated in sterile PBS for 24 h. Scaffolds and composites 
were then soaked in a PBS solution of 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride 
(EDAC, Sigma-Aldrich, St. Louis, MO) and N-hydroxysulfosuccinimide (NHS, Sigma-Aldrich, St. 
Louis, MO) at a molar ratio of 5:2:1 EADC:NHS:COOH where COOH represents the amount of 
carboxylic acid present in the collagen [94, 198]. 
 
4.3.5 Pore Size Analysis of Specimens. 
The visualization of the topology and interface between the PCL support and CGCaP scaffold within the 
composite was performed using SEM analysis with a JEOL JSM-6060LV Low Vacuum Scanning 
Electron Microscope (JEOL USA, Peabody, MA). To examine whether the addition of the PCL had any 
effect on the pore architecture within the composite, pore size analysis of samples was performed via the 
staining of collagen using aniline blue of samples embedded in a glycomethacrylate (Polysciences Inc., 
Warrington, PA) [48, 92]. Briefly, whole samples were divided into quarters and soaked in ethanol 
overnight prior to being stored in glycomethacrylate monomer and catalyst benzoyl peroxide 
(Polysciences Inc., Warrington, PA) solution for 24 h. Samples were then embedded in glycomethacrylate 
in both longitudinal and transverse orientations and sectioned into 5 µm slices. Slices were mounted, 
stained with aniline blue (Thermo Fisher Scientific Inc., Waltham, MA), and imaged with an optical 
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microscope (Leica Microsystems, Wetzlar, Germany). Subsequent image analysis was performed using a 
linear intercept method using a custom Matlab program to determine average pore size [91, 199]. 
 
4.3.6 Mechanical Behavior of Specimens. 
The stress-strain behavior of the PCL frame, CGCaP scaffold, and PCL-CGCaP composite was measured 
via compressive loading in a TA.XTplus Texture Analyzer (StableMicro Systems Ltd., Surrey, UK) using 
a 5 kg load cell. Samples were loaded to 4 kg or 50% strain at a rate of 0.01 mm/min. The elastic moduli 
of each sample (11 mm diameter, 10 mm height) was determined from the linear elastic region of each 
stress-strain plot. 
 
4.3.7 Permeability of Specimens. 
Permeability was measured as previously described [48, 185, 196]. Briefly, axial permeability was 
assessed with flow through using a custom polycarbonate rig and a constant pressure head (ΔP) of 26.7 
cm of de-ionized water. The resulting flow rate (Q) of de-ionized water with viscosity (µ) through a 
defined cross-sectional area (A) and thickness (l) of each sample (empty chamber, PCL frame, CGCaP 
scaffold, and PCL-CGCaP composite, n = 3) was measured using a graduated cylinder (10 ± 0.1 mL). 
Sample permeability (K) was defined via Darcy’s law [185]: 
𝐾𝐾 =  𝑄𝑄 ∙ 𝑙𝑙 ∙ 𝜇𝜇
∆𝑃𝑃 ∙ 𝐴𝐴
 
 
4.3.8 Porcine Adipose Derived Stem Cell (pASC) Culture and Seeding. 
To examine the effect of the CGCaP mineral scaffold on composite bioactivity porcine adipose derived 
stem cells (gift of Dr. M. Wheeler, Department of Animal Science, UIUC, Urbana, IL) were seeded onto 
the PCL support and the composite. Porcine adipose derived stem cells were expanded at 37°C and 5% 
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CO2 in complete mesenchymal stem cell growth media (low glucose DMEM, 10% MSC FBS and 1% 
antibiotic-antimycotic). Passage 8 pASCs were seeded onto PCL frames and PCL-CGCaP composites 
using one of two different seeding methods. Briefly, a previously described static seeding method was 
used to seed a total of 1.0 x106 cells onto each sample [97]. Alternatively, samples were soaked in a 
suspension of 1.0 x106 cells in complete mesenchymal stem cell growth media for a period of 2 h. 
Subsequently, all pASC seeded samples were cultured at 37°C and 5% CO2 in complete mesenchymal 
stem cell growth media for 24 h. 
 
4.3.9 Measurement of Porcine ASC Metabolic Activity. 
The metabolic activity of pASC seeded specimens was quantified via an alamarBlue® assay [200]. 
Briefly, after 24 h of culture, cell-seeded constructs were incubated in an alamarBlue® solution 
(Invitrogen) at 37ºC under gentle shaking. The fluorescence of the reduced resazurin byproduct, resorufin, 
via the metabolically active pASCs was compared to a prepared standard. Using a F200 
spectrophotometer (Tecan) the fluorescence was measured at 540(52)/580(20) nm (excitation/ emission). 
The resulting metabolic activity of each sample (n =6) was normalized to the metabolic activity of a 
control constructed from the metabolic activity of the number of cells seeded (1.0 x106 cells). 
 
4.3.10 Statistics Analysis 
Statistical analysis was performed via analysis of variance (ANOVA) tests after which a Tukey-HSD post-
hoc test was used. Independent factors included the seeding method (static seeding vs cell soak) and scaffold 
type (PCL frame vs PCL-CGCaP composite). Mechanical and metabolic studies were carried out with n = 
6 samples per group, while permeability was carried out with n = 3 samples per group. Significance was 
set at p < 0.05. Error bars are reported as standard deviation unless otherwise stated. 
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4.4  Results and Discussion 
This study has identified a new way to balance the design criteria using a multi-scale composite approach 
to the development of biomaterials with the development of this PCL-CGCaP composite biomaterial for 
craniofacial defects. Here we hypothesize that by combining the PCL frame and mineralized CGCaP 
scaffold into the PCL-CGCaP composite the most favorable properties, increased elastic modulus and 
increased surface area, will be maintained for future in vivo studies. The impact of incorporating the 
mineralized CGCaP scaffold into the PCL frame, creating the PCL-CGCaP composite, was determined by 
measurements of the pore size, mechanics, microstructure, and cell attachment.  
 
In support of our hypothesis, we identified that the incorporation of the mineral CGCaP scaffold into the 
PCL frame significantly increased the bulk modulus of the material compared to the mineral CGCaP 
scaffold alone (Figure 4.2). This drastic 6000-fold increase in modulus to 6.8 ± 0.4 MPa approaches the 
range necessary to mimic in vivo cortical bone (90 to 230 MPa) and cancellous bone (2 to 45 MPa) [201]. 
This change is likely due to the incorporation of the PCL frame acting as the load bearing component. 
Notably, the increase in mechanical properties in the collagen-PCL composite was achieved without any 
deleterious changes to the average pore size of the collagen scaffold itself (Figure 4.3). Here, significant 
decreases in pore size or increased in scaffold density would have significantly impacted specific surface 
area and nutrient biotransport, which would compromise the bioactivity of the composite [185, 202]. It is 
further anticipated that this composite architecture will protect the CGCaP matrix within the PCL-CGCaP 
composite from loads exceeding its yield point, allowing the CGCaP matrix to be tailored specifically to 
meet requirements regarding cell bioactivity. Previous work has already demonstrated the bioactivity of 
this matrix and its effect on endogenous BMP2 production [169], integrin activation [203], 
mechanotransduction [204], and gene expression [122]. So removing the requirement for meeting 
mechanical constraints offers the potential to further optimize the scaffold solely in the context of driving 
enhanced MSC osteogenic activity. This finding also suggests a more generic approach to overcome 
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trade-offs between mechanical robustness and qualities associated with bioactivity via composite design 
principles [201, 205, 206].  
 
We then examined the effect of the specific surface area of the constructs on construct permeability. In 
the case of the CGCaP scaffold and PCL-CGCaP composite, a high degree of specific surface area was 
reflected in the significantly lower permeability compared to the PCL support alone (Figure 4.4). The 
relatively lower specific surface area and resultant increased permeability in the 3D printed PCL construct 
has been previously attributed to limitations in feature size (mm-scale, rather than micron-scale, pores) 
[196]. The significance of specific surface area as a biomaterial design parameter has similarly been 
addressed [92, 185, 202]. If too low, the specific surface area can severely limit attachment and alter fluid 
flow within a construct [207], while if too high results in poor infiltration into the construct. Earlier 
efforts regarding development of collagen-glycosaminoglycan scaffolds have examined the influence in 
changes in scaffold specific surface area on a range of cellular responses [185]. Importantly these results 
again suggest it is possible to focus design of the collagen scaffold compartment on structural and 
bioactivity, rather than mechanical, concerns. 
 
The influence of specific surface area on cell response was then demonstrated via comparison of early 
metabolic activity metrics for porcine ASCs seeded within the PCL support versus the PCL-CGCaP 
composite. Here the metabolic activity of pASCs within the PCL support alone was significantly (p < 
0.05) lower than that within the PCL-CGCaP composite at 24 hours regardless of seeding method tested 
(Figure 4.5). This observed difference in metabolic activity is likely a function of an increase in initial cell 
infiltration and attachment as a result of the enhanced specific surface area of the composite. Here the 24 
hour timepoint was used both to be consistent with previous work that evaluated the effect of scaffold 
specific surface area on cell attachment [92], but also because 24 hours offers only a limited period for 
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any potential proliferation which could affect the results. Interestingly, the static seeding method led to a 
significant increase in cell attachment compared to the cell soak method in the presence of the increased 
specific surface area of the PCL-CGCaP composite, suggesting a preferred cell seeding method for future 
in vitro and in vivo experiments.  
 
4.5  Conclusions 
This work described the development of a multi-scale composite approach for engineering biomaterials 
for critical-size bone defects. This approach was intended to circumvent the typical design trade-offs 
found in biomaterials where there is often a tension between optimizing the bioactivity versus mechanical 
strength of an implant. We report a strategy to create a PCL-CGCaP composite that combines a CGCaP 
scaffold able to promote MSC osteogenesis in the absence of traditional osteogenic supplementation with 
a mechanically-robust, patient-customizable PCL support frame generated via 3D-printing. The PCL-
CGCaP composite demonstrated a bulk modulus significantly higher than the CGCaP scaffold alone but 
consistent with the PCL support alone. Similarly, the permeability of the PCL-CGCaP composite was 
dictated by the CGCaP scaffold compartment. Evaluation of porcine ASC seeded constructs revealed that 
the increased specific surface area of the composite led to significantly higher overall metabolic activity 
after 24h consistent with higher ASC attachment rates. In conclusion, the PCL-CGCaP composite was 
found to be mechanically robust compared to the CGCaP scaffold while maintaining the inherent 
bioactivity of the CGCaP scaffold and a degree of customizability inherent in its multi-scale composite 
design.  
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4.6  Figures and Tables 
 
 
 
Figure 4.1 Schematic of the polycaprolactone (PCL) support construct and the unit cell. 
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Figure 4.2 Elastic modulus of the scaffold support, and resulting composite. 
Compression data comparing the mineralized CGCaP scaffold, PCL support construct, and PCL-CGCaP 
composite as measured in both dry and hydrated unconfined compression testing. The elastic moduli was 
determined from the linear elastic regime of the resulting stress-strain behavior measured. 
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Figure 4.3 Average pore size of the mineral scaffold and the scaffold matrix within the 
composite. 
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Figure 4.4 Permeability of the support, scaffold, and composite.  
The permeability of the empty chamber, PCL support construct, mineral CGCaP scaffold, and PCL-
CGCaP composite as measured by a constant head permeability rig. Significance (*: p < 0.05) compared 
to the PCL support construct was indicated. A significant difference between the empty chamber and the 
PCl support indicates that the PCL support permeability was not limited by the testing apparatus. 
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Figure 4.5  The metabolic activity of pACs cultured on the support and the composite. 
Here the metabolic activity as measured via AlamarBlue of porcine adipose derived stem cells (pASCs) 
cultured on the PCL-support and the CGCaP-PCL composite was measured. Two different seeding 
methodologies, a cell suspension soak and a static cell seeding, were used when seeding the 
polycaprolactone support construct and the mineral polycaprolactone-collagen-glycosaminoglycan 
composite. Significance (*: p < 0.05) between indicated groups was identified. 
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CHAPTER 5  
IN VIVO IMPLANTATION OF THE MINERAL 
POLYCAPROLACTONE-COLLAGEN-
GLYCOSAMINOGLYCAN COMPOSITE INTO A 
SUBCRITICAL PORCINE MANDIBULAR RAMUS DEFECT: 
ASSESSMENT OF IN VIVO EFFICACY4 
5.1  Overview 
Initial chapters in this thesis examined the development of the mineralized collagen-glycosaminoglycan 
scaffold determining the inherent biophysical and biochemical properties, the flexibility in design and 
fabrication, as well as their effect on the cellular behavior in vitro. Further work then evaluated the 
adaptation of this mineralized collagen-glycosaminoglycan design for in vivo implantation by the 
formation of a mineral polycaprolactone-collagen-glycosaminoglycan composite increasing the inherent 
mechanical properties. Here we examine the in vivo efficacy of the prepared mineral polycaprolactone-
collagen-glycosaminoglycan composite as tested in a porcine animal model. Here the mineralized 
collagen-glycosaminoglycan scaffolds, polycaprolactone support structures, and finally, mineral 
polycaprolactone-collagen-glycosaminoglycan composites were implanted into a subcritical mandibular 
                                                     
4 This work is adapted from the study 124. Weisgerber, D.W., R.A. Hortensius, Milner D., Rubessa 
M., Lopez-Lake H., M. Wheeler, B.A.C. Harley, In vivo implantation of the mineral polycaprolactone-
collagen-glycosaminoglycan composite into a subcritical porcine mandibular ramus defect: assessment 
of in vivo efficacy. Ibid. In preparation. 
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ramus defect with subsequent wound healing being evaluated 6 weeks post-surgery. Metrics used to 
evaluate the in vivo efficacy of these constructs included mineral deposition via micro-computed 
tomography, bone mineral density via dual energy x-ray absorptiometry, and a histological analysis of the 
defect location. 
 
5.2  Introduction 
Treatment of craniofacial orthopedic defects, resultant from either acute trauma or surgical resection, 
remains a difficult procedure due to their often large size, complex geometry, and load bearing function. 
These difficulties arise from the limitations and concerns of the current standard for surgical treatment, 
namely the autologous and allogenic bone graft. The autologous bone graft, harvested from the patient, is 
limited by the quantity of bone able to be harvested without compromising donor bone function and the 
morbidity and pain associated with the donor site [175]. Similarly, the allogenic bone graft offers an 
alternative with limited availability with concerns over disease transmission [175]. The current focus of 
regenerative medicine and tissue engineering studies has been the development of degradable biomaterial 
alternatives capable of invoking and enhancing the native physiological repair processes for the treatment 
of orthopedic [178, 179], cardiovascular [208, 209], and nerve defects [184, 210]. However, the 
significance of biophysical and biochemical properties has been established not only for inducing a 
physiological repair processes, but also for maintaining mechanical competence in complex geometries 
during implantation and subsequent in vivo repair in orthopedic defects [177, 180].  
 
To address the need for maintaining mechanical competence and complex geometries a variety of 
solutions have been proposed, most involving the formation of a composite biomaterial with individual 
components addressing either mechanical competence or bioactivity. Examples of such biomaterials 
include silk hydrogel mechanically reinforced with silk microfibers for cartilage repair [211], and 
chitosan/β-1,3-glucan/calcium phosphate ceramic for orthopedic defects [60]. Orthopedic biomaterial 
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composites often simulate the native bone extracellular matrix and consist of a calcium phosphate 
ceramic, such as beta-tricalcium phosphate (Ca3(PO4)2; β-TCP) or calcium hydroxyapatite 
(Ca10(PO4)6(OH)2; HA) influencing mechanical properties and bioactivity [35, 39, 212], with polymeric 
components, ranging from synthetic polycaprolactone to natural chitosan or silk fibroin [40, 59-61, 64, 
187]. 
 
Effects described in this thesis has evaluated the in vitro efficacy of one such biomaterial composite for 
the treatment of orthopedic defects that consists of a macro-scale polycaprolactone support construct 
impregnated with a micro-scale mineralized collagen-glycosaminoglycan matrix [123]. Regenerative 
medicine and tissue engineering literature has identified the successful in vitro and in vivo applications of 
collagen-glycosaminoglycan scaffolds influencing cell bioactivity towards osteochondral [67-69, 89], 
orthopedic [48, 73-75], cardiatric [100], tendinous [97, 101], muscular [70-72], neurological [65, 66, 83-
85], and skin [78, 79] repair, while polycaprolactone has been implemented in numerous orthopedic 
biomaterial applications [42, 64, 187, 189, 213]. 
 
Chapter 5 of this thesis continues the evaluation of the previously developed multi-scale 
polycaprolactone-collagen-glycosaminoglycan composite with the in vivo implantation in a porcine 
animal model. Here a 10 mm cylindrical sub-critical mandibular ramus defect in male Yorkshire pigs was 
created and treated with the polycaprolactone support construct, the mineralized collagen-
glycosaminoglycan scaffold, and the mineral polycaprolactone-collagen-glycosaminoglycan composite. 
Efficacy was evaluated after 6 weeks in vivo culture, and was based upon new bone volume as well as 
new bone density as measured by micro-computed tomography and dual x-ray absorptiometry techniques. 
Additionally, histological analysis also evaluated the efficacy of the biomaterial implants with assessment 
of new bone mineralization and integration. It is hypothesized that the mineralized collagen-
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glycosaminoglycan scaffold and the polycaprolactone-collagen-glycosaminoglycan composite will 
enhance new bone formation. 
 
5.3  Fabrication of the Collagen-GAG Scaffold, Polycaprolactone Support, and 
Composite 
Fabrication of the polycaprolactone-collagen-glycosaminoglycan (PCL-CGCaP) composite, the 
mineralized collagen-glycosaminoglycan (CGCaP) scaffold, and the polycaprolactone (PCL) support 
construct were fabricated as previously described. Briefly, the mineral CGCaP scaffold and matrix 
precursor suspension was prepared from the 40 wt% mineral CGCaP precursor suspension, fabricated by 
the homogenization of 1.9% w/v type-I collagen (Collagen Matrix, Oakland, NJ) and 0.84% w/v 
chondroitin-6-sulfate (Sigma-Aldrich, St. Louis, MO) with calcium hydroxide (Ca(OH)2; Sigma-Aldrich, 
St. Louis, MO) and calcium nitrate tetra-hydrate (Ca(NO3)2∙4H2O, Sigma-Aldrich, St. Louis, MO) in 
phosphoric acid (Sigma-Aldrich, St. Louis, MO). Similarly, the PCL support construct was fabricated via 
the selected laser sintering of 4 wt% hydroxyapatite with construct geometry dictated via an Interactive 
Data Language program (IDL, Research Systems, Inc.) .STL file, with the same 11 mm diameter, 10 mm 
height with 3.5 mm cylindrical pores being employed (Figure 4.1). Likewise, the PCL-CGCaP composite 
was also fabricated by the impregnation of 1 mL of the mineral CGCaP precursor suspension into the 
PCL support construct following the initial soak of the PCL support construct in the mineral CGCaP 
precursor suspension. Lyophilization of the mineral CGCaP scaffold and the PCL-CGCaP composite was 
performed in a 6 well (12 mm diameter, 10 mm height) custom polysulfone array mold with a Genesis 
freeze-dryer (VisTis, Gardener, NY) at a final freezing temperature of -10°C, a cooling rate of 1°C/min, a 
175 min anneal at -10°C, followed by sublimation at 0°C and 200 mTorr. 
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5.4  Sterilization and Crosslinking of the Scaffold and Composite for In Vivo 
Implantation 
Sterilization of all specimens was then performed in 100% ethanol for 24 h, 5 days prior to surgery. 
Subsequent hydration was accomplished with the step wise addition of sterile phosphate buffered saline 
over a period of 3 days. Mineral CGCaP scaffolds and PCL-CGCaP composites were then chemically 
crosslinked via the addition of 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDAC, 
Sigma-Aldrich, St. Louis, MO) and N-hydroxysulfosuccinimide (NHS, Sigma-Aldrich, St. Louis, MO) in 
a molar ratio of 5:2:1 (EDAC:NHS:COOH) relative to moles of carboxylic acid (COOH) groups present 
in collagen. Samples were then stored in sterile phosphate buffered saline at 37°C and 5% CO2 until in 
vivo implantation. 
 
5.5  Porcine Subcritical Mandibular Ramus Defect Animal Model 
In vivo implantation of the CGCaP scaffold, PCL support, and CGCaP-PCL composite specimens was 
performed on 5 male Yorkshire pigs approximately 6 months of age and weighing between 88.4 and 94.4 
kg. Specimens were randomized and implanted into three 10 mm diameter bilateral surgical ramus defects 
situated on either side of the mandible. In total, 10 of each specimen (CGCaP scaffolds, PCL supports, 
and CGCaP-PCL composites) were implanted, 2 of each in each pig, with 1 of each on either side of the 
mandible (Figure 5.1). 
 
5.6  Surgical Methods, In Vivo Implantation, and Animal Recovery 
The described surgical procedures and associated protocols and facilities were approved by the University 
of Illinois at Urbana-Champaign Institutional Animal Care and Use committee. Prior to surgery, all pigs 
received a sedative cocktail (TARK) consisting of Telazol (tiletamine and zolazepam; Pfizer, New York, 
NY), Atropine (Neogen Corporation, Lexington, KY), Rompun (xylaazine; Lloyd Laboratories, 
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Shenandoah, IA) and Ketamine (Ketaset®, Fort Dodge Animal Health, Fort Dodge, IA) intramuscularly, 
then again intravenously via the ear vein canula, as necessary. Additionally, a standard endotracheal 
administration of 3-5% isoflurane was administered in oxygen as anesthesia during surgery as necessary.  
The surgical approach first consisted of a single submandibular and retromandibular incision tracing the 
exterior contour of the mandible. The underlying superficial fat and masseter muscle were then incised 
and elevated. Then the periosteum was incised and prised, exposing the posterior region of the underlying 
hemimandible. Utilizing a right-angle surgical drill with a 10 mm (outer diameter) trephine (Stryker, 
Portage, MI) three bicortical (full thickness) 10 mm diameter cylindrical defects were made to the 
exposed region of the hemimandible (ramus) (Figure 5.2). Sufficient irrigation with 0.9% physiological 
saline was provided during drilling to prevent damage to the surrounding tissue during operation. Self-
tapping bone screws (Stryker Osteosynthesis Freiburg, Freiburg, Germany) were placed adjacent to each 
10 mm defect as a means of localizing the defect after harvest, with the distance between each measured. 
The PCL support and CGCaP-PCL composite specimens were then press fit into the 10 mm cylindrical 
defects, while the CGCaP scaffold was fit into the 10 mm defect, rehydrated using 0.9% physiological 
saline, and anchored at one point to the surrounding mandible using Vetbond (3-M, Minneapolis, MN) 
(Figure 5.3).  
 
The wound site was closed by suturing the previously described incisions in the periosteum, masseter 
muscle, superficial fat, and finally the skin using 3-0 Vicryl (Ethicon, Inc, San Angelo, TX) in a three 
layer continuous stitch with Vetbond additionally applied to the skin layer incision as an auxiliary means 
of closure. Following surgery, all pigs received a treatment of an antibiotic Excede (1 mL/20 kg; Pfizer, 
New York, NY) and an analgesia Banamine S (2.2 mg/kg; Schering Plough Animal Health, Summit, NJ). 
Both during and after surgery each pig was monitored and temperature taken every 15 min until the pig 
became sternally recumbent. Additionally, both physical and social behavior was evaluated along with 
any other complication that may have developed twice daily for the first 2 weeks post-surgery. Following 
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6 weeks, animals were sedated and euthanized, with explants from the mandible cleared of excess tissue 
(Figure 5.4). 
 
5.7  Analysis of New Bone Formation via Micro-Computed Tomography 
Mid-culture assessment and post-harvest quantification of bone fill and relative density within the 
subcritical 10 mm mandibular ramus defects was evaluated via micro-computed tomography. Prior to 
harvest, 21 and 28 days in vivo culture, animal specimens were sedated and scanned in a Lightspeed 16 
slice Helical CT scanner (General Electric, Fairfield, CT). Following harvest, samples were fixed in 
formalin. Following 5 washes in fresh de-ionized water, samples were then individually scanned in a 50 
mL conical tube via an Xradia MicroXCT-400 (Zeiss, Oberkochen, Germany). Scans were performed at 
25 kEV and 5 watts with 793 projections and an associated voxel size of 24 µm. An image z-stack was 
then outputted and analyzed with a custom Matlab (MathWorks, Natick, MA) program (Figure 5.5). 
Briefly, based upon previous work analyzing mineral deposition within the mineralized collagen-
glycosaminoglycan scaffold [122], the axis of the cylindrical defect was traced throughout the image z-
stack, an appropriate radius was selected with respect to the cylindrical defect axis, and voxels falling 
within the specified radius from the cylindrical defect axis were analyzed (Figure 5.6). Depth was 
calculated with respect to the defect axis with each voxel grouped into radial and angular partitions 
counting towards the average voxel intensity and number of voxels above the bone threshold. These 
results were then used to calculate the relative average bone density and the bone fill fraction as a 
function of radial position or angle from the cylindrical defect axis. Normalization of the average bone 
density of the defect was performed using the average bone density of the surrounding bone. 
 
Initial analysis during the culture period identified new bone formation (Figure 5.7). From this 
experiment, no significant differences were observed in the new bone fill fraction between the mineral 
CGCaP scaffold, the PCL support construct, and the PCL-CGCaP composite (Figure 5.8). This suggests 
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that the initial impregnation of the PCL support construct within the mineral CGCaP matrix did not 
compromise the in vivo healing potential of the PCL-CGCaP composite compared to the PCL support 
construct and the mineral CGCaP scaffold alone.  
 
Additionally, a radial analysis of the new bone fill fraction did suggest possible enhancement of bone 
formation within the center of the defect within the mechanically robust PCL support construct and 
especially the PCL-CGCaP composite (Figure 5.9). Because some bicortical defects passed through or 
near the bone marrow, an angular analysis of the new bone formation was performed to identify any 
potential influence due to the presence of the bone marrow. Angular results did not identify any angular 
difference in new bone formation that may have been due to the presence of the bone marrow (Figure 
5.10). 
 
5.8  Analysis of Bone Mineral Density via Dual X-Ray Absorptiometry 
Following micro-computed tomography, bone mineral density of samples was sequentially analyzed via 
dual x-ray absorptiometry.mineralized collagen Specimens were stored in formalin and washed 4 times in 
fresh de-ionized water before being individually scanned using a dual x-ray absorptiometry (DXA; 
Hologic QDR 4500R, Bedford, MA). Within the entire bone sample (global) and an octagonal sub-region 
(defect) that traced the 10 mm sub-critical defect, the resulting area of the bone specimen (cm2), bone 
mineral content (g), and bone mineral density (g/cm2) were recorded. The bone mineral density of the 
entire bone sample excluding the defect, or that of the surrounding bone, was calculated by subtracting 
the global bone mineral content from that of the defect ([global (g) – defect (g)]), and dividing this by the 
global area of bone specimen by that of the defect ([global (g) – defect (g)]/[ global (cm2) – defect (cm2)]. 
For comparison between specimens, the normalized bone mineral density was then taken as the bone 
mineral density of the defect divided by the bone mineral density of the surrounding bone. 
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In agreement with new bone fill fraction as measured in micro-computed tomography, there was no 
significant differences in the bone mineral density observed between the polycaprolactone support 
construct, mineralized collagen-glycosaminoglycan scaffold, and mineral polycaprolactone-collagen-
glycosaminoglycan composite (Figure 5.10). A more direct comparison of the bone mineral density as 
measured by the dual energy x-ray absorptiometry to the average voxel density and the volume of new 
bone determined via micro-computed tomography identified no significant differences between the two 
methods (Figure 5.11).  
 
5.9  Conclusions 
This chapter evaluated the in vivo implantation of the mineral polycaprolactone-collagen-
glycosaminoglycan composite into a sub-critical porcine mandibular ramus defect. Previous work within 
the literature has established the efficacy of the polycaprolactone support for in vivo applications treating 
both orthopedic and osteochondral defects [64, 190]. Here the mineralized collagen-glycosaminoglycan 
scaffold and the mineral polycaprolactone-collagen-glycosaminoglycan composite successfully 
demonstrated equivalent to enhanced healing within a sub-critical defect at early time points. The healing 
of the sub-critical porcine mandibular ramus defect was determined through new bone formation via 
micro-computed tomography and bone density via dual energy x-ray absorptiometry. In both cases no 
significant differences were observed, suggesting that over a period of 6 weeks of in vivo culture the 
mineral polycaprolactone-collagen-glycosaminoglycan composite, mineralized collagen-
glycosaminoglycan scaffold, and the polycaprolactone support construct exhibited the same healing. 
Future endeavors will evaluate the in vivo efficacy of the mineral polycaprolactone-collagen-
glycosaminoglycan composite in critically sized porcine mandibular defects. 
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5.10  Figures and Tables 
 
Figure 5.1 Sub-critical and critically sized porcine mandibular ramus defects.  
Here the mineralized collagen-glycosaminoglycan scaffold, polycaprolactone support, and mineral 
polycaprolactone-collagen-glycosaminoglycan composite were implanted into a sub-critical 10 mm 
defect.  
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Figure 5.2 Sub-critical defects prior to in vivo implantation. 
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Figure 5.3 Sub-critical defects post-implantation. 
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Figure 5.4 Explant of the porcine mandible. 
The general vicinity of the mineralized collagen-glycosaminoglycan scaffold, polycaprolactone support 
construct, and mineral polycaprolactone-collagen-glycosaminoglycan composite has been circled with a 
boney ridge obscuring the self-tapping bone screws traced with a dashed line. 
 
 
  
 103 
 
 
 
 
Figure 5.5 Schematic indicating micro-computed tomography analysis. 
Each bone sample was scanned with the sample region and orientation identified. Subsequent analysis 
evaluated the voxel intensity as a function of depth (relative to the sample), radius (relative to the sample 
axis), and angle (relative to the sample center). 
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Figure 5.6 Example output of the custom Matlab program analyzing new bone formation. 
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Figure 5.7 Example of micro-computed tomography during in vivo culture. 
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Figure 5.8 Average fill fraction observed within the support, scaffold, and composite. 
The PCL support construct, mineralized CGCaP scaffold, and mineralized PCL-CGCaP composite after 
42 days of in vivo culture within a sub-critical porcine mandibular ramus defect was determined via 
micro-computed tomography analysis. 
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Figure 5.9 Radial analysis of the new bone and density after in vivo culture. 
A radial analysis performed on the micro-computed tomography results evaluating the new bone 
formation and density (normalized to surrounding bone) of the PCL support construct, the mineralized 
CGCaP scaffold, and the mineralized PCL-CGCaP composite. 
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Figure 5.10 Angular an analysis of the new bone and density after in vivo culture. 
An angular analysis performed on the micro-computed tomography results evaluating the new bone 
formation and density (normalized to surrounding bone) of the PCL support construct, the mineralized 
CGCaP scaffold, and the mineralized PCL-CGCaP composite. 
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Figure 5.11 Normalized bone mineral density as measured by DXA. 
In addition to micro-computed tomography, dual energy x-ray absorptiometry was used to determine the 
bone mineral density (normalized to surrounding bone) of the PCL support construct, the mineralized 
CGCaP scaffold, and the mineralized PCL-CGCaP composite. 
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Figure 5.12 A comparison between DXA and uCT results. 
In order to directly compare the dual energy x-ray absorptiometry results and the micro-computed 
tomography results the normalized bone mineral density as measured by dual energy absorptiometry was 
compared to the product of the normalized bone mineral density and the normalized fill fraction as 
measured by micro-computed tomography. 
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CHAPTER 6  
ALTERATIONS IN MINERALIZED COLLAGEN-
GLYCOSAMINOGLYCAN SCAFFOLD COMPOSITION: 
EFFECT OF MINERAL ADDITION AND PROTEIN 
CONSTITUENTS5 
6.1  Overview 
Thus far, this chapters 2 and 3 has previously followed the fabrication and characterization of mineralized 
collagen-glycosaminoglycan scaffold material properties and bioactivity in the presence of human 
mesenchymal stem cells. The scaffold design was then adapted for in vivo implantation by the formation 
of a mineral polycaprolactone-collagen-glycosaminoglycan composite with in vivo efficacy verified in a 
porcine subcritical mandibular ramus defect. Chapter 6, the mineral content and protein composition of 
the mineralized collagen-glycosaminoglycan scaffold and its potential benefits investigated with the in 
vitro culture of porcine adipose derived stem cells. In this chapter, the effect of a denser non-mineralized 
collagen-glycosaminoglycan scaffold was compared to the mineralized collagen-glycosaminoglycan 
scaffold with the glycosaminoglycans employed varying between the standard chondroitin-sulfate 
                                                     
5 This work is adapted from the study 125. Weisgerber, D.W., R.A. Hortensius, B.A.C. Harley, 
Alterations in mineralized collagen-glycosaminoglycan scaffold composition: effect of mineral addition 
and protein constituents. Ibid. In preparation. 
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previously employed in this lab and heparin. Scaffold bioactivity and matrix deposition was investigated 
in vitro over the course of 28 days. 
 
6.2  Introduction 
In both regenerative medicine and tissue engineering fields, it has been established that the biophysical, 
biochemical, and biomolecular biomaterial properties serve essential roles in achieving material 
bioactivity that is capable of guiding cellular behavior that positively influences or invokes the 
physiological healing process [22, 23]. For orthopedic biomaterials, especially composites comprised of 
two or more contributing constituents, the material properties governing the bioactivity are heavily 
influenced by individual constituent properties. Examples of such constituent influences include the 
increased degradation and ductility of calcium phosphate ceramic biomaterials with the incorporation of a 
polymeric phase [42], or the fiber reinforcement of both natural and synthetic polymeric biomaterials 
[214, 215]. Biomolecular alterations have similarly garnered much attention in the form of soluble 
supplementation or biomolecule tethering [164, 170, 216]. 
 
One approach for influencing the bioactivity of biomaterials has been the incorporation of heparin as a 
biochemical regulator of biomolecules [217]. While its physiological function is poorly understood, 
heparin has been identified as influencing the retention and binding of multiple growth factors throughout 
the body [218-220], and has been employed clinically for its anticoagulation and anti-inflammatory 
properties [221]. The influence of heparin on biomolecule retention due to electrostatic interactions has 
been attributed to its relatively high degree of negative charge compared to other glycosaminoglycans, as 
well as its amino acid sequencing for biomolecule binding affinity [222, 223].  
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One such application of heparin in biomaterial design has been the exchange of chondroitin sulfate for 
heparin in collagen-glycosaminoglycan scaffolds. The collagen-glycosaminoglycan biomaterial design 
has been successfully employed for the treatment of a variety of tissue defects ranging from cartilage [67-
69, 89], to bone [48, 73-75], to tendon [97, 101], muscular [70-72], and skin [78, 79]. Previous work has 
investigated the benefits imparted by the incorporation of heparin into the anisotropic collagen-
glycosaminoglycan scaffold design for treating tendon defects [106]. However, the effect of heparin 
within a mineralized collagen-glycosaminoglycan scaffold variant for orthopedic applications has not 
been investigated. 
 
An additional application of incorporating heparin into the collagen-glycosaminoglycan scaffold is the 
potential sequestration of osteogenic growth factors such as bone morphogenetic protein 2 (BMP2). 
Collaborative work has previously established an endogenous BMP2 feedback loop in mesenchymal stem 
cells seeded onto the mineralized collagen-glycosaminoglycan scaffold [169]. Literature work has 
identified the complexation and sequestration of BMP2 with heparin [224]. Combined with the 
endogenous production of BMP2, the mineralized collagen-heparin scaffolds offers the possibility of 
stable sequestration, potentially prolonging the BMP2 feedback loop identified with mesenchymal stem 
cells. However, previous literature has suggested that the addition of heparin introduces inhibitory effects 
on osteogenic activity via soluble BMP2 supplementation in vitro [225], necessitating the investigation of 
the interaction between heparin and the endogenous BMP2 feedback loop observed within the 
mineralized collagen-glycosaminoglycan scaffold. 
 
This work further investigates the benefits of heparin incorporation in the collagen-glycosaminoglycan 
scaffold design for orthopedic applications. Here, within the mineralized collagen-glycosaminoglycan 
scaffold previously described [48, 87, 88, 122], chondroitin-sulfate was exchanged for heparin and the 
resultant bioactivity was assessed. In vitro culture of porcine adipose derived stem cells was investigated 
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in the presence of non-mineral and mineralized collagen-glycosaminoglycan scaffolds fabricated with 
either chondroitin-sulfate or heparin. Changes in the metabolic activity, mineral deposition, and changes 
in modulus were evaluated over the course of the 28 day in vitro culture as metrics of scaffold bioactivity. 
 
6.3  Fabrication of Non-Mineralized Collagen-Glycosaminoglycan Precursor 
Suspensions 
In this study a denser non-mineralized collagen-glycosaminoglycan and the previous mineralized 
collagen-glycosaminoglycan precursor suspensions were fabricated using previously described methods 
with alternating glycosaminoglycan content. In the case of the non-mineralized collagen-
glycosaminoglycan precursor, 2.0% w/v type-I fibrillar collagen isolated from bovine Achilles tendon 
(Sigma-Aldrich, St. Louis, MO) was homogenized with 0.176% w/v glycosaminoglycan isolated from 
shark cartilage (Sigma-Aldrich, St. Louis, MO), with a ratio of 11.25:1 collagen:glycosaminoglycan, in 
0.05M acetic acid (Sigma-Aldrich, St. Louis, MO). The non-mineralized collagen-chondroitin sulfate 
(Col:CS) scaffold was fabricated using chondroitin sulfate isolated from shark cartilage (Sigma-Aldrich, 
St. Louis, MO) as the glycosaminoglycan during fabrication, while the non-mineralized collagen-heparin 
(Col:HA) was fabricated using heparin as the glycosaminoglycan during fabrication. 
 
6.4  Fabrication of Mineralized Collagen-Glycosaminoglycan Precursor Suspensions 
The mineralized collagen-glycosaminoglycan precursor suspensions were fabricated as the previously 
described 40 wt% mineral CGCaP precursor suspension. Briefly, 1.9% w/v type-I collagen (Collagen 
Matrix, Oakland, NJ), 0.044% w/v glycosaminoglycan, calcium hydroxide (Ca(OH)2, Sigma-Aldrich, St. 
Louis, MO), and calcium nitrate tetra-hydrate (Ca(NO3)2∙4H2O, Sigma-Aldrich, St. Louis, MO) were 
homogenized in phosphoric acid (Sigma-Aldrich, St. Louis, MO). As with the non-mineral Col:CS and 
Col:HA scaffolds, the mineralized collagen-chondroitin sulfate (Col:CS:CaP) and mineralized collagen-
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heparin (Col:HA:CaP) were fabricated with the addition of chondroitin sulfate isolated from shark 
cartilage (Sigma-Aldrich, St. Louis, MO) and heparin (Sigma-Aldrich, St. Louis, MO) during 
homogenization respectively. 
 
6.5  Fabrication of Non-Mineral and Mineral Scaffolds via Lyophilization 
All Col:CS, Col:HA, Col:CS:CaP, and Col:HA:CaP scaffold variants were lyophilized from 23 mL of the 
corresponding precursor suspensions using a custom polyfulfone tray (76.2 mm by 76.2 mm, 1.5 mm 
thick base). Lyophilization proceeded with a 1°C/min cooling from 20°C to a final freezing temperature -
10°C, a 175 min hold at -10°C, with sublimation then occurring at 0°C and 200 mTorr. Scaffolds were 
then obtained from each 72.6 mm x 72.6 mm x 4 mm sheets via biopsy punches for cellular bioactivity (6 
mm diameter, 4 mm thick) and mechanical (12 mm diameter, 4 mm thick) analysis. 
 
6.6  Visualization of Chondroitin Sulfate and Heparin Scaffolds 
Differences in microstructure was observed via scanning electron microstructure. Specimens were sliced 
vertically and oriented for imaging the transverse plane using a JEOL JSM-6060LV Low Vacuum 
Scanning Electron Microscope (JEOL USA, Peabody, MA).  Qualitatively, no differences in scaffold 
microstructure were observed between chondroitin sulfate and heparin scaffolds (Figure 6.1). 
 
6.7  Sterilization and Crosslinking of Scaffolds for In Vitro Culture 
Non-mineral Col:CS and Col:HA scaffolds were dehydrothermally crosslinked in a vacuum oven (Welch, 
Niles, IL) for 24 h at 105°C and <25 Torr. All scaffold variants were then sterilized in 100% ethanol and 
stepwise hydrated in sterile phosphate buffered saline at 37°C and 5% CO2 before being chemically 
crosslinked. Chemical crosslinking was performed via 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
hydrochloride (EDC; Sigma-Aldrich, St. Louis, MO) and N-hydroxysulfosuccinimide (NHS; Sigma-
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Aldrich, St. Louis, MO) chemistry added at a 5:2:1 (EDC:NHS:COOH) molar ratio to the moles of 
caroboxylic acid groups (COOH) present on collagen. 
 
6.8  In Vitro Culture of Porcine Adipose Derived Stem Cells 
To determine the effect of mineral and glycosaminoglycans on the osteogenic potential of the mineralized 
collagen-glycosaminoglycan scaffold was investigated in vitro with porcine adipose derived stem cells 
(pASCs) courtesy of Dr. M. Wheeler (Department of Animal Science, University of Illinois at Urbana-
Champaign, Urbana, IL). Briefly, pASCs were cultured in complete mesenchymal stem cell growth 
media, low glucose Dulbecco’s modified eagle medium (DMEM), 10% mesenchymal stem cell fetal 
bovine serum (MSC FBS; Invitrogen, Carlsbad, CA), 1% antibiotic-antimycotic (Invitrogen, Carlsbad, 
CA) at 37°C and 5% CO2. At passage 8, pASCs were seeded onto Col:CS, Col:HA, Col:CS:CaP, 
Col:HA:CaP scaffolds using a previously established static seeding method wherein 3.5 x106 pASCs were 
seeded onto each side of the disc with 15 min allotted for attachment between. After an additional 2 h for 
attachment, complete mesenchymal stem cell growth media was added and scaffolds were cultured in 
vitro at 37°C and 5% CO2 over a period of 28 days. 
 
6.9  Evaluation of Cellular Metabolic Activity during In Vitro Culture 
The effect on bioactivity of the mineral and glycosaminoglycan content within the collagen-
glycosaminoglycan scaffolds was assessed by the metabolic activity of pASCs cultured in vitro via the 
non-destructive AlamarBlue® assay. Briefly, in vitro pASCs cultured scaffolds were rinsed of dead or 
unattached cells in phosphate buffered saline and then cultured in 1 mL AlamarBlue® assay solution at 
37°C and 5% CO2 under gentle agitation. The metabolic activity of the pASCs within the scaffold was 
measured via the uptake and subsequent conversion of resazurin within the cell into resorufin, the 
fluorescent byproduct. Quantification of resorufin was then measured via a F200 spectrophotometer 
(Tecan, Männedorf, Switzerland) at the excitation/emission of 540(52)/580(20) nm. The results were then 
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reported as the metabolic activity normalized to that of the number of cells originally seeded, 0.75 x106 
cells. 
 
Across all scaffold variants, non-mineral vs mineral and chondroitin vs heparin, a significant (p < 0.05) 
increase in the metabolic activity was observed over the 28 day in vitro culture (Figure 6.2). This result 
agrees with previous work identifying that the collagen-glycosaminoglycan scaffold supports cell 
proliferation and healthy metabolic activity in the presence of a calcium phosphate mineral phase and 
either heparin or chondroitin sulfate [106, 122]. The presence of the calcium phosphate mineral phase was 
observed to induce a significantly (p < 0.05) lower metabolic activity over the first 14 days in vitro before 
inducing a significantly (p < 0.05) higher degree of metabolic activity by day 28 (Figure 6.2). This 
observation precisely coincides with an earlier observation in which 0.5 wt% non-mineral CG scaffolds 
possessed a significantly higher degree of human mesenchymal stem cell metabolic activity than the 
mineral CGCaP scaffolds until day 28 at which point the mineral CGCaP scaffold possessed a higher 
degree of metabolic activity [122]. This strongly suggests that the mineralized collagen-
glycosaminoglycan scaffold induces a degree of phenotype differentiation within the first 28 days in the 
absence of soluble supplementation independent of stem cell line and scaffold density [122, 169, 170]. In 
evaluating the effect of glycosaminoglycan (chondroitin sulfate vs heparin) non-mineral heparin scaffolds 
exhibited a significantly (p < 0.05) higher metabolic activity as early as day 3 and as late as day 28 
(Figure 6.2), while mineral heparin scaffolds only possessed a significantly (p < 0.05) higher degree of 
activity between days 7 and 14 (Figure 6.2). This is in agreement with previous work that has identified a 
positive effect of heparin on the cellular metabolic activity of equine tenocytes in a highly aligned 
collagen-glycosaminoglycan scaffold aimed at the repair of tendon defects [106]. However, this positive 
effect was modulated in the presence of the calcium phosphate mineral phase within the mineral CGCaP 
scaffolds, blunting this observed difference by day 28 (Figure 6.2). 
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6.10  Evaluation of Mineral Deposition during In Vitro Culture 
The effect of mineral and glycosaminoglycan content on collagen-glycosaminoglycan scaffold bioactivity 
was also assessed by the in vitro deposition of mineral content as measured via micro-computed 
tomography (µCT). Briefly, after 1, 7, 14, and 28 days of in vitro pASC culture all scaffold variants were 
transferred into fresh deionized water and immediately flash frozen in liquid nitrogen to stop all cellular 
activity and preserve mineral deposition. Subsequent lyophilization was performed at a final freezing 
temperature of -10°C on a precooled shelf with sublimation at 0°C and 200 mTorr to remove any liquid 
constituents. Samples were then scanned in an Xradia MicroXCT-400 (Zeiss, Oberkochen, Germany) at 
25 kEV and 5 watts with 793 projections and an associated voxel size of 31 µm. The resulting z-stacks 
were then analyzed using a custom Matlab (MathWorks, Natick, MA) program assessing radial intensity 
through the height of the sample (Figure 6.3). 
 
The analysis of the resulting data indicated a significant (p < 0.05) degree of mineralization in the mineral 
Col:CS:CaP and Col:HA:CaP scaffolds over the 28 day in vitro culture, while the non-mineral Col:CS 
and Col:HA indicated a lesser degree of significant (p < 0.05) mineral deposition (Figure 6.4). Within the 
mineral Col:CS:CaP scaffolds a significant (p < 0.05) increase in mineral was observed by day 28, 
significantly (p < 0.05) higher than Col:CS, Col:HA, and Col:HA:CaP at that time point (Figure 6.4). 
Mineralization of the 2% w/v non-mineral Col:CS scaffolds seeded with pASCs suggests either a cell 
specific or density specific response compared to previous work evaluating the mineral deposition of a 
0.5% w/v non-mineral Col:CS scaffold seeded with human mesenchymal stem cells [122]. Literature has 
suggested that alterations in substrate stiffness can modulate the cellular response, particularly in regards 
to differentiation [28]. In both the non-mineral and mineral scaffolds the addition of heparin (Col:CS vs 
Col:HA; Col:CS:CaP vs Col:HA:CaP) corresponded to no significant change in the observed mineral 
deposition (Figure 6.4). While the incorporation of heparin was observed to increase in metabolic activity 
of porcine adipose derived stem cells up to day 28 (Figure 6.2). This initial increase in metabolic activity 
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did not correspond to an increase in mineral deposition observed. As suggested previously, this 
discrepancy between metabolic activity and mineral deposition highlights the tradeoff between cell 
proliferation and cell phenotype observed within the collagen-glycosaminoglycan scaffold, previously 
between unsupplemented and osteogenic supplemented mineralized collagen-glycosaminoglycan 
scaffolds [122]. 
 
6.11  Evaluation of Matrix Mechanics during In Vitro Culture 
Finally, the quantitative changes in scaffold mechanical properties was used as a qualitative measure of in 
vitro porcine adipose derived stem cell remodeling within all collagen-glycosaminoglycan variants. 
Col:CS, Col:HA, Col:CS:CaP, and Col:HA:CaP in vitro were tested in unconfined hydrated compression 
with the elastic modulus determined from the measured stress-strain behavior. Briefly, in vitro 
mechanical samples (12 mm diameter, 4 mm thick) were removed after 1, 7, 14, and 28 days of in vitro 
pASC culture at 37°C and 5% CO2 and kept in sterile phosphate buffer saline while undergoing 
compression. Hydrated unconfined compression tests were performed via a TA.XTplus Texture Analyzer 
(StableMicro Systems Ltd., Surrey, UK) with a 1 kg load cell at a strain rate of 0.01 mm/min to 0.75 
strain. Pure phosphate buffered saline controls were performed under identical conditions in the absence 
of a specimen as a blank control. The force-displacement due to the blank control was then subtracted 
from the hydrated specimen force-displacement in order to determine the specimen stress-strain behavior 
alone. The elastic modulus was then determined from the linear elastic regime of the resulting stress-
strain curve. 
 
The mineralized collagen-glycosaminoglyan scaffold variants (Col:CS:CaP and Col:HA:CaP) possessed a 
significantly (p < 0.05) higher modulus compared to their non-mineral counterparts (Col:CS and Col:HA 
respectively) (Figure 6.5). The incorporation of a mineral component to the collagen-glycosaminoglycan 
scaffold significantly increased the modulus of the resultant scaffold. This result agrees with previous 
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work that has investigated the mechanical properties [48]. Additionally, altering the glycosaminoglycan 
component from chondroitin sulfate to heparin did not significantly affect the modulus of non-mineral 
(Col:CS vs Col:HA) and mineral (Col:CS:CaP vs Col:HA:CaP) scaffolds after 28 days of in vitro porcine 
adipose derived stem cell culture (Figure 6.5). The lack of difference between the mineral (Col:CS:CaP vs 
Col:HA:CaP) scaffolds is in agreement with the lack of difference observed due to mineral deposition, 
suggesting that the reinforcement due to cellular remodeling was unaffected by the presence of the 
heparin in the Col:HA:CaP scaffold (Figure 6.5).  
 
6.12  Conclusions 
The incorporation of heparin was observed to positively influence the metabolic activity of the non-
mineral scaffolds throughout the study in agreement with previous work [226], and increase the metabolic 
activity through day 21 within the mineral scaffold. Previously observed differences between non-mineral 
and mineralized collagen-glycosaminoglycan scaffolds were also reaffirmed with the in vitro culture of 
porcine adipose derived stem cells. The incorporation of heparin had no effect on mineral deposition or 
mechanics within the compared to the chondroitin sulfate counterpart. As such, the incorporation of 
heparin was concluded to not interfere with the osteogenic bioactivity of the mineralized collagen-
glycosaminoglycan scaffold. In agreement with previous work, the mineralized collagen-
glycosaminoglycan scaffolds exhibited a significant increase in the mineral deposition and modulus over 
the culture period, with no change in the non-mineralized variants. Finally, previous inhibitory effects 
identified with heparin were not observed to negatively affect the osteogenic potential of the porcine 
adipose derived stem cells in mineral deposition or modulus within this chapter.  
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6.13  Figures and Tables 
 
Figure 6.1 Microstructural differences between heparin and chondroitin sulfate scaffolds. 
Microstructural differences between non-mineralized (Col:CS vs Col:HP) and mineralized (Col:CS:CaP 
vs Col:HP:CaP) as observed via scanning electron microscopy. Qualitatively, no differences were 
observed between the two glycosaminoglycans (heparin vs chondroitin sulfate) used during fabrication. 
  
 122 
 
 
 
Figure 6.2 Metabolic activity of ASCs cultured on chondroitin sulfate and heparin scaffolds. 
The metabolic activity of porcine adipose derived stem cells (ASCs) cultured on non-mineralized and 
mineralized scaffolds containing either chondroitin sulfate or heparin over a period of 28 days was 
determined via an AlamarBlue assay. Significance (*: p< 0.05) between indicated groups and significance 
(α: p < 0.05) between corresponding glycosaminoglycan (Col:CS vs Col:CS:CaP; Col:HP vs 
Col:HP:CaP) at each time point was indicated. 
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Figure 6.3 Procedure of micro-computed tomographic analysis of mineral deposition. 
A step by step procedure indicating the procedure performed in Matlab to analyze the mineral deposition 
within scaffolds cultured in vitro as measured by micro-computed tomography (uCT). Procedure analysis 
was performed as: (1) selection of a start and end uCT z-stack slice; (2) selection of the entire scaffold 
and surrounding air; (3) subtraction of the background not selected in step 2; (4) a selection of only the 
scaffold region; (5) division of the scaffold into radial partitions; (6) analysis of the voxels contained 
within each radial partition; (7) repeat of this analysis throughout the z-stack, or the uCT volume.  
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Figure 6.4 In vitro mineral deposition observed in chondroitin sulfate and heparin scaffolds. 
Mineral deposition of porcine adipose derived stem cells (ASCs) cultured on non-mineralized and 
mineralized scaffolds containing either chondroitin sulfate or heparin over a period of 28 days was 
determined via micro-computed tomography. Significance (*: p< 0.05) between indicated groups and 
significance (β: p < 0.05) of a single group between days 1 and 28 was indicated. 
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Figure 6.5 Elastic moduli of heparin or chondroitin sulfate scaffolds cultured with pASCs. 
The elastic moduli of non-mineralized and mineralized scaffolds containing either chondroitin sulfate or 
heparin cultured with porcine adipose derived stem cells (ASCs) over a period of 28 days was determined 
in hydrated unconfined compression. Significance (*: p< 0.05) between indicated groups, significance (β: 
p < 0.05) of a single group between days 1 and 28, and significance (α: p < 0.05) between corresponding 
glycosaminoglycan (Col:CS vs Col:CS:CaP; Col:HP vs Col:HP:CaP) at each time poin was indicated. 
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CHAPTER 7  
MULTI-COMPARTMENT SCAFFOLDS FOR TREATING 
BONE-LIGAMENT AND BONE-TENDON INTERFACES: 
SCAFFOLD DESIGN AND FABRICATION6 
7.1  Overview 
Previous chapters have considered monolithic non-mineral and mineralized collagen-glycosaminoglycan 
scaffolds for the treatment of orthopedic defects within various bones. However, many orthopedic defects 
either occur at or encompass the enthesis or the junction between bone and connective tissues, such as 
tendon or ligament. Chapter 7 of this thesis details the continued development of a multi-compartment 
collagen-glycosaminoglycan scaffold fabricated via a liquid phase co-synthesis technique for the 
treatment of orthopedic defects involving bone. Work described in this chapter combines a liquid phase 
co-synthesis technique to create a multi-compartment scaffold with graded mineral content, then the use 
of visualization via scanning electron microscopy and histological methods to assess the properties and 
performance of the graded materials. Additionally, the bulk mechanical properties and the local strain 
environment during compression were assessed in unconfined compression. 
 
                                                     
6 This work is a partial adaption from the study 48. Weisgerber, D.W., et al., The impact of discrete compartments 
of a multi-compartment collagen-GAG scaffold on overall construct biophysical properties. Journal of the 
mechanical behavior of biomedical materials, 2013. 28: p. 26-36. The work in Chapter 2 concludes this adaptation 
from the study ibid. 
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7.2  Introduction 
In addition to the native complexities associated with recapitulating complex geometries and load bearing 
capacities, the difficulty in applying regenerative medicine and tissue engineering approaches is 
compounded by the spatial heterogeneity often encompassed by orthopedic injuries around the enthesis, 
or the insertion site between bone and connective tissues [227]. Some of the more common orthopedic 
injuries occurring at or encompassing the enthesis include tears in the anterior cruciate ligament (ACL) 
essential for knee alignment and function, or osteoarthritis with damage to the articular cartilage 
responsible for providing smooth and painless movement in joints [228, 229]. Mechanically, the enthesis 
between bone and tendon provides the anatomical solution to the complex physiological junction between 
two mechanically distinct tissues (Ebone ~ 102 Etendon) by an equally complex interfacial zone comprised of 
spatially graded biochemical and microstructural components [227, 230]. The enthesis remains a common 
site of injury despite its complex yet efficient design, treatment of more than seventy five thousand 
injuries occurring at the enthesis in the United States alone remains a difficult challenge motivated by the 
high degree of re-failure rates after surgical intervention [231-238]. The need for regenerative medicine 
and tissue engineering solutions have driven the search for multi-compartment biomaterials capable of 
spatially guiding cellular differentiation and bioactivity towards physiologically relevant repair in each 
compartment at the enthesis. 
 
While the clinical relevance of spatially distinct multi-compartment biomaterials remains dominate, the 
approach and characterization of such multi-compartment biomaterials remains a critical point of interest. 
To address these approaches, a range of biomaterial fabrication strategies include sequential dipping in 
mineralized solutions [239], stereolithographic and 3D-printing approaches [144, 240, 241], and the 
layering of hydrogel constructs [242, 243]. Previous literature has investigated the development of the 
collagen-glycosaminoglycan scaffolds for the treatment of injuries occurring at the dermis, peripheral 
nerves, cartilage, and tendon [78, 85, 97, 98], as well as the development of the mineralized collagen-
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glycosaminoglycan scaffold for the treatment of orthopedic injuries [87, 88, 108, 135]. This chapter will 
focus on the development and characterization of a non-mineral to mineral multi-compartment collagen-
glycosaminoglycan scaffold for the treatment of orthopedic injuries occurring at the enthesis. 
 
Previous work has described the application of a liquid phase co-synthesis technique layering distinct 
non-mineral and mineral precursor suspensions and subsequent lyophilization to produce a highly porous 
(>95%) collagen-glycosaminoglycan scaffold with distinct non-mineral and mineral compartments with a 
gradient interface between the two for the treatment of osteochondral tissue engineering applications [89, 
90]. However, none of these works examined how this fabrication process directly affected local 
structural and biophysical properties of the composite scaffold. The goal of this chapter was to evaluate 
the fabrication and characterization of microstructure, mechanical, and permeability properties of one 
such non-mineral to mineral multi-compartment collagen-glycosaminoglycan scaffold for the future 
development of in vivo and in vitro studies. 
 
7.3  Preparation of Non-Mineral and Mineral Precursor Suspensions 
Here the multi-compartment collagen-glycosaminoglycan scaffold consisted of a two compartments, non-
mineral and mineral, mimicking the physiological enthesis between bone and either tendon or ligament. 
Here the previously described non-mineral and mineral suspensions were layered via a liquid phase co-
synthesis technique previously described [89]. For comparison, monolithic non-mineral and mineralized 
collagen-glycosaminoglycan scaffolds were also fabricated in addition to the multi-compartment 
collagen-glycosaminoglycan scaffold. 
 
As before, the non-mineralized collagen-glycosaminoglycan (CG) precursor suspension was fabricated 
from the homogenization of collagen and glycosaminoglycans. Briefly, type-I fibrillar collagen isolated 
from bovine Achilles tendon (Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate isolated from shark 
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cartilage (Sigma-Aldrich, St. Louis, MO) was homogenized in 0.05 M acetic acid (Sigma-Aldrich, St. 
Louis, MO). This suspension was stored at 4°C and degassed prior to use in non-mineral CG and the 
multi-compartment scaffold lyophilization. 
 
Additionally, the mineralized collagen-glycosaminoglycan (CGCaP) suspension was fabricated from the 
co-precipitation of collagen, glycosaminoglycans, and a calcium phosphate mineral phase as previously 
described. An 80 wt% mineralized collagen-glycosaminoglycan (CGCaP) precursor suspension was 
fabricated from the homogenization of type-I fibrillar collagen from bovine Achilles tendon (Sigma-
Aldrich, St. Louis, MO), chondroitin sulfate isolated from shark cartilage (Sigma-Aldrich, St. Louis, 
MO), calcium hydroxide (Ca(OH)2; Sigma-Aldrich, St. Louis, MO) and calcium nitrate tetra-hydrate 
(Ca(NO3)2 4H2O; Sigma-Aldrich, St. Louis, MO) in phosphoric acid (Sigma-Aldrich, St. Louis, MO). 
Control over the calcium phosphate mineral phase mass yield was achieved through concurrent mapping 
technique dictating the calcium hydroxide to calcium nitrate tetra-hydrate molar ratio and phosphoric acid 
molarity [87, 107]. Similar to the non-mineral CG precursor suspension, the mineral precursor suspension 
was stored at 4°C and degassed prior to use in mineral CGCaP and the multi-compartment scaffold 
lyophilization. 
 
7.4  Fabrication of Non-Mineral and Mineralized Collagen-Glycosaminoglycan Scaffolds 
Monolithic non-mineral CG and mineral CGCaP scaffolds were fabricated from the lyophilization of the 
corresponding CG and CGCaP precursor suspensions. Briefly, 1 mL of the non-mineral CG and mineral 
CGCaP precursor suspensions were pipetted into each well of a custom polysulfone 6 well array mold (12 
mm deep, 13 mm diameter, 1.5 mm thick base). Lyophilization consisted of a constant cooling rate of 
1°C/min to a final freezing temperature of either -10°C or -40°C, a 175 min anneal at the final freezing 
temperature, and sublimation at 0°C and 200 mTorr in a Genesis freeze-dryer (VirTis, Gardener, NY). 
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For the monolithic non-mineral CGCaP scaffolds an extra 24 h dehydrothermal crosslinking step was 
performed in a vacuum oven (Welch, Niles, IL) at 105°C and <25 Torr. 
 
7.5  Fabrication of the Non-Mineral Mineral Multi-Compartment Collagen-GAG 
Scaffold 
The non-mineral mineral multi-compartment (CG-CGCaP) scaffold was fabricated by the liquid phase co-
synthesis of a 1:1 ratio of non-mineral CG precursor suspension and mineral CGCaP precursor 
suspension. To start 0.5 mL of the mineral CGCaP precursor suspension was pipetted into the custom 6 
well polysulfone array mold (12 mm deep, 13 mm diameter, 1.5 mm thick base). An additional 0.5 mL 
non-mineral CG precursor suspension was then carefully pipetted with only minimal disruption to the 
surface of the previously pipetted mineral CGCaP precursor suspension. A period of 20 min was then 
allotted for the inter-diffusion of the two precursor suspensions. The relative viscosity of the suspensions 
slowed the inter-diffusion creating distinct non-mineral CG and mineral CGCaP compartments with an 
interface between the two. Subsequent lyophilization proceeded in a Genesis freeze-dryer (VirTis, 
Gardener, NY) with a constant cooling rate of 1°C/min to a final freezing temperature of either -10°C or -
40°C, a 175 min anneal at the final freezing temperature, and sublimation at 0°C and 200 mTorr. 
 
7.6  Evaluation of Multi-Compartment Scaffold Microstructure 
Initial verification of the multi-compartment CG-CGCaP scaffold was performed via visualization using 
scanning electron microscopy (SEM) and histological analysis to determine the localization of the mineral 
phase and the average pore size within each scaffold. The scanning electron microscopy of the interface 
utilized a JEOL JSM-6060LV Low Vacuum Scanning Electron Microscope (JEOL USA, Peabody, MA). 
Histological analysis proceeded as previously described with 6 mm cores biopsied (Integra Miltex, York, 
PA) from the multi-compartment CG-CGCaP scaffold and sectioned either transverse or longitudinal. 
These sections were then embedded in glycomethacrylate (Polysciences Inc., Warrington, PA) with 
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histological sectioning into 5 µm thick slices oriented in the transverse or longitudinal planes. Aniline 
blue (Thermo Fisher Scientific Inc, Waltham, Ma) staining then enabled the imaging of collagen struts in 
each section via an optical microscope (Thermo Fisher Scientific Inc, Waltham, Ma). Identification of the 
average pore size was accomplished from a linear intercept macro within Scion Image. 
 
Scanning electron microscopy clearly identified the non-mineral CG and mineral CGCaP compartments 
within the multi-compartment CG-CGCaP scaffold and the resulting interface between the two (Figure 
7.1). A qualitative investigation of the image revealed no apparent voids or points of delamination that 
would jeopardize scaffold integrity. The resulting average pore size of the multi-compartment scaffold 
was compared to the monolithic non-mineral CG and mineral CGCaP scaffold variations previously 
fabricated under identical conditions (Figure 2.4, Table 2.1). Within the multi-compartment CG-CGCaP, 
a significant (p < 0.05) decrease in the average pore size was observed from the non-mineral CG 
compartment, across the interface, and finally in the mineral CGCaP compartment was observed at a final 
freezing temperature of -10°C (Figure 7.2, Table 7.1). An identical non-significant trend in average pore 
size was also observed between the non-mineral CG, interface, and mineral CGCaP scaffold fabricated at 
a final freezing temperature of -40°C (Figure 7.2, Table 7.1). This apparent difference in average pore 
size between the non-mineral CG and mineral CGCaP compartments in the multi-compartment CG-
CGCaP scaffold suggests a difference in freezing rate between the two, with the non-mineral CG 
compartment freezing at a slower rate. Such a difference in freezing rate is attributed to the different 
internal heat transfer coefficients between the non-mineral CG and mineral CGCaP precursor 
suspensions. Previous work with monolithic scaffold variants has identified the internal heat transfer due 
to the mold as dictating pore microstructure, these results suggest that the relative precursor suspension 
ordering within the multi-compartment CG-CGCaP scaffold significantly affects the pore microstructure. 
Additionally, a significant difference was observed between the non-mineral CG compartment and the 
monolithic non-mineral CG scaffold (Figure 7.2, Table 7.1). Here the significantly higher average pore 
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size in the non-mineral CG compartment can again be attributed to the slower freezing rate due to the 
presence of the mineral CGCaP precursor suspension and its associated internal heat transfer coefficient. 
This highlights the importance of both the precursor suspension and the mold internal heat transfer 
coefficients in multi-compartment scaffold design. In agreement with these conclusions, no significant 
difference in average pore size was observed between the mineral CGCaP compartment and the 
monolithic mineral CGCaP scaffold, as identical freezing kinetics was experienced in both situations 
(Figure 7.2, Table 7.1). 
 
7.7  Quantification of Multi-Compartment Scaffold Interface via Micro-Computed 
Tomography 
Although the interface between the non-mineral CG and mineral CGCaP compartments in the multi-
compartment CG-CGCaP scaffold was previously observed via scanning electron microscopy, the width 
of the interface was quantified via micro-computed tomography (µCT). Micro computed tomography was 
performed at 25 kEv and 5 watts on a Xradia MicroXCT-400 (Xradia, Pleasanton, CA) with 1021 
projections and a voxel size of 20 µm. An analysis of the voxel intensity and localization of the mineral 
content was performed via a custom Matlab (MathWorks, Natick, MA) program. The area of interest, 
7.56 mm x 7.56 mm bounded by the surface of the multi-compartment CG-CGCaP scaffold, was selected 
(Figure 7.3). This square area of interest was then partitioned into 225 equally sized sections, 25 x 25 
voxels, 0.25 mm2, and the average intensity calculated within each partition. This process was then 
repeated throughout the image z-stack resulting in the 225 section profiles of the average intensity versus 
z-position, or depth. The monolithic non-mineral CG and mineral CGCaP compartment intensities were 
determined from the top and bottom images within the sample z-stack respectively. Image slices 
possessing an intensity between the monolithic non-mineral CG and mineral CGCaP mean intensities ± 3 
standard deviations were taken to be part of the interfacial region.  
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Here visualization of the non-mineral to mineral multi-compartment CG-CGCaP scaffold was 
accomplished by scanning electron microscopy (Figure 7.1). Qualitative analysis of the scans clearly 
differentiated the individual non-mineral CG and mineral CGCaP compartment by the difference in 
intensity due to the presence of the mineral content. Additionally, the interface was identified as the 
junction between the non-mineral CG and mineral CGCaP compartments. No apparent delamination or 
defects, such as voids, that may act as stress concentrators and result in the mechanical failure were 
identified from the scan (Figure 7.1). An in depth quantitative analysis of the non-mineral to mineral 
multi-compartment CG-CGCaP scaffold interface was performed via micro-computed tomography 
(Figure 7.4). Here 225 intensity profiles were followed through the sample thickness (Figure 7.5). The 
average intensity of the non-mineral CG and mineral CGCaP compartments were clearly identified, with 
the interfacial region between the two possessing an average intensity lying between the average intensity 
± 3 standard deviations of these two (Figure 7.5). Knowing the image slice location within the image z-
stack, or depth within the scaffold, allows a quantification of the interface width. This analysis has 
identified an interfacial region of 1.9 ± 0.7 mm. This interfacial region was controlled by the degree of 
inter-diffusion allowed during fabrication, which in the multi-compartment scaffold fabricated by the 
liquid phase co-synthesis methodology can be tuned for an appropriately sized interfacial region. 
 
7.8  Mechanical Properties of Multi-Compartment Scaffolds 
The mechanical properties of the non-mineral to mineral multi-compartment CG-CGCaP scaffold was 
appraised via the determination of modulus following lyophilization at a final freezing temperature of -
10°C and -40°C. This appraisal of the multi-compartment CG-CGCaP modulus was accomplished via 
unconfined compression with a MTS Insight Electromechanical load frame (MTS, Eden Prairie, MN). 
Unconfined compression to 0.75 strain at a rate of 1 mm/sec was performed with a 250 N load cell. 
Stress-strain profiles were then calculated from the resulting load-displacement via specimen height and 
diameter recorded via calipers prior to testing. The elastic modulus, collapse stress, and collapse strain 
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were then determined from the stress-strain behavior based on the low density cellular solids model. The 
resulting moduli were then compared to the equivalent monolithic scaffold counterparts (Figure 2.5, 
Table 2.1).  
 
As in the monolithic non-mineral CG and 80 wt% mineral CGCaP scaffolds, the non-mineral to mineral 
multi-compartment CG-CGCaP scaffold was observed to possess the linear elastic, collapse plateau, and 
densification regimes observed in low density open cell foams according to cellular solids theory [142]. 
Statistical significance (p < 0.05) was observed between the monolithic non-mineral CG and mineral 
CGCaP scaffolds and the non-mineral to mineral multi-compartment CG-CGCaP scaffold for specimens 
lyophilized at a final freezing temperature of -10°C (Figure 7.6). However, no significance was detected 
between the monolithic non-mineral CG and non-mineral mineral multi-compartment CG-CGCaP 
scaffold lyophilized at -40°C (Figure 7.6). Statistic differences (p < 0.05) in collapse strain reflected the 
significant differences observed in the elastic modulus (Table 7.1). All variations were observed to 
possess similar collapse strains within the regime 0.07-0.14, an observation consistent with cellular solids 
predictions and previous results (Table 7.1) [94, 142].  
 
7.9  Conclusions 
This work evaluated the fabrication of a non-mineral mineral CG-CGCaP multi-compartment scaffold for 
the treatment of enthesis for orthopedic interface repair. The average pore size was observed to decrease 
with increasing density from the non-mineral CG compartment to the mineral CGCaP compartment. 
Additionally, the mechanical properties and permeability of the non-mineral mineral CG-CGCaP multi-
compartment scaffold reflected those of the limiting compartment, the softer non-mineral CG 
compartment in both cases. 
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7.10  Figures and Tables 
 
 
Figure 7.1 Visualization of the multi-compartment scaffold interface. 
Visualization of the interface (grey arrow) between the non-mineral CG (red arrow) and mineral CGCaP 
(blue arrow) compartments within the CG-CGCaP multi-compartment scaffold as measured by scanning 
electron microscopy. Scale bar: 1mm.   
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Figure 7.2 The average pore size within the multi-compartment scaffold.  
The average pore size within multi-compartment scaffold divided into the CG compartment region, the 
interface, and the mineral CGCaP region. Pore size was determined via alanine staining of the collagen 
struts and a linear intercept macro. Scaffolds were fabricated at -10°C and -40°C.  
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Figure 7.3 uCT with cross sections of the multi-compartment scaffold.  
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Figure 7.4 Average uCT intensity profiles across the multi-compartment scaffold interface. 
Four representative average intensity profiles as a function of distance through the multi-compartment 
CG-CGCaP scaffold. Mineral content associated with individual non-mineral CG and mineral CGCaP 
compartments are representative by the red and blue regions present respectively. 
  
 139 
 
 
Figure 7.5 Multi-compartment scaffold stress-strain profiles observed during compression. 
The stress-strain profiles of the non-mineral CG-CGCaP multi-compartment scaffold compared to the 
monolithic non-mineral CG and mineral CGCaP scaffolds in unconfined compression. 
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Figure 7.6 Elastic moduli of the multi-compartment scaffold. 
The elastic moduli were determined from the linear elastic regime of the stress-strain profiles of the multi-
compartment CG-CGCaP scaffold, the non-mineralized CG scaffold, and the mineralized CGCaP 
scaffold as measured in unconfined compression. With significance (*: p < 0.05) indicated between 
groups. 
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Table 7.1 Values for microstructure and mechanics of the multi-compartment scaffold. 
 Multi-compartment CG-CGCaP scaffold 
Final freezing 
temperature 
-10°C -40°C 
CG Inter CGCaP CG Inter CGCaP 
Average pore 
size (um) 
232 ± 20 240 ± 19 186 ± 15 193 ± 25 181 ± 13 167 ± 26 
Average pore 
aspect ratio 
0.93 ± 0.02 0.94 ± 0.02 0.95 ± 0.02 0.94 ± 0.02 0.92 ± 0.04 0.93 ± 0.02 
Elastic 
modulus (E; 
kPa) 
22.5 ± 1.1 18.9 ± 3.2 
Collapse strain 
(ε*el) 
 
0.11 ± 0.04 0.13 ± 0.02 
Collapse stress 
(σ*el; kPa) 
2.1 ± 0.8 2.1 ± 0.2 
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Table 7.2 Values for microstructure and mechanics of the non-mineral and mineral scaffold. 
 Non-mineral CG scaffold Mineral CGCaP scaffold 
Final Freezing 
Temperature 
-10°C -40°C -10°C -40°C 
Average pore 
size (µm) 
163 ± 14 166 ± 56 152 ± 24 156 ± 6 
Average pore 
aspect ratio 
0.92 ± 0.03 0.92 ± 0.03 0.94 ± 0.02 0.95 ± 0.01 
Elastic modulus 
(E; kPa) 
8.8 ± 1.1 8.1 ± 0.4 159.0 ± 18.3 123.4 ± 11.3 
Collapse strain 
(ε*el) 
0.09 ± 0.06 0.14 ± 0.04 0.09 ± 0.05 0.07 ± 0.03 
Collapse stress 
(σ*el; kPa) 
0.7 ± 0.4 0.9 ± 0.3 11.2 ± 2.5 7.5 ± 2.0 
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CHAPTER 8  
SUMMARY AND FUTURE OPPORTUNITIES 
8.1  Summary 
This work has provided knowledge of the characterization and manipulation of the biochemical and 
biophysical properties of a mineralized collagen-glycosaminoglycan scaffold for the treatment of 
craniofacial orthopedic defects. For such injuries requiring surgical intervention, the current gold standard 
of treatment involves the use of either an autograft or allograft implant. However, concerns over autograft 
donor site morbidity, pain, and availability, along with concerns over allograft disease transmission and 
availability represent limitations in this field.  
 
Following an overview of the physiological aspects and tissue engineering treatment of bone, chapter 2 
highlighted the ability of the mineralized collagen-glycosaminoglycan scaffold to remain flexible in its 
biophysical and biochemical properties for meeting the treatment criteria imposed by both different 
orthopedic defects and patient specific considerations. Here the biochemical and biophysical properties 
implicated in influencing cellular behavior were evaluated. The amount of mineral content (40 wt% - 80 
wt%) was varied within the physiological range (35 wt% - 70 wt%), with the corresponding micron-scale 
porous microstructure, moduli under compression, and permeability determined. 
 
Chapter 3 evaluated the ability of the mineralized collagen-glycosaminoglycan scaffold to influence 
cellular behavior towards a functionally relevant physiological wound healing outcome only by the 
biochemical and biophysical material properties in the absence of biomolecule supplementation. Here the 
influence of the mineralized collagen-glycosaminoglycan scaffold on the primary stem cell population, 
mesenchymal stem cells, associated with the physiological bone healing process was evaluated over a 56 
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day in vitro culture period. Cellular health and activity within the collagen-glycosaminoglycan scaffolds 
was measured via cellular metabolic activity, while the expression of osteogenic genes was investigated 
with qPCR, and cellular remodeling reflected in temporal changes in mineral deposition via µCT and 
elastic moduli under hydrated unconfined compression. 
 
Chapter 4 addressed the mechanical reinforcement of the mineralized collagen-glycosaminoglycan 
scaffold for the treatment of load bearing craniofacial defects through the development of a multi-scale 
mineral polycaprolactone-collagen-glycosaminoglycan composite biomaterial. Here a mechanically 
competent macro-porous polycaprolactone support construct was impregnated with highly bioactive 
micro-porous mineralized collagen-glycosaminoglycan matrix. The biophysical material properties, 
including the bulk elastic moduli under compression and micron-scale pore architecture, were evaluated, 
while initial bioactivity was demonstrated over a 24 h in vitro culture of an animal model inspired porcine 
adipose derived stem cell culture. 
 
Chapter 5 confirmed the in vivo efficacy of the multi-scale polycaprolactone-collagen-glycosaminoglycan 
composite in a 6 week sub-critical mandibular ramus defect with a porcine animal model. Here both the 
mineralized collagen-glycosaminoglycan scaffold and the mineral polycaprolactone-collagen-
glycosaminoglycan composite was identified to have no deleterious effect on a sub-critical mandibular 
ramus defect compared to the previously established polycaprolactone support construct. The evaluation 
of new bone formation via µCT and new bone density via DXA were used as criteria to evaluate this 
initial in vivo efficacy. 
 
Chapter 6 evaluated the compositional flexibility of the mineralized collagen-glycosaminoglycan scaffold 
with the incorporation of a heparin alternative glycosaminoglycan as opposed to chondroitin sulfate. Here 
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the in vitro consequences of heparin on adipose derived stem cells was identified to promote early cellular 
metabolic activity compared to chondroitin sulfate. 
 
Chapter 7 further expanded upon the previously developed multi-compartment collagen-
glycosaminoglycan scaffold design for the treatment of craniofacial defects and supporting entheses by 
evaluating the biochemical and biophysical properties that have been identified as influencing in vitro and 
in vivo bioactivity. The incorporation of two distinct non-mineral and mineral compartments with a 
gradient interface was verified using SEM and µCT techniques, while identifying the pore microstructure 
and limiting compartments for mechanical properties and permeability. 
 
Within the context of the regenerative medicine and tissue engineering, the treatment of orthopedic 
defects, specifically craniofacial defects, requires: (1) the flexibility in design for meeting bone, defect, 
and patient specific criteria; (2) guiding and supporting orthopedic repair and remodeling both in vitro 
and in vivo; (3) the demonstration of mechanical competence for surgical implantation and subsequent 
loading during in vivo culture. This work has demonstrated the ability of the mineralized collagen-
glycosaminoglycan scaffold to meet all of these criteria. Chapters 2, 6, and 7 highlighted the flexibility of 
the collagen-glycosaminoglycan scaffold design. Chapter 3 identified the influence of the collagen-
glycosaminoglycan scaffold biophysical and biochemical properties on mesenchymal stem cells, while 
chapters 4 and 5 addressed the successful reinforcement and in vivo implantation of the polycaprolactone-
collagen-glycosaminoglycan composite biomaterial. 
 
8.2  Outstanding Questions and Future Opportunities 
The work summarized within chapters 2 through 7 has established the efficacy of the mineralized 
collagen-glycosaminoglycan scaffold in influencing cellular behavior via biophysical and biochemical 
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properties in the absence of biomolecular supplementation towards the treatment of orthopedic defects. 
Additionally, this work has outlined the development and in vivo efficacy of a multi-scale mineralized 
polycaprolactone-collagen-glycosaminoglycan composite for sub-critical craniofacial defects. However, 
future work continuing the investigation of the mineralized collagen-glycosaminoglycan platform has yet 
to investigate further grow factor integration, possible immunomodulatory effects, and the long-term and 
critical-size repair potential for craniofacial defects. 
 
Chapter 3 and 4 established that the mineralized collagen-glycosaminoglycan scaffold and multi-scale 
polycaprolactone-collagen-glycosaminoglycan composite were capable of guiding cellular behavior 
towards an osteogenic-like phenotype in the absence of growth factor supplementation. With 
collaborative work elucidating an endogenous bone morphogenetic protein (BMP) feedback loop being 
responsible for described cellular influence. However, while not necessary, the incorporation of growth 
factors, such as vascular endothelial growth factor (VEGF), may serve to enhance the innate bioactivity, 
by enhancing early vasculogenesis. This avenue of biomolecular design represents an opportunity for the 
controlled tethering and subsequent release of growth factors enhancing not only the osteogenic potential, 
but other aspects of the physiological repair process. 
Chapter 5 affirmed the in vivo efficacy of the mineral polycaprolactone-collagen-glycosaminoglycan 
composite in a sub-critical porcine mandibular ramus defect. In this study the mineral polycaprolactone-
collagen-glycosaminoglycan composite and mineralized collagen-glycosaminoglycan scaffold 
demonstrated equivalent healing potential compared to the previously established polycaprolactone 
support construct for the treatment of orthopedic defects. However, a critical-size and long term 
assessment of in vivo efficacy represents the next step in biomaterial development. 
 
Chapter 6 evaluated the potential use of heparin as an alternative glycosaminoglycan within the 
mineralized collagen-glycosaminoglycan scaffold design. While the chapter presented early metabolic 
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enhancement as a possible benefit, the effect of heparin incorporation on bone morphogenetic protein 2 
sequestration and the endogenous feedback loop activation has not been investigated. This represents a 
potential avenue of future work evaluating the role of heparin in the mineralized scaffold variants by 
influencing cellular behavior through the modulation of growth factor presentation. 
 
Finally, Chapter 7 investigated the development of a multi-compartment collagen-glycosaminoglycan 
scaffold for the treatment of entheses that may be involved in craniofacial defects. Additional efforts 
within the lab have evaluated the mechanical reinforcement of the interface and the potential for spatial 
differentiation along the interface of the multi-compartment scaffold. However, opportunities yet remain 
for the in vivo implantation of such scaffolds into a large animal model for treating craniofacial defects 
involving the enthesis.  
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APPENDIX A  
CUSTOM MATLAB CODE WRITTEN FOR DATA ANALYSIS 
A.1 Average Pore Size Analysis of Histological Samples 
 
close all 
clear 
clc 
  
list_input=dir; 
list_output=cell(1, 1);  
list_output(1) = []; 
for i = 3: length(list_input) 
    input_string = getfield(list_input(i), 'name'); 
    if ~isempty(input_string) 
        if sum(input_string(length(input_string) - 3:length(input_string)) == '.tif') == 4 
            list_output{length(list_output) + 1} = input_string; 
        end 
    end 
end 
  
for ii=1:length(list_output); 
     
    ii 
    filename=list_output{ii}; 
     
    image=imread(filename); 
     
    SETleft=0; 
    SETwidth=1; 
    SETtop=0; 
    SETheight=1; 
    AspectRatio=1; 
    scale=867; 
     
    width=round(size(image,2)*SETwidth); 
    top=round(size(image,1)*SETtop); 
    height=round(size(image,1)*SETheight); 
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    left=round(size(image,2)*SETleft); 
     
    MLxSTART=left+1; 
    MLxEND=left+width; 
    MLySTART=top+1; 
    MLyEND=top+height; 
     
    image=image(MLySTART:MLyEND,MLxSTART:MLxEND); 
     
    if size(gray,3)==3 
        gray=double(0.3*image(:,:,1)+0.59*image(:,:,2)+0.11*image(:,:,3)); 
    else 
        gray=image; 
    end 
    gray=round(double(gray)); 
    gray=abs(255-gray); 
     
    clear image 
     
    val=0:255; 
    feq=0*ones(1,256); 
    trigger=0; 
    for i=0:255 
     feq(i+1)=sum(sum(gray==i)); 
    end 
    for oo=(val(feq==max(feq))+1):256 
        if feq(oo)<=max(feq)/2 && trigger==0 
            trigger=1; 
            HWHM=oo-(val(feq==max(feq))+1); 
        end 
    end 
    threshold=val(feq==max(feq))+2.548*HWHM/3*12; 
     
    clear feq val trigger HWHM 
     
    binary=gray; 
    binary(binary<threshold)=0; 
    binary(binary>=threshold)=255; 
     
    binary=abs(255-binary); 
     
    clear gray 
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    if width<height 
        MinDim=width; 
    else 
        MinDim=height; 
    end 
    ThetaStep=pi/36; 
     
    rUser1=0*ones(36,1); 
    rUser2=rUser1; 
     
    for j=0:1:35 
         
        LineSum=0; 
        Intercepts=0; 
        x1=left; 
        y1=top; 
        Theta=j*ThetaStep; 
        nx=10*sin(Theta)*width/height; 
        ny=10*abs(cos(Theta));           
        for i=0:1:nx 
            if Theta==0 
                x1=left; 
                x2=x1+width; 
            else 
                x1=left+(width*i/(nx+1))+width/(2*(nx+1)); 
                x2=x1+(height*cos(Theta)/sin(Theta)); 
            end 
            y2=top+height; 
            if x2>=left+width 
                x2=left+width; 
                y2=y1+(x2-x1)*sin(Theta)/cos(Theta); 
            elseif x2<left 
                x2=left; 
                if Theta>pi/2 
                    y2=y1+(x2-x1)*sin(Theta)/cos(Theta); 
                end 
            end 
            plength=sqrt((x2-x1)^2+((y2-y1)/AspectRatio)^2); 
            valx=x1; 
            valy=y1; 
            dx=(x2-x1)/plength; 
            dy=(y2-y1)/plength; 
            switchh=true;      
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            if plength>=MinDim 
                LineSum=LineSum+(plength/scale); 
                for k=0:1:plength                 
                    if round(y1+k*dy+1)<=size(binary,1) && round(x1+k*dx+1)<=size(binary,2) 
                        if binary(round(y1+k*dy+1),round(x1+k*dx+1))>0 
                            indicator=true; 
                        else 
                            indicator=false; 
                        end 
                    end 
                    if switchh==true && indicator==true 
                        Intercepts=Intercepts+1; 
                        switchh=false; 
                    end 
                    if indicator==false 
                        switchh=true; 
                    end 
                end 
            end 
        end 
        for i=1:1:ny 
            if Theta<=pi/2 
                x1=left; 
                x2=left+width; 
            else 
                x1=left+width; 
                x2=left; 
            end 
            y1=top+height*i/(ny+1); 
            y2=y1+(width*sin(Theta)/abs(cos(Theta))); 
            if y2>top+height 
                y2=top+height; 
                x2=x1+((y2-y1)*cos(Theta)/sin(Theta)); 
            end 
            plength=sqrt((x2-x1)^2+((y2-y1)/AspectRatio)^2); 
            valx=x1; 
            valy=y1; 
            dx=(x2-x1)/plength; 
            dy=(y2-y1)/plength; 
            switchh=true; 
            if plength>=MinDim 
                LineSum=LineSum+(plength/scale); 
                for k=0:1:plength 
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                    if round(y1+k*dy+1)<=size(binary,1) && round(x1+k*dx+1)<=size(binary,2) 
                        if binary(round(y1+k*dy+1),round(x1+k*dx+1))>0 
                            indicator=true; 
                        else 
                            indicator=false; 
                        end 
                    end 
                    if switchh==true && indicator==true 
                        Intercepts=Intercepts+1; 
                        switchh=false; 
                    end 
                    if indicator==false 
                        switchh=true; 
                    end 
                end 
            end 
        end 
        IntLength=LineSum/Intercepts; 
        rUser1(j+1)=180*Theta/pi; 
        rUser2(j+1)=IntLength*1000; 
    end 
    maxdim=0; 
    for i=1:1:36 
        if rUser2(i)>maxdim 
            maxdim=rUser2(i); 
        end 
    end 
    width1=400; 
    height1=400; 
    pscale=0.8*(width1+height1)/(2*maxdim); 
    for i=1:1:36 
        dx1=pscale*0.5*rUser2(i)*cos(rUser1(i)*pi/180); 
        dy1=pscale*0.5*rUser2(i)*sin(rUser1(i)*pi/180); 
        if i<36 
            dx2=pscale*0.5*rUser2(i+1)*cos(rUser1(i+1)*pi/180); 
            dy2=pscale*0.5*rUser2(i+1)*sin(rUser1(i+1)*pi/180); 
        else 
            dx2=-pscale*0.5*rUser2(1)*cos(rUser1(1)*pi/180); 
            dy2=-pscale*0.5*rUser2(1)*sin(rUser1(1)*pi/180); 
        end 
    end 
    n=36; 
    sumX=0; 
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    sumY=0; 
    sumZ=0; 
    sumXY=0; 
    sumYZ=0; 
    sumXZ=0; 
    sumZsqr=0; 
    sumXsqr=0; 
    for i=1:1:n 
        Y=1/((rUser2(i)/2)^2); 
        X=cos(2*pi*rUser1(i)/180); 
        Z=sin(2*pi*rUser1(i)/180); 
        sumX=sumX+X; 
        sumY=sumY+Y; 
        sumZ=sumZ+Z; 
        sumXY=sumXY+X*Y; 
        sumYZ=sumYZ+Y*Z; 
        sumXZ=sumXZ+X*Z; 
        sumZsqr=sumZsqr+Z^2; 
        sumXsqr=sumXsqr+X^2; 
    end 
    C1=((sumXY*sumZsqr)-(sumXZ*sumYZ))/((sumXsqr*sumZsqr)-sumXZ^2); 
    C2=((sumYZ*sumXsqr)-(sumXY*sumXZ))/((sumXsqr*sumZsqr)-sumXZ^2); 
    C0=(sumY/n)-C1*(sumX/n)-C2*(sumZ/n); 
    a=1/sqrt(C0+sqrt(C1^2+C2^2)); 
    b=sqrt(sqrt(C1^2+C2^2)/(C0*sqrt(C1^2+C2^2)+C2^2-C1^2)); 
    d=1.5*2*sqrt((a^2+b^2)/2); 
       
    results(ii+1,:)={filename,threshold,C1,C2,C0,a,b,a/b,d}; 
     
end 
  
results(1,:)={'filename','threshold','C1','C2','C0','a','b','pore aspect ratio','diameter'}; 
  
time=clock; 
  
xlswrite(['PoreSizeAnalysis_' int2str(time(1)) '_' int2str(time(2)) '_' int2str(time(3)) '_' int2str(time(4)) '_' 
int2str(time(5))],results); 
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A.2 Analysis of Mineral Deposition by Human Mesenchymal Stem Cells during In Vitro 
Culture via Micro-Computed Tomography 
 
close all 
clear 
clc 
  
%%% INGREDIENTS %%% 
  
slices = 15; % Max is 225. 
voxel = 16; % Voxel size in um. 
  
filename = 'W4RG_Tomo_AreaA_Recon_Export'; 
filestart = 180; 
fileend = 325; 
  
%%% MAKE MATRIX %%% 
  
time = clock; 
time_label = ['_' int2str(time(1)) '_' int2str(time(2)) '_' int2str(time(3)) '_' int2str(time(4)) '_' 
int2str(time(5)) '_' int2str(time(6))]; 
  
for i = filestart:fileend 
    if i<10 
        file = [filename '000' int2str(i)]; 
    elseif i<100 
        file = [filename '00' int2str(i)]; 
    elseif i<1000 
        file = [filename '0' int2str(i)]; 
    else 
        file = [filename int2str(i)]; 
    end  
    image = imread(file,'tif');  
    if i==filestart 
        matrix=0.*ones(size(image,1),size(image,2),fileend-filestart+1); 
        matrix(:,:,i-filestart+1)=image(:,:,1); 
    else 
        matrix(:,:,i-filestart+1)=image(:,:,1); 
    end 
    disp([int2str(i-filestart) '/' int2str(fileend-filestart)]); 
 155 
 
end 
clear image file i 
  
%%% DEFINING CIRCULAR LOGIC %%% 
  
north=[]; 
south=[]; 
east=[]; 
west=[]; 
for z = 1:size(matrix,3) 
    count = 1; 
    crust = 0; 
    while crust == 0 
            if sum(matrix(count,:,z)~=0)>0 
                crust = 1; 
                if isempty(north) 
                    north = count; 
                else 
                    north = mean([north count]); 
                end 
            end 
        count = count+1; 
    end 
    count = size(matrix,1); 
    crust = 0; 
    while crust == 0 
            if sum(matrix(count,:,z)~=0)>0 
                crust = 1; 
                if isempty(south) 
                    south = count; 
                else 
                    south = mean([south count]); 
                end 
            end 
        count = count-1; 
    end 
    count = 1; 
    crust = 0; 
    while crust == 0 
        if sum(matrix(:,count,z)~=0)>0 
            crust = 1; 
            if isempty(west) 
                west = count; 
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            else 
                west = mean([west count]); 
            end 
        end 
        count = count+1; 
    end  
    count = size(matrix,2); 
    crust = 0; 
    while crust == 0 
        if sum(matrix(:,count,z)~=0)>0 
            crust = 1; 
            if isempty(east) 
                east = count; 
            else 
                east = mean([east count]); 
            end 
        end 
        count = count-1; 
    end 
end 
center = [round(mean([north south])) round(mean([west east]))]; 
radius = max([center(1)-north south-center(1) center(2)-west east-center(2)]); 
image = ceil(0.8.*matrix(:,:,round(size(matrix,3)/2))); 
remember = image; 
count = 3; 
crust = 0; 
while crust == 0 
    if center(1)+count<=size(image,1) && center(1)-count>=1 && center(2)+count<=size(image,2) && 
center(2)-count>=1 
        crust = 1; 
        image(center(1)-count:center(1)+count,center(2)-count:center(2)+count)=255; 
    else 
        count=count-1; 
    end 
end 
count = 3; 
crust = 0; 
vector = [center(1)-north south-center(1) center(2)-west east-center(2)]; 
while crust == 0 
    if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
        crust = 1; 
        for theta = 0:2*pi()/180:2*pi() 
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            x = round(radius*cos(theta)); 
            y = round(radius*sin(theta)); 
            image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
        end 
    elseif count > 0 
        count = count-1; 
    elseif count == 0 && length(vector)>1 
        count = 3; 
        vector(vector == max(vector)) = []; 
        radius = max(vector); 
        disp('STATUS: Decreased radius.'); 
    else 
        crust = 1; 
        disp('ERROR: Radius is too big.'); 
    end 
end 
condition = 'no'; 
while ~strcmp(condition,'yes') 
    close all; 
    figure; 
    imshow(image, [0 255]); 
    condition = input('Is ths correct (yes or no): ','s'); 
    if strcmp(condition,'no')     
        condition = input('What is wrong (center or radius): ','s');         
        if strcmp(condition,'center')         
            disp(['Current center is: ' int2str(center(1)) ',' int2str(center(2))]); 
            disp(['Current radius is: ' int2str(radius)]); 
            center(1) = input('Please input new row (y,1) coordinate for center: '); 
            center(2) = input('Please input new column (x,2) coordinate for center: ');                                     
        elseif strcmp(condition,'radius') 
            disp(['Current center is: ' int2str(center(1)) ',' int2str(center(2))]); 
            disp(['Current radius is: ' int2str(radius)]);         
            radius = input('Please input new radius: ');             
        end 
        image = ceil(0.8.*matrix(:,:,round(size(matrix,3)/2))); 
        count = 3; 
        crust = 0; 
        while crust == 0 
            if center(1)+count<=size(image,1) && center(1)-count>=1 && center(2)+count<=size(image,2) 
&& center(2)-count>=1 
                crust = 1; 
                image(center(1)-count:center(1)+count,center(2)-count:center(2)+count)=255; 
            else 
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                count=count-1; 
            end 
        end         
        count = 3; 
        crust = 0; 
        while crust == 0 
            if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
                crust = 1; 
                for theta = 0:2*pi()/90:2*pi() 
                    x = round(radius*cos(theta)); 
                    y = round(radius*sin(theta)); 
                    image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
                end 
            elseif count > 0 
                count = count-1; 
            elseif count == 0 
                count = 3; 
                radius = input('Radius is too big. Please input new radius: '); 
            end 
        end 
    end 
end 
imwrite(image,[filename '_center_and_radius_C' time_label],'gif'); 
clear count y x image theta crust condition vector north south east west 
  
%%% CLEARING THE AIR %%% 
  
air = cell(1,2); 
airzone = 0.*matrix(:,:,round(size(matrix,3)/2)); 
for y = 1:size(airzone,1) 
    for x = 1:size(airzone,2) 
        if sqrt((y-center(1))^2+(x-center(2))^2)>radius 
            airzone(y,x) = 1; 
        end 
    end 
end 
image = matrix(:,:,round(size(matrix,3)/2)); 
air{1,1} = max(max(image(airzone>0))); 
air{1,2}='max'; 
image = image - air{1,1}; 
image(image<0) = 0; 
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disp(['Background removed: ' int2str(sum(sum(image(airzone>0)==0))) ' out of ' 
int2str(sum(sum(airzone==1)))]); 
histogram = zeros(1,256); 
count = 3; 
crust = 0; 
while crust == 0 
    if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
        crust = 1; 
        for theta = 0:2*pi()/90:2*pi()                    
            x = round(radius*cos(theta)); 
            y = round(radius*sin(theta)); 
            image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
        end 
    elseif count > 0 
        count = count-1; 
    else 
        crust = 1; 
    end 
end 
close all 
figure; 
imshow(image, [0 255]); 
condition = 'no'; 
while ~strcmp(condition,'yes') 
    disp(['Current background value: ' int2str(air{1,1})]); 
    condition = input('Is this correct (yes or no): ','s'); 
    if strcmp(condition,'no') 
        image = matrix(:,:,round(size(matrix,3)/2)); 
        condition = input('Set air as (max, mean, custom): ','s'); 
        if strcmp(condition,'max') 
            air{1,1} = max(max(image(airzone>0))); 
            air{1,2} = 'max'; 
        elseif strcmp(condition,'mean') 
            air{1,1} = mean(mean(image(airzone>0))); 
            air{1,2} = 'mean'; 
        elseif strcmp(condition,'custom') 
            for z = 0:255 
                histogram(z+1) = sum(sum(image==z)); 
            end 
            figure; 
            plot(0:255,histogram); 
            air{1,1} = input('Please input new background value: '); 
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            air{1,2} = 'custom'; 
        end 
        image = image - air{1,1}; 
        image(image<0) = 0; 
        disp(['Background removed: ' int2str(sum(sum(image(airzone>0)==0))) ' out of ' 
int2str(sum(sum(airzone==1)))]); 
        count = 3; 
        crust = 0; 
        while crust == 0 
            if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
                crust = 1; 
                for theta = 0:2*pi()/90:2*pi()                    
                    x = round(radius*cos(theta)); 
                    y = round(radius*sin(theta)); 
                    image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
                end 
            elseif count > 0 
                count = count-1; 
            else 
                crust = 1; 
            end 
        end 
        close all 
        figure; 
        imshow(image,[0 255]); 
    end 
end 
imwrite(image,[filename '_threshold_post_C' time_label],'gif'); 
image = matrix(:,:,round(size(matrix,3)/2)); 
image = image - air{1,1}; 
imwrite(image,[filename '_threshold_post' time_label],'gif'); 
if strcmp(air{1,2},'max') 
    for z = 1:size(matrix,3) 
        temporary = matrix(:,:,z); 
        temporary = temporary-max(max(temporary(airzone==1))); 
        matrix(:,:,z)=temporary; 
    end 
elseif strcmp(air{1,2},'mean') 
    temporary = matrix(:,:,z); 
    temporary = temporary-mean(mean(temporary(airzone==1))); 
    matrix(:,:,z)=temporary; 
elseif strcmp(air{1,2},'custom') 
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    matrix=matrix-air{1,1}; 
end         
matrix(matrix<0) = 0; 
clear crust count image y x theta histogram z condition temporary airzone 
  
%%% REDO CIRCULAR LOGIC %%% 
  
condition = input('Would you like to alter the radius prior to partitioning (yes or no): ','s'); 
if strcmp(condition,'yes') 
     
    image = ceil(0.8.*matrix(:,:,round(size(matrix,3)/2))); 
    count = 3; 
    crust = 0; 
    while crust == 0 
        if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
            crust = 1; 
            for theta = 0:2*pi()/90:2*pi()                    
                x = round(radius*cos(theta)); 
                y = round(radius*sin(theta)); 
                image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
            end 
        elseif count > 0 
            count = count-1; 
        else 
            crust = 1; 
        end 
    end  
     
    condition = 'no'; 
    contrast = 0; 
    while ~strcmp(condition,'yes') 
        close all; 
        figure; 
        imshow(image, [0 255]); 
        condition = input('Is ths correct (yes or no): ','s'); 
        if strcmp(condition,'no')     
            condition = input('What is wrong (center, radius, or contrast): ','s');         
            if strcmp(condition,'center')         
                disp(['Current center is: ' int2str(center(1)) ',' int2str(center(2))]); 
                disp(['Current radius is: ' int2str(radius)]); 
                center(1) = input('Please input new row (y,1) coordinate for center: '); 
                center(2) = input('Please input new column (x,2) coordinate for center: ');                                     
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            elseif strcmp(condition,'radius') 
                disp(['Current center is: ' int2str(center(1)) ',' int2str(center(2))]); 
                disp(['Current radius is: ' int2str(radius)]);         
                radius = input('Please input new radius: ');    
            elseif strcmp(condition,'contrast') 
                contrast = 1; 
            end 
            if contrast == 1 
                image = remember; 
            else 
                image = ceil(0.8.*matrix(:,:,round(size(matrix,3)/2))); 
            end 
            count = 3; 
            crust = 0; 
            while crust == 0 
                if center(1)+count<=size(image,1) && center(1)-count>=1 && 
center(2)+count<=size(image,2) && center(2)-count>=1 
                    crust = 1; 
                    image(center(1)-count:center(1)+count,center(2)-count:center(2)+count)=255; 
                else 
                    count=count-1; 
                end 
            end 
            count = 3; 
            crust = 0; 
            while crust == 0 
                if center(1)+radius+count<=size(image,1) && center(1)-radius-count>=1 && 
center(2)+radius+count<=size(image,2) && center(2)-radius-count>=1 
                    crust = 1; 
                    for theta = 0:2*pi()/90:2*pi() 
                        x = round(radius*cos(theta));                     
                        y = round(radius*sin(theta));                         
                        image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
                    end 
                elseif count > 0 
                    count = count-1; 
                elseif count == 0                 
                    count = 3; 
                    radius = input('Radius is too big. Please input new radius: '); 
                end 
            end 
        end 
    end 
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    imwrite(image,[filename '_center_and_radius_C' time_label],'gif'); 
end 
  
%%% TANGENTIAL PIE SLICING %%% 
     
if slices > radius 
    slices = radius; 
end 
zones = zeros(size(matrix,1),size(matrix,2),slices); 
for y = 1:size(matrix,1) 
    for x = 1:size(matrix,2) 
        if sqrt((y-center(1))^2+(x-center(2))^2)<radius 
            for z = 1:slices 
                if sqrt((y-center(1))^2+(x-center(2))^2)>=(z-1)*radius/slices && sqrt((y-center(1))^2+(x-
center(2))^2)<z*radius/slices 
                    zones(y,x,z)=1; 
                    break 
                end 
            end 
        end 
    end 
end 
image = zeros(size(zones,1),size(zones,2)); 
for z = 1:slices 
    image = image+zones(:,:,z)*round((z-1)*255/slices); 
end 
figure; 
imshow(image,[0 255]); 
imwrite(image,[filename '_slices' time_label],'gif'); 
  
image = round(0.8*matrix(:,:,round(size(matrix,3)/2))); 
for z = 1:slices 
    count = 1; 
    crust = 0; 
    filling = z/slices*radius; 
    while crust == 0; 
        if center(1)+filling+count<=size(image,1) && center(1)-filling-count>=1 && 
center(2)+filling+count<=size(image,2) && center(2)-filling-count>=1 
            crust = 1; 
            for theta = 0:2*pi()/180:2*pi() 
                x = round(filling*cos(theta)); 
                y = round(filling*sin(theta)); 
                image(center(1)+y-count:center(1)+y+count,center(2)+x-count:center(2)+x+count)=255; 
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            end 
        elseif count>0 
            count = count+1; 
        else 
            crust = 1; 
            disp(['ERROR IN CREATING ' filename '_slices_overlay']); 
        end 
    end 
end 
figure; 
imshow(image,[0 255]); 
imwrite(image,[filename '_slices_overlay' time_label],'gif'); 
  
clear z image y x filling crust theta count 
  
%%% PREPARING THE PIE PAN %%% 
  
excel = cell(size(matrix,3)+4,size(zones,3)+2); 
excel{4,1} = 'File Name:'; 
excel{4,2} = 'Stack Distance:'; 
excel{3,2} = 'Radial Distance:'; 
for z = 1:slices 
    excel{2,2+z} = ['Slice #' int2str(z)]; 
    excel{3,2+z} = [int2str((z-1)*radius/slices*voxel) '-' int2str(z*radius/slices*voxel) ' um']; 
end 
for z = filestart:filestart+size(matrix,3)-1 
    if z<10 
        excel{5+z-filestart,1} = [filename '000' int2str(z)]; 
    elseif z<100 
        excel{5+z-filestart,1} = [filename '00' int2str(z)]; 
    elseif z<1000 
        excel{5+z-filestart,1} = [filename '0' int2str(z)]; 
    else 
        excel{5+z-filestart,1} = [filename int2str(z)]; 
    end  
    excel{5+z-filestart,2} = [int2str((z-filestart)*voxel) ' um']; 
end    
     
%%% BAKING THE SLICED PIE %%% 
  
for y = 1:size(matrix,3) 
    for x = 1:size(zones,3) 
        temporary=matrix(:,:,y).*zones(:,:,x)+zones(:,:,x)-1; 
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        excel{4+y,2+x}=mean(temporary(temporary>=0)); 
    end 
end 
excel{1,2}=['Variables: filename = ' filename '; filestart = ' int2str(filestart) '; fileend = ' int2str(fileend) '; 
slices = ' int2str(slices) '; air setting = ' air{1,2} '; air threshold = ' int2str(air{1,1}) 'center = [' 
int2str(center(1)) ',' int2str(center(2)) ']; radius = ' int2str(radius) ' pixels']; 
time=clock; 
excel{1,1}=['Time: Year = ' int2str(time(1)) '; Month = ' int2str(time(2)) '; Day = ' int2str(time(3)) '; Hour 
= ' int2str(time(4)) '; Minute = ' int2str(time(5)) '; Second = ' int2str(time(6))]; 
if slices+2<225 
    xlswrite(['IMAGE_DENSITY_' int2str(time(1)) '_' int2str(time(2)) '_' int2str(time(3)) '_' 
int2str(time(4)) '_' int2str(time(5)) '_' int2str(time(6))],excel,1); 
end 
load gong; 
wavplay(y,Fs); 
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A.3 Analysis of New Bone Formation in Sub-Critical Porcine Mandibular Ramus 
Defects during In Vivo Culture 
 
close all 
clear 
clc 
  
%%% Settings %%% 
  
filename = input('Please input the file name without the file number (ie 
pig1390_R3_Tomo_AreaA_recon2_Export0001 inputs pig1390_R3_Tomo_AreaA_recon2_Export): ','s'); 
filestart = input('Please input the file number associated with the first file (ie 0230 is added as 230): '); 
fileend = input('Please input the file number associated with the last file (ie 0832 maybe added as 832): '); 
type = input('Please input the file extension (jpeg, tif, gif, etc): ','s'); 
version = 'fff.1440.09092015'; 
font = input('Please input font for identification of ROI (2 is recommeneded): '); 
parts = input('Please input the number of radial partitions (15 is recommended): '); 
angles = input('Please input the number of angular partitions (18 is recommended): '); 
voxel = input('Please input the voxel size in um: '); 
bit_d = input('Please input the image bit depth (8 is typical): '); 
  
%%% Select plane %%% 
  
i = round((fileend+filestart)/2); 
if i<10 
    file = [filename '000' int2str(i)]; 
elseif i<100 
    file = [filename '00' int2str(i)]; 
elseif i<1000 
    file = [filename '0' int2str(i)]; 
else 
    file = [filename int2str(i)]; 
end 
image = imread(file,type); 
y_size = size(image,1); 
x_size = size(image,2); 
z_size = fileend-filestart+1; 
y_end = size(image,1); 
x_end = size(image,2); 
y_start = 1; 
x_start = 1; 
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z_start = 1; 
z_end = fileend-filestart+1; 
YX = zeros(size(image,1),size(image,2),2); 
YX(:,:,1) = image(:,:,1); 
ZY = zeros(fileend-filestart+1,size(image,1),2); 
ZX = zeros(fileend-filestart+1,size(image,2),2); 
clear image i 
  
for i = filestart:fileend 
    if i<10 
        file = [filename '000' int2str(i)]; 
    elseif i<100 
        file = [filename '00' int2str(i)]; 
    elseif i<1000 
        file = [filename '0' int2str(i)]; 
    else 
        file = [filename int2str(i)]; 
    end 
    image = imread(file,type); 
    ZX(i-filestart+1,:,1) = image(round(size(image,1)/2),:,1); 
    ZY(i-filestart+1,:,1) = rot90(image(:,round(size(image,2)/2),1)); 
    clear image 
end 
clear file i 
ref = round(0.8*YX(:,:,1)); 
  
figure(1); 
subplot(1,3,1); 
subimage(YX(:,:,1),[0 2^bit_d-1]); 
title('YX plane'); 
subplot(1,3,2); 
subimage(ZY(:,:,1),[0 2^bit_d-1]); 
title('ZY plane'); 
subplot(1,3,3); 
subimage(ZX(:,:,1),[0 2^bit_d-1]); 
title('ZX plane'); 
saveas(1,[filename '_planes.jpg']); 
shg; 
  
answer = 'figure'; 
while ~strcmp(answer,'yes') 
    plane = input('Please select a plane to perform analysis on (YX, ZY, or ZX): ','s'); 
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    if strcmp(answer,'figure') 
        figure(2); 
        answer = 'no'; 
    end 
    if strcmp(plane,'YX') 
        imshow(YX(:,:,1),[0 2^bit_d-1]); 
        shg; 
        answer = input('Is this correct the correct plane (yes or no): ','s'); 
    elseif strcmp(plane,'ZY') 
        imshow(ZY(:,:,1),[0 2^bit_d-1]); 
        shg; 
        answer = input('Is this correct the correct plane (yes or no): ','s'); 
    elseif strcmp(plane,'ZX') 
        imshow(ZX(:,:,1),[0 2^bit_d-1]); 
        shg; 
        answer = input('Is this correct the correct plane (yes or no): ','s'); 
    end 
end 
saveas(2,[filename '_planeselected.jpg']); 
close all 
  
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%% ALL CODING FOR ZY PLANE %% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
%%% Select start and end %%% 
  
if strcmp(plane,'ZY') 
     
    figure(1); 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
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            image = imread(file,type); 
            ZY(i-filestart+1,:,1) = rot90(image(:,x_start,1)); 
            clear image file i 
        end 
        i = round((filestart+fileend)/2); 
        if i<10 
            file = [filename '000' int2str(i)]; 
        elseif i<100 
            file = [filename '00' int2str(i)]; 
        elseif i<1000 
            file = [filename '0' int2str(i)]; 
        else 
            file = [filename int2str(i)]; 
        end 
        image = imread(file,type); 
        ref = image(:,:,1); 
        clear image file i 
         
        if x_start-font<1 
            ref(:,x_start:x_start+2*font,1) = 2^bit_d-1; 
        elseif x_start+font>x_size 
            ref(:,x_start-2*font:x_start,1) = 2^bit_d-1; 
        else 
            ref(:,x_start-font:x_start+font,1) = 2^bit_d-1; 
        end 
        subplot(1,2,1); 
        subimage(ref,[0 2^bit_d-1]); 
        title('XY reference'); 
        subplot(1,2,2); 
        subimage(ZY(:,:,1),[0 2^bit_d-1]); 
        shg; 
        title(['First image ' int2str(x_start)]); 
        answer = input('Is this the image to start analysis on (yes or no): ','s'); 
        if strcmp(answer,'no') 
            x_start = input(['Please select a new image to start analysis on (1 to ' int2str(x_end) '): ']); 
        elseif strcmp(answer,'yes') 
            saveas(1,[filename '_firstimage.jpg']); 
        end 
    end 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        for i = filestart:fileend 
            if i<10 
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                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            x_size = size(image,2); 
            ZY(i-filestart+1,:,2) = rot90(image(:,x_end,1)); 
            clear image file i ref 
        end 
        ref = round(0.8*YX(:,:,1)); 
        if x_end-font<1 
            ref(:,x_end:x_end+2*font,1) = 2^bit_d-1; 
        elseif x_end+font>x_size 
            ref(:,x_end-2*font:x_end,1) = 2^bit_d-1; 
        else 
            ref(:,x_end-font:x_end+font,1) = 2^bit_d-1; 
        end 
        subplot(1,2,1); 
        subimage(ref,[0 2^bit_d-1]); 
        title('XY reference'); 
        subplot(1,2,2); 
        subimage(ZY(:,:,2),[0 2^bit_d-1]); 
        title(['Last image ' int2str(x_end)]); 
        shg; 
        answer = input('Is this the image to end analysis on (yes or no): ','s'); 
        if strcmp(answer,'no') 
            x_end = input(['Please select a new image to end analysis on (' int2str(x_start+1) ' to ' 
int2str(x_size) '): ']); 
        elseif strcmp(answer,'yes') 
            saveas(1,[filename '_lastimage.jpg']); 
        end 
    end 
     
    close all 
    clear ref 
     
     
    %%% Select radius and center %%% 
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    for i = filestart:fileend 
        if i<10 
            file = [filename '000' int2str(i)]; 
        elseif i<100 
            file = [filename '00' int2str(i)]; 
        elseif i<1000 
            file = [filename '0' int2str(i)]; 
        else 
            file = [filename int2str(i)]; 
        end 
        image = imread(file,type); 
        ZY(i-filestart+1,:,1) = rot90(round(0.8*image(:,x_start,1))); 
        ZY(i-filestart+1,:,2) = rot90(round(0.8*image(:,x_end,1))); 
        clear image file i 
    end 
    center = zeros(x_size,2); 
    center(x_start,1) = round(size(ZY,1)/2);%% 
    center(x_start,2) = round(size(ZY,2)/2);%% 
    radius = round((sqrt(center(x_start,1)^2+center(x_start,2)^2))/2); 
    answer = 'no'; 
    figure(1); 
    while ~strcmp(answer,'yes') 
        for theta = 0:2*pi()/180:2*pi() 
            y = round(radius*cos(theta))+center(x_start,2); 
            z = round(radius*sin(theta))+center(x_start,1); 
            if y < 1 
                y = 1; 
            elseif y>y_size 
                y = y_size; 
            end 
            if z<1 
                z = 1; 
            elseif z>z_size 
                z = z_size; 
            end 
            if y-font<1 
                if z-font<1 
                    ZY(z:z+2*font,y:y+2*font,1) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
                    ZY(z-2*font:z,y:y+2*font,1) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y:y+2*font,1) = 2^bit_d-1; 
                end 
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            elseif y+font>size(ZY,2) 
                if z-font<1 
                    ZY(z:z+2*font,y-2*font:y,1) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
                    ZY(z-2*font:z,y-2*font:y,1) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y-2*font:y,1) = 2^bit_d-1; 
                end 
            else 
                if z-font<1 
                    ZY(z:z+2*font,y-font:y+font,1) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
                    ZY(z-2*font:z,y-font:y+font,1) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y-font:y+font,1,1) = 2^bit_d-1; 
                end 
            end 
        end 
        subplot(1,2,1); 
        imshow(ZY(:,:,1),[0 2^bit_d-1]); 
        title('First image'); 
        subplot(1,2,2); 
        imshow(ZY(:,:,2),[0 2^bit_d-1]); 
        title('Last image'); 
        shg; 
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (center or radius): ','s'); 
            if strcmp(answer,'center') 
                disp(['Current center is: ' int2str(center(x_start,1)) ',' int2str(center(x_start,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(x_start,1) = input('Please input new row (z,1) coordinate for the center: '); 
                center(x_start,2) = input('Please input new column (y,2) coordinate for the center: '); 
            elseif strcmp(answer,'radius') 
                disp(['Current center is: ' int2str(center(x_start,1)) ',' int2str(center(x_start,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input new radius: '); 
            end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
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                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZY(i-filestart+1,:,1) = rot90(round(0.8*image(:,x_start,1))); 
                clear image file i 
            end 
             
        end 
    end 
    answer = 'no'; 
    if center(x_end,1)==0 && center(x_end,2)==0%% 
        center(:,1) = center(x_start,1);%% 
        center(:,2) = center(x_start,2);%% 
    end%% 
    while ~strcmp(answer,'yes') 
        for theta = 0:2*pi()/180:2*pi() 
            y = round(radius*cos(theta))+center(x_end,2); 
            z = round(radius*sin(theta))+center(x_end,1); 
            if y < 1 
                y = 1; 
            elseif y>y_size 
                y = y_size; 
            end 
            if z<1 
                z = 1; 
            elseif z>z_size 
                z = z_size; 
            end 
            if y-font<1 
                if z-font<1 
                    ZY(z:z+2*font,y:y+2*font,2) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
                    ZY(z-2*font:z,y:y+2*font,2) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y:y+2*font,2) = 2^bit_d-1; 
                end 
            elseif y+font>size(ZY,2) 
                if z-font<1 
                    ZY(z:z+2*font,y-2*font:y,2) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
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                    ZY(z-2*font:z,y-2*font:y,2) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y-2*font:y,2) = 2^bit_d-1; 
                end 
            else 
                if z-font<1 
                    ZY(z:z+2*font,y-font:y+font,2) = 2^bit_d-1; 
                elseif z+font>size(ZY,1) 
                    ZY(z-2*font:z,y-font:y+font,2) = 2^bit_d-1; 
                else 
                    ZY(z-font:z+font,y-font:y+font,2) = 2^bit_d-1; 
                end 
            end 
        end 
        subplot(1,2,2); 
        imshow(ZY(:,:,2),[0 2^bit_d-1]); 
        title('Last image'); 
        shg; 
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (center or radius): ','s'); 
            if strcmp(answer,'center') 
                disp(['Current center is: ' int2str(center(x_end,1)) ',' int2str(center(x_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(x_end,1) = input('Please input new row (z,1) coordinate for the center: '); 
                center(x_end,2) = input('Please input new column (y,2) coordinate for the center: '); 
            elseif strcmp(answer,'radius') 
                disp(['Current center is: ' int2str(center(x_end,1)) ',' int2str(center(x_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input new radius: '); 
            end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZY(i-filestart+1,:,2) = rot90(round(0.8*image(:,x_end,1))); 
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                clear image file i 
            end 
        end 
    end 
    saveas(1,[filename '_ROI1.jpg']); 
    close all 
     
    %%% Shifting ROI %%% 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        z_change = (center(x_end,1)-center(x_start,1))/(x_end-x_start); 
        y_change = (center(x_end,2)-center(x_start,2))/(x_end-x_start); 
        x_change = 1; 
        for x = 1:x_start-1 
            center(x,1) = center(x_start,1)-round(z_change*(x_start-x)); 
            center(x,2) = center(x_start,2)-round(y_change*(x_start-x)); 
        end 
        for x = x_start+1:x_end-1 
            center(x,1) = center(x_start,1)+round(z_change*(x-x_start)); 
            center(x,2) = center(x_start,2)+round(y_change*(x-x_start)); 
        end 
        for x = x_end+1:x_size 
            center(x,1) = center(x_end,1)+round(z_change*(x-x_end)); 
            center(x,2) = center(x_end,2)+round(y_change*(x-x_end)); 
        end 
        a = x_end-x_start;%% 
        b = center(x_end,2)-center(x_start,2);%% 
        c = center(x_end,1)-center(x_start,1);%% 
        count = 1; 
        figure(3); 
        for x = x_start:round((x_end-x_start)/5):x_end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
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                ZY(i-filestart+1,:,1) = rot90(round(0.8*image(:,x,1))); 
                clear image file i 
            end 
            for y = 1:y_size 
                for z = 1:z_size 
                    xo = x-x_start;%% 
                    yo = y-center(x_start,2);%% 
                    zo = z-center(x_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        if z-font<1 
                            if y-font<1 
                                ZY(z:z+2*font,y:y+2*font) = 2^bit_d-1; 
                            elseif y+font>y_size 
                                ZY(z:z+2*font,y-2*font:y) = 2^bit_d-1; 
                            else 
                                ZY(z:z+2*font,y-font:y+font) = 2^bit_d-1; 
                            end 
                        elseif z+font>z_size 
                            if y-font<1 
                                ZY(z-2*font:z,y:y+2*font) = 2^bit_d-1; 
                            elseif y+font>y_size 
                                ZY(z-2*font:z,y-2*font:y) = 2^bit_d-1; 
                            else 
                                ZY(z-2*font:z,y-font:y+font) = 2^bit_d-1; 
                            end 
                        else 
                            if y-font<1 
                                ZY(z-font:z+font,y:y+2*font) = 2^bit_d-1; 
                            elseif y+font>y_size 
                                ZY(z-font:z+font,y-2*font:y) = 2^bit_d-1; 
                            else 
                                ZY(z-font:z+font,y-font:y+font) = 2^bit_d-1; 
                            end 
                        end 
                    end 
                end 
            end 
            subplot(2,3,count); 
            imshow(ZY(:,:,1),[0 2^bit_d-1]); 
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            title(['Image ' int2str(x)]); 
            count = count+1; 
        end 
        shg; 
        answer = input('Is this ROI correct for all images displaed (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (radius, center): ','s'); 
            if strcmp(answer,'radius') 
                disp(['First image center is: ' int2str(center(x_start,1)) ',' int2str(center(x_start,2))]); 
                disp(['Last image center is: ' int2str(center(x_end,1)) ',' int2str(center(x_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input a new radius: '); 
            elseif strcmp(answer,'center') 
                disp(['First center is: ' int2str(center(x_start,1)) ',' int2str(center(x_start,2))]); 
                disp(['Current radius is: ' int2str(radius)]); 
                center(x_start,1) = input('Please input a new row (z,1) for the first image center: '); 
                center(x_start,2) = input('Please input a new column (y,2) for the first image center: '); 
                disp(['Last image center is: ' int2str(center(x_end,1)) ',' int2str(center(x_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(x_end,1) = input('Please input a new row (z,1) for the last image center: '); 
                center(x_end,2) = input('Please input a new column (y,2) for the last image center: '); 
            end 
        elseif strcmp(answer,'yes') 
            saveas(3,[filename '_ROI2.jpg']); 
            ostart = ['x' int2str(x_start) ',y' int2str(center(x_start,2)) ',z' int2str(center(x_start,1))]; 
            oend = ['x' int2str(x_end) ',y' int2str(center(x_end,2)) ',z' int2str(center(x_end,1))]; 
        else 
            disp('Invalid input'); 
        end 
        close all 
    end 
    o_start = x_start; 
    o_end = x_end; 
     
    %%% Threshold %%% 
     
    ZY = zeros(z_size,y_size,1); 
    threshold_in = zeros(1,2^bit_d); 
    threshold_all = zeros(1,2^bit_d); 
    for x = x_start:round((x_end-x_start)/5):x_end 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
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            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZY(i-filestart+1,:,1) = rot90(round(image(:,x,1))); 
            clear image file i 
        end 
        for y = 1:y_size 
            for z = 1:z_size 
                threshold_all(1,ZY(z,y)+1) = threshold_all(1,ZY(z,y)+1)+1; 
                 
                xo = x-x_start;%% 
                yo = y-center(x_start,2);%% 
                zo = z-center(x_start,1);%% 
                t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                 
                if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                    threshold_in(1,ZY(z,y)+1) = threshold_in(1,ZY(z,y)+1)+1; 
                end 
            end 
        end 
    end 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        figure(1); 
        subplot(1,2,1); 
        plot(0:2^bit_d-1,threshold_all) 
        title('Histogram'); 
        subplot(1,2,2); 
        plot(0:2^bit_d-1,threshold_in); 
        title('ROI histogram'); 
        threshold = input(['Please select a threshold value (0 to ' int2str(2^bit_d-1) '): ']); 
        figure(2) 
        count = 1; 
        for x = x_start:x_end-x_start:x_end 
            for i = filestart:fileend 
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                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZY(i-filestart+1,:,1) = rot90(round(image(:,x,1))); 
                clear image file i 
            end 
            subplot(2,2,count); 
            subimage(ZY,[0 2^bit_d-1]); 
            title(['ZY' int2str(x)]); 
            ZY(ZY<threshold) = 0; 
            ZY(ZY>=threshold) = 2^bit_d-1; 
            subplot(2,2,count+1); 
            subimage(ZY,[0 2^bit_d-1]); 
            title(['ZY' int2str(x) ' binary']); 
            count = count+2; 
        end 
        answer = input('Is this threshold value correct (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_threshold.jpg']); 
            saveas(2,[filename '_binary1.jpg']); 
        end 
        close all 
    end 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        count = 1; 
        figure(1); 
        for x = x_start:round((x_end-x_start)/5):x_end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
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                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZY(i-filestart+1,:,1) = rot90(round(image(:,x,1))); 
                clear image file i 
            end 
            subplot(2,3,count); 
            ZY(ZY<threshold) = 0; 
            ZY(ZY>=threshold) = 2^bit_d-1; 
            subimage(ZY,[0 2^bit_d-1]); 
            title(['ZY' int2str(x) ' binary']); 
            count = count+1; 
        end 
        answer = input('Is this threshold value correct throughout the depth (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_binary2.jpg']); 
        elseif strcmp(answer,'no') 
            figure(2); 
            subplot(1,2,1); 
            plot(threshold_all,0:2^bit_d-1) 
            title('Histogram'); 
            subplot(1,2,2); 
            plot(threshold_in,0:2^bit_d-1); 
            title('ROI histogram'); 
            threshold = input(['Please select a threshold value (0 to ' int2str(2^bit_d-1) '): ']); 
        end 
        close all 
    end 
    clear count x ZY threshold_all threshold_in x y z xt yt zt xtt ytt ztt r d 
     
    %%% Trimming %%% 
     
    c_start = x_start; 
    c_end = x_end; 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        YX = zeros(y_size,x_size,3); 
        ZY = zeros(z_size,y_size,3); 
        ZX = zeros(z_size,x_size,3); 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
 181 
 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZY(i-filestart+1,:,1) = rot90(image(:,x_start,1)); 
            ZY(i-filestart+1,:,2) = rot90(image(:,round((x_start+x_end)/2),1)); 
            ZY(i-filestart+1,:,3) = rot90(image(:,x_end,1)); 
            ZX(i-filestart+1,:,1) = image(y_start,:,1); 
            ZX(i-filestart+1,:,2) = image(round((y_start+y_end)/2),:,1); 
            ZX(i-filestart+1,:,3) = image(y_end,:,1); 
            clear image file i 
        end 
        count = 1; 
        for i = round(z_start:(z_end-z_start)/2:z_end) 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            YX(:,:,count) = image(:,:,1); 
            count = count+1; 
            clear image file i 
        end 
        image = YX(:,:,2); 
        YX(:,:,2) = YX(:,:,3); 
        YX(:,:,3) = image; 
        clear count image 
         
        a = c_end-c_start; 
        b = center(c_end,2)-center(c_start,2); 
        c = center(c_end,1)-center(c_start,1); 
         
        count = 0; 
        for z = round(z_start:(z_end-z_start)/2:z_end) 
 182 
 
            count = count+1; 
            for x = 1:x_size 
                if center(x,2)-font<1 
                    if x-font<1 
                        YX(center(x,2):center(x,2)+2*font,x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        YX(center(x,2):center(x,2)+2*font,x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        YX(center(x,2):center(x,2)+2*font,x-font:x+font,count) = 2^bit_d-1; 
                    end 
                elseif center(x,2)+font>y_size 
                    if x-font<1 
                        YX(center(x,2)-2*font:center(x,2),x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        YX(center(x,2)-2*font:center(x,2),x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        YX(center(x,2)-2*font:center(x,2),x-font:x+font,count) = 2^bit_d-1; 
                    end 
                else 
                    if x-font<1 
                        YX(center(x,2)-font:center(x,2)+font,x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        YX(center(x,2)-font:center(x,2)+font,x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        YX(center(x,2)-font:center(x,2)+font,x-font:x+font,count) = 2^bit_d-1; 
                    end 
                end 
                for y = 1:y_size 
                     
                    xo = x-c_start;%% 
                    yo = y-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        YX(y,x,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
                        YX(y,x,count) = round(0.5*YX(y,x,count)); 
                    end 
                end 
            end 
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        end 
         
        count = 0; 
        for y = round(y_start:(y_end-y_start)/2:y_end) 
            count = count+1; 
            for x = 1:x_size 
                if center(x,1)-font<1 
                    if x-font<1 
                        ZX(center(x,1):center(x,1)+2*font,x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        ZX(center(x,1):center(x,1)+2*font,x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        ZX(center(x,1):center(x,1)+2*font,x-font:x+font,count) = 2^bit_d-1; 
                    end 
                elseif center(x,1)+font>z_size 
                    if x-font<1 
                        ZX(center(x,1)-2*font:center(x,1),x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        ZX(center(x,1)-2*font:center(x,1),x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        ZX(center(x,1)-2*font:center(x,1),x-font:x+font,count) = 2^bit_d-1; 
                    end 
                else 
                    if x-font<1 
                        ZX(center(x,1)-font:center(x,1)+font,x:x+2*font,count) = 2^bit_d-1; 
                    elseif x+font>x_size 
                        ZX(center(x,1)-font:center(x,1)+font,x-2*font:x,count) = 2^bit_d-1; 
                    else 
                        ZX(center(x,1)-font:center(x,1)+font,x-font:x+font,count) = 2^bit_d-1; 
                    end 
                end 
                for z = 1:z_size 
                     
                    xo = x-c_start;%% 
                    yo = y-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        ZX(z,x,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
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                        ZX(z,x,count) = round(0.5*ZX(z,x,count)); 
                    end 
                end 
            end 
        end 
         
        count = 0; 
        for x = round(x_start:(x_end-x_start)/2:x_end) 
            count = count+1; 
            if center(x,1)-font<1 
                if center(x,2)-font<1 
                    ZY(center(x,1):center(x,1)+2*font,center(x,2):center(x,2)+2*font,count) = 2^bit_d-1; 
                elseif center(x,2)+font>y_size 
                    ZY(center(x,1):center(x,1)+2*font,center(x,2)-2*font:center(x,2),count) = 2^bit_d-1; 
                else 
                    ZY(center(x,1):center(x,1)+2*font,center(x,2)-font:center(x,2)+font,count) = 2^bit_d-1; 
                end 
            elseif center(x,1)+font>z_size 
                if center(x,2)-font<1 
                    ZY(center(x,1)-2*font:center(x,1),center(x,2):center(x,2)+2*font,count) = 2^bit_d-1; 
                elseif center(x,2)+font>y_size 
                    ZY(center(x,1)-2*font:center(x,1),center(x,2)-2*font:center(x,2),count) = 2^bit_d-1; 
                else 
                    ZY(center(x,1)-2*font:center(x,1),center(x,2)-font:center(x,2)+font,count) = 2^bit_d-1; 
                end 
            else 
                if center(x,2)-font<1 
                    ZY(center(x,1)-font:center(x,1)+font,center(x,2):center(x,2)+2*font,count) = 2^bit_d-1; 
                elseif center(x,2)+font>y_size 
                    ZY(center(x,1)-font:center(x,1)+font,center(x,2)-2*font:center(x,2),count) = 2^bit_d-1; 
                else 
                    ZY(center(x,1)-font:center(x,1)+font,center(x,2)-font:center(x,2)+font,count) = 2^bit_d-1; 
                end 
            end 
            for y = 1:y_size 
                for z = 1:z_size 
                     
                    xo = x-c_start;%% 
                    yo = y-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
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                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        ZY(z,y,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
                        ZY(z,y,count) = round(0.5*ZY(z,y,count)); 
                    end 
                end 
            end 
        end 
         
        for x = x_start:x_end-x_start:x_end 
            if x-font<1 
                YX(:,x:x+2*font,:) = 2^bit_d-1; 
                ZX(:,x:x+2*font,:) = 2^bit_d-1; 
            elseif x+font>x_size 
                YX(:,x-2*font:x,:) = 2^bit_d-1; 
                ZX(:,x-2*font:x,:) = 2^bit_d-1; 
            else 
                YX(:,x-font:x+font,:) = 2^bit_d-1; 
                ZX(:,x-font:x+font,:) = 2^bit_d-1; 
            end 
        end 
        for y = y_start:y_end-y_start:y_end 
            if y-font<1 
                YX(y:y+2*font,:,:) = 2^bit_d-1; 
                ZY(:,y:y+2*font,:) = 2^bit_d-1; 
            elseif y+font>y_size 
                YX(y-2*font:y,:,:) = 2^bit_d-1; 
                ZY(:,y-2*font:y,:) = 2^bit_d-1; 
            else 
                YX(y-font:y+font,:,:) = 2^bit_d-1; 
                ZY(:,y-font:y+font,:) = 2^bit_d-1; 
            end 
        end 
        for z = z_start:z_end-z_start:z_end 
            if z-font<1 
                ZY(z:z+2*font,:,:) = 2^bit_d-1; 
                ZX(z:z+2*font,:,:) = 2^bit_d-1; 
            elseif z+font>z_size 
                ZY(z-2*font:z,:,:) = 2^bit_d-1; 
                ZX(z-2*font:z,:,:) = 2^bit_d-1; 
            else 
                ZY(z-font:z+font,:,:) = 2^bit_d-1; 
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                ZX(z-font:z+font,:,:) = 2^bit_d-1; 
            end 
        end 
         
        figure(1); 
        subplot(1,3,1); 
        subimage(ZX(:,:,1),[0 2^bit_d-1]); 
        title(['ZX ' int2str(y_start)]); 
        subplot(1,3,2); 
        subimage(ZX(:,:,2),[0 2^bit_d-1]); 
        title(['ZX ' int2str(round((y_end+y_start)/2))]); 
        subplot(1,3,3); 
        subimage(ZX(:,:,3),[0 2^bit_d-1]); 
        title(['ZX ' int2str(y_end)]); 
        figure(2); 
        subplot(1,3,1); 
        subimage(ZY(:,:,1),[0 2^bit_d-1]); 
        title(['ZY ' int2str(x_start)]); 
        subplot(1,3,2); 
        subimage(ZY(:,:,2),[0 2^bit_d-1]); 
        title(['ZY ' int2str(round((x_end+x_start)/2))]); 
        subplot(1,3,3); 
        subimage(ZY(:,:,3),[0 2^bit_d-1]); 
        title(['ZY ' int2str(x_end)]); 
        figure(3); 
        subplot(1,3,1); 
        subimage(YX(:,:,1),[0 2^bit_d-1]); 
        title(['YX ' int2str(z_start)]); 
        subplot(1,3,2); 
        subimage(YX(:,:,2),[0 2^bit_d-1]); 
        title(['YX ' int2str(round((z_end+z_start)/2))]); 
        subplot(1,3,3); 
        subimage(YX(:,:,3),[0 2^bit_d-1]); 
        title(['YX ' int2str(z_end)]); 
         
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_trimZX.jpg']); 
            saveas(2,[filename '_trimZY.jpg']); 
            saveas(3,[filename '_trimYX.jpg']); 
        elseif strcmp(answer,'no') 
            answer = input('Change ROI cutoff (x) (yes or no): ','s'); 
            if strcmp(answer,'yes') 
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                disp(['Current ROI start (x): ' int2str(c_start)]); 
                disp(['Current ROI end (x): ' int2str(c_end)]); 
                c_start = input(['Input a new ROI start (1 to ' int2str(x_size) '): ']); 
                c_end = input(['Input a new ROI end ' int2str(c_start+1) ' to ' int2str(x_size) '): ']); 
            end 
            answer = input('Change (x,y,z) scan ranges (yes or no): ','s'); 
            if strcmp(answer,'yes') 
                disp(['Current x start: ' int2str(x_start)]); 
                disp(['Current x end: ' int2str(x_end)]); 
                x_start = input(['Input x start (1 to ' int2str(x_size) '): ']); 
                x_end = input(['Input x end (' int2str(x_start+1) ' to ' int2str(x_size) '): ']); 
                disp(['Current y start: ' int2str(y_start)]); 
                disp(['Current y end: ' int2str(y_end)]); 
                y_start = input(['Input y start (1 to ' int2str(y_size) '): ']); 
                y_end = input(['Input y end (' int2str(y_start+1) ' to ' int2str(y_size) '): ']); 
                disp(['Current z start: ' int2str(z_start)]); 
                disp(['Current z end: ' int2str(z_end)]); 
                z_start = input(['Input z start (1 to ' int2str(z_size) '): ']); 
                z_end = input(['Input z end (' int2str(z_start+1) ' to ' int2str(z_size) '): ']); 
            end 
            answer = 'no'; 
        else 
            disp('Invalid input.'); 
        end 
    end 
    close all 
     
    %%% Data analysis %%% 
     
    disp('Starting data analysis.'); 
    a = c_end-c_start; 
    b = center(c_end,2)-center(c_start,2); 
    c = center(c_end,1)-center(c_start,1); 
    d = ceil(sqrt(a^2+b^2+c^2)); 
     
    radial_data = zeros(d+1,2*parts,4); 
    angular_data = zeros(d+1,2*angles+1,4); 
    inside_data = zeros(d+1,1,4); 
    outside_data = zeros(d+1,1,4); 
     
    stopwatch_count = 0; 
    stopwatch_sum = 0; 
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    for x = x_start:x_end 
        stopwatch_start = clock; 
        view = zeros(z_size,y_size,5); 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZY(i-filestart+1,:,1) = rot90(image(:,x,1)); 
            if i==round((filestart+fileend)/2) 
                YX = image(:,:,1); 
            end 
            clear image file i 
        end 
        view(:,:,1) = ZY(:,:,1); 
        view(:,:,3) = view(:,:,3)-1; 
        for y = y_start:y_end 
            for z = z_start:z_end 
                 
                xo = x-c_start;%% 
                yo = y-center(c_start,2);%% 
                zo = z-center(c_start,1);%% 
                t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                 
                p = atan2(z-center(x,1),y-center(x,2));%% 
                if p<0 
                    p = 2*pi+p; 
                end 
                 
                dd = round(h); 
                rr = ceil(r/(radius/parts)); 
                pp = ceil(p/2/pi*angles); 
                 
                if r>0 && r<=radius && h>=0 && h<=sqrt(a^2+b^2+c^2) %inside ROI 
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                    view(z,y,3) = dd; 
                    view(z,y,4) = 55+round(rr*200/parts); 
                     
                    inside_data(dd+1,1,1) = inside_data(dd+1,1,1)+ZY(z,y); 
                    inside_data(dd+1,1,2) = inside_data(dd+1,1,2)+1; 
                     
                    radial_data(dd+1,rr,1) = radial_data(dd+1,rr,1)+ZY(z,y); 
                    radial_data(dd+1,rr,2) = radial_data(dd+1,rr,2)+1; 
                     
                    if r<=radius/sqrt(angles+1) 
                        angular_data(dd+1,1,1) = angular_data(dd+1,1,1)+ZY(z,y); 
                        angular_data(dd+1,1,2) = angular_data(dd+1,1,2)+1; 
                        view(z,y,5) = 55; 
                    else  
                        angular_data(dd+1,pp+1,1) = angular_data(dd+1,pp+1,1)+ZY(z,y); 
                        angular_data(dd+1,pp+1,2) = angular_data(dd+1,pp+1,2)+1; 
                        view(z,y,5) = 55+round(pp*200/angles); 
                    end 
                     
                    if ZY(z,y)>=threshold 
                        radial_data(dd+1,rr,3) = radial_data(dd+1,rr,3)+ZY(z,y); 
                        radial_data(dd+1,rr,4) = radial_data(dd+1,rr,4)+1; 
                        inside_data(dd+1,1,4) = inside_data(dd+1,1,4)+1; 
                        inside_data(dd+1,1,3) = inside_data(dd+1,1,3)+ZY(z,y); 
                        if r<=radius/sqrt(angles+1) 
                            angular_data(dd+1,1,3) = angular_data(dd+1,1,3)+ZY(z,y); 
                            angular_data(dd+1,1,4) = angular_data(dd+1,1,4)+1; 
                        else 
                            angular_data(dd+1,pp+1,3) = angular_data(dd+1,pp+1,3)+ZY(z,y); 
                            angular_data(dd+1,pp+1,4) = angular_data(dd+1,pp+1,4)+1; 
                        end 
                        view(z,y,2) = 200; 
                    end 
                     
                    if round(r)==radius 
                        view(z,y,2) = 255; 
                    end 
                     
                elseif r>radius && h>=0 && h<=sqrt(a^2+b^2+c^2) && ceil(r/(radius/parts))<=2*parts 
                     
                    view(z,y,4) = round(ceil((r-radius)/(radius/parts))*200/parts); 
                    view(z,y,5) = round(pp*200/angles); 
                    radial_data(dd+1,rr,1) = radial_data(dd+1,rr,1)+ZY(z,y); 
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                    radial_data(dd+1,rr,2) = radial_data(dd+1,rr,2)+1; 
                    outside_data(dd+1,1,1) = outside_data(dd+1,1,1)+ZY(z,y); 
                    outside_data(dd+1,1,2) = outside_data(dd+1,1,2)+1; 
                    angular_data(dd+1,pp+angles,1) = angular_data(dd+1,pp+angles,1)+ZY(z,y); 
                    angular_data(dd+1,pp+angles,2) = angular_data(dd+1,pp+angles,2)+1; 
                     
                    if ZY(z,y)>=threshold 
                        view(z,y,2) = 100; 
                        radial_data(dd+1,rr,3) = radial_data(dd+1,rr,3)+ZY(z,y); 
                        radial_data(dd+1,rr,4) = radial_data(dd+1,rr,4)+1; 
                        outside_data(dd+1,1,3) = outside_data(dd+1,1,3)+ZY(z,y); 
                        outside_data(dd+1,1,4) = outside_data(dd+1,1,4)+1; 
                        angular_data(dd+1,pp+angles,3) = angular_data(dd+1,pp+angles,3)+ZY(z,y); 
                        angular_data(dd+1,pp+angles,4) = angular_data(dd+1,pp+angles,4)+1; 
                    else 
                        view(z,y,2) = 55; 
                    end 
                end 
            end 
        end 
         
        matrix = view(:,:,3); 
        if max(max(matrix))>=0 
            value = [min(min(matrix(matrix>-1))) max(max(matrix))]; 
            matrix = matrix-min(min(matrix(matrix>-1))); 
            matrix(matrix<0) = 0; 
            matrix = round(matrix/max(max(matrix))*200)+55; 
            view(:,:,3) = matrix; 
        else 
            view(:,:,3) = 0; 
            value = [0 0]; 
        end 
        clear matrix 
         
        if x-font<1 
            YX(:,x:x+2*font) = 2^bit_d-1; 
        elseif x+font>x_size 
            YX(:,x-2*font:x) = 2^bit_d-1; 
        else 
            YX(:,x-font:x+font) = 2^bit_d-1; 
        end 
        figure(x); 
        subplot(2,3,1); 
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        subimage(YX,[0 2^bit_d-1]); 
        title(['YX ' int2str(round((filestart+fileend)/2))]); 
        subplot(2,3,2); 
        subimage(view(:,:,1),[0 2^bit_d-1]); 
        title(['ZY ' int2str(x)]); 
        subplot(2,3,3); 
        subimage(view(:,:,2),[0 255]); 
        title(['ZY ' int2str(x) ' binary']); 
        subplot(2,3,4); 
        subimage(view(:,:,3),[0 255]); 
        title(['Depth: ' int2str(value(1)*voxel) '-' int2str(value(2)*voxel) ' um']); 
        subplot(2,3,5); 
        subimage(view(:,:,4),[0 255]); 
        title(['ZY ' int2str(x) ' radial']); 
        subplot(2,3,6); 
        subimage(view(:,:,5),[0 255]); 
        title(['ZY ' int2str(x) ' angular']); 
        saveas(x,[filename '_result' int2str(x) '.jpg']); 
        close all 
         
        stopwatch_end = clock; 
        stopwatch_sum = stopwatch_sum+stopwatch_end(6)-stopwatch_start(6)+stopwatch_end(5)*60-
stopwatch_start(5)*60+stopwatch_end(4)*3600-stopwatch_start(4)*3600; 
        stopwatch_count = stopwatch_count+1; 
        hh = floor((x_end-x)*stopwatch_sum/stopwatch_count/3600); 
        mm = floor(((x_end-x)*stopwatch_sum/stopwatch_count-hh*3600)/60); 
        ss = (x_end-x)*stopwatch_sum/stopwatch_count-hh*3600-mm*60; 
        disp(['Approximate time remaining: ' int2str(hh) 'h ' int2str(mm) 'm ' int2str(ss) 's (status: ' int2str(x-
x_start+1) '/' int2str(x_end-x_start+1) ')']) 
    end 
     
    %%% Data write %%% 
     
    disp('Generating excel file.'); 
    data_radial = cell(d+1+3,2*parts+3,3); 
    data_angular = cell(d+1+3,2*angles+1+3,3); 
     
    for k = 1:3 
        data_radial{3,3,k} = 'Depth (um):'; 
        data_angular{3,3,k} = 'Depth (um):'; 
        for j = 1:d+1 
            data_radial{j+3,3,k} = (j-1)*voxel; 
            data_angular{j+3,3,k} = (j-1)*voxel; 
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        end 
    end 
     
    data_radial{3,1,1} = 'Outside average intensity:'; 
    data_angular{3,1,1} = 'Outside average intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,1,1} = outside_data(j,1,1)/outside_data(j,1,2); 
        data_angular{j+3,1,1} = outside_data(j,1,1)/outside_data(j,1,2); 
    end 
     
    data_radial{3,2,1} = 'Inside average intensity:'; 
    data_angular{3,2,1} = 'Inside average intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,2,1} = inside_data(j,1,1)/inside_data(j,1,2); 
        data_angular{j+3,2,1} = inside_data(j,1,1)/inside_data(j,1,2); 
    end 
     
    data_radial{3,1,2} = 'Outside average >threshold intensity:'; 
    data_angular{3,1,2} = 'Outside average >threshold intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,1,2} = outside_data(j,1,3)/outside_data(j,1,4); 
        data_angular{j+3,1,2} = outside_data(j,1,3)/outside_data(j,1,4); 
    end 
     
    data_radial{3,2,2} = 'Inside average >threshold intensity:'; 
    data_angular{3,2,2} = 'Inside average >threshold intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,2,2} = inside_data(j,1,3)/inside_data(j,1,4); 
        data_angular{j+3,2,2} = inside_data(j,1,3)/inside_data(j,1,4); 
    end 
     
    data_radial{3,1,3} = 'Outside fill fraction:'; 
    data_angular{3,1,3} = 'Outside fill fraction:'; 
    for j = 1:d+1 
        data_radial{j+3,1,3} = outside_data(j,1,4)/outside_data(j,1,2); 
        data_angular{j+3,1,3} = outside_data(j,1,4)/outside_data(j,1,2); 
    end 
     
    data_radial{3,2,3} = 'Inside fill fraction:'; 
    data_angular{3,2,3} = 'Inside fill fraction:'; 
    for j = 1:d+1 
        data_radial{j+3,2,3} = inside_data(j,1,4)/inside_data(j,1,2); 
        data_angular{j+3,2,3} = inside_data(j,1,4)/inside_data(j,1,2); 
 193 
 
    end 
     
    for i = 1:parts 
        for k = 1:3       
            data_radial{2,i+3,k} = ['Inside partition ' int2str(i)]; 
            data_radial{3,i+3,k} = [int2str((i-1)*radius/parts*voxel) ' to ' int2str(i*radius/parts*voxel) ' um']; 
            data_radial{2,i+3+parts,k} = ['Outside partition ' int2str(i)]; 
            data_radial{3,i+3+parts,k} = [int2str((i-1)*radius/parts*voxel) ' to ' int2str(i*radius/parts*voxel) ' 
um']; 
        end 
    end 
    for i = 1:2*parts 
        for j = 1:d+1 
            data_radial{j+3,i+3,1} = radial_data(j,i,1)/radial_data(j,i,2); 
            data_radial{j+3,i+3,2} = radial_data(j,i,3)/radial_data(j,i,4); 
            data_radial{j+3,i+3,3} = radial_data(j,i,4)/radial_data(j,i,2); 
        end 
    end 
     
    for k = 1:3 
        data_angular{2,4,k} = 'Center partition:'; 
        data_angular{3,4,k} =  ['0 to ' int2str(radius/sqrt(angles+1)) ' um']; 
        for i = 1:angles 
            data_angular{2,i+4,k} = ['Inside angle ' int2str(i)]; 
            data_angular{3,i+4,k} = [int2str((i-1)*360/angles) ' to ' int2str((i)*360/angles) ' deg']; 
            data_angular{2,i+4+angles,k} = ['Outside angle ' int2str(i)]; 
            data_angular{3,i+4+angles,k} = [int2str((i-1)*360/angles) ' to ' int2str((i)*360/angles) ' deg']; 
        end 
    end 
    for j = 1:d+1 
        data_angular{j+3,4,1} = angular_data(j,1,1)/angular_data(j,1,2); 
        data_angular{j+3,4,2} = angular_data(j,1,3)/angular_data(j,1,4); 
        data_angular{j+3,4,3} = angular_data(j,1,4)/angular_data(j,1,2); 
        for i = 1:2*angles 
            data_angular{j+3,i+4,1} = angular_data(j,i+1,1)/angular_data(j,i+1,2); 
            data_angular{j+3,i+4,2} = angular_data(j,i+1,3)/angular_data(j,i+1,4); 
            data_angular{j+3,i+4,3} = angular_data(j,i+1,4)/angular_data(j,i+1,2); 
        end 
    end 
     
    data_radial{1,1,1} = 'RADIAL (average intensity)'; 
    data_radial{1,1,2} = 'RADIAL (average >threshold intensity)'; 
    data_radial{1,1,3} = 'RADIAL (fill fraction)'; 
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    data_angular{1,1,1} = 'ANGULAR (average intensity)'; 
    data_angular{1,1,2} = 'ANGULAR (average >threshold intensity)'; 
    data_angular{1,1,3} = 'ANGULAR (fill fraction)'; 
    
    history = cell(6,10,1); 
    history{1,1,1} = 'HISTORY'; 
    history{1,3,1} = 'filename: '; 
    history{1,4,1} = filename; 
    history{1,5,1} = 'filestart: '; 
    history{1,6,1} = filestart; 
    history{1,7,1} = 'fileend: '; 
    history{1,8,1} = fileend; 
    history{1,9,1} = 'version: '; 
    history{1,10,1} = version; 
     
    history{2,1,1} = 'x_start:'; 
    history{2,2,1} = x_start; 
    history{2,3,1} = 'x_end: '; 
    history{2,4,1} = x_end; 
    history{2,5,1} = 'x_change: '; 
    history{2,6,1} = x_change; 
    history{2,7,1} = 'x:[c_start,c_end]: '; 
    history{2,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
    history{2,9,1} = 'x_size: '; 
    history{2,10,1} = x_size; 
     
    history{3,1,1} = 'y_start: '; 
    history{3,2,1} = y_start; 
    history{3,3,1} = 'y_end: '; 
    history{3,4,1} = y_end; 
    history{3,5,1} = 'y_change: '; 
    history{3,6,1} = y_change; 
    history{3,7,1} = 'y:[c_start,c_end]: '; 
    %         history{3,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
    history{3,9,1} = 'y_size: '; 
    history{3,10,1} = y_size; 
     
    history{4,1,1} = 'z_start: '; 
    history{4,2,1} = z_start; 
    history{4,3,1} = 'z_end: '; 
    history{4,4,1} = z_end; 
    history{4,5,1} = 'z_change: '; 
    history{4,6,1} = z_change; 
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    history{4,7,1} = 'z:[c_start,c_end]: '; 
    %         history{4,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
    history{4,9,1} = 'z_size: '; 
    history{4,10,1} = z_size; 
     
    history{5,1,1} = 'threshold: '; 
    history{5,2,1} = threshold; 
    history{5,3,1} = 'radius: '; 
    history{5,4,1} = radius; 
    history{5,5,1} = 'type: '; 
    history{5,6,1} = type; 
    history{5,7,1} = 'parts: '; 
    history{5,8,1} = parts; 
    history{5,9,1} = 'angles: '; 
    history{5,10,1} = angles; 
     
    history{6,1,1} = 'voxel: '; 
    history{6,2,1} = voxel; 
    history{6,3,1} = 'bit depth: '; 
    history{6,4,1} = bit_d; 
    history{6,5,1} = 'plane: '; 
    history{6,6,1} = plane; 
    history{6,7,1} = 'start coordinates: '; 
    history{6,8,1} = o_start; 
    history{6,9,1} = 'end coordinates: '; 
    history{6,10,1} = o_end; 
     
    time = clock; 
    data_name = [filename(1:12) '_' int2str(time(2)) int2str(time(3)) int2str(time(1)) '_' int2str(time(4)) 
int2str(time(5))]; 
    xlswrite(data_name,data_radial(:,:,1),1); 
    xlswrite(data_name,data_radial(:,:,2),2); 
    xlswrite(data_name,data_radial(:,:,3),3); 
    xlswrite(data_name,data_angular(:,:,1),4); 
    xlswrite(data_name,data_angular(:,:,2),5); 
    xlswrite(data_name,data_angular(:,:,3),6); 
    xlswrite(data_name,history(:,:,1),7); 
    raw_name = [filename(1:5) '_RAWDATA_' int2str(time(2)) int2str(time(3)) int2str(time(1)) '_' 
int2str(time(4)) int2str(time(5))]; 
    xlswrite(raw_name,radial_data(:,:,1),1); 
    xlswrite(raw_name,radial_data(:,:,2),2); 
    xlswrite(raw_name,radial_data(:,:,3),3); 
    xlswrite(raw_name,radial_data(:,:,4),4); 
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    xlswrite(raw_name,angular_data(:,:,1),5); 
    xlswrite(raw_name,angular_data(:,:,2),6); 
    xlswrite(raw_name,angular_data(:,:,3),7); 
    xlswrite(raw_name,angular_data(:,:,4),8); 
    xlswrite(raw_name,[inside_data(:,:,1) inside_data(:,:,2) inside_data(:,:,3) inside_data(:,:,4)],9); 
    xlswrite(raw_name,[outside_data(:,:,1) outside_data(:,:,2) outside_data(:,:,3) outside_data(:,:,4)],10); 
     
    %%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    %%% ALL CODING FOR ZX PLANE %% 
    %%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
     
    %%% Select start and end %%% 
     
elseif strcmp(plane,'ZX') 
     
    figure(1); 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZX(i-filestart+1,:,1) = image(y_start,:,1); 
            clear image file i 
        end 
        i = round((filestart+fileend)/2); 
        if i<10 
            file = [filename '000' int2str(i)]; 
        elseif i<100 
            file = [filename '00' int2str(i)]; 
        elseif i<1000 
            file = [filename '0' int2str(i)]; 
        else 
            file = [filename int2str(i)]; 
        end 
        image = imread(file,type); 
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        ref = round(0.8*image(:,:,1)); 
        clear image file i 
         
        if y_start-font<1 
            ref(y_start:y_start+2*font,:,1) = 2^bit_d-1; 
        elseif y_start+font>y_size 
            ref(y_start-2*font:y_start,:,1) = 2^bit_d-1; 
        else 
            ref(y_start-font:y_start+font,:,1) = 2^bit_d-1; 
        end 
        subplot(1,2,1); 
        subimage(ref,[0 2^bit_d-1]); 
        title('XY reference'); 
        subplot(1,2,2); 
        subimage(ZX(:,:,1),[0 2^bit_d-1]); 
        shg; 
        title(['First image ' int2str(y_start)]); 
        answer = input('Is this the image to start analysis on (yes or no): ','s'); 
        if strcmp(answer,'no') 
            y_start = input(['Please select a new image to start analysis on (1 to ' int2str(y_end) '): ']); 
        elseif strcmp(answer,'yes') 
            saveas(1,[filename '_firstimage.jpg']); 
        end 
    end 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZX(i-filestart+1,:,2) = image(y_end,:,1); 
            clear image file i ref 
        end 
        i = round((filestart+fileend)/2); 
        if i<10 
            file = [filename '000' int2str(i)]; 
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        elseif i<100 
            file = [filename '00' int2str(i)]; 
        elseif i<1000 
            file = [filename '0' int2str(i)]; 
        else 
            file = [filename int2str(i)]; 
        end 
        image = imread(file,type); 
        ref = round(0.8*image(:,:,1)); 
        clear image file i 
         
        if y_end-font<1 
            ref(y_end:y_end+2*font,:,1) = 2^bit_d-1; 
        elseif y_end+font>y_size 
            ref(y_end-2*font:y_end,:,1) = 2^bit_d-1; 
        else 
            ref(y_end-font:y_end+font,:,1) = 2^bit_d-1; 
        end 
        subplot(1,2,1); 
        subimage(ref,[0 2^bit_d-1]); 
        title('XY reference'); 
        subplot(1,2,2); 
        subimage(ZX(:,:,2),[0 2^bit_d-1]); 
        title(['Last image ' int2str(y_end)]); 
        shg; 
        answer = input('Is this the image to end analysis on (yes or no): ','s'); 
        if strcmp(answer,'no') 
            y_end = input(['Please select a new image to end analysis on (' int2str(y_start+1) ' to ' 
int2str(y_size) '): ']); 
        elseif strcmp(answer,'yes') 
            saveas(1,[filename '_lastimage.jpg']); 
        end 
    end 
     
    close all 
    clear ref 
     
     
    %%% Select radius and center %%% 
     
    for i = filestart:fileend 
        if i<10 
            file = [filename '000' int2str(i)]; 
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        elseif i<100 
            file = [filename '00' int2str(i)]; 
        elseif i<1000 
            file = [filename '0' int2str(i)]; 
        else 
            file = [filename int2str(i)]; 
        end 
        image = imread(file,type); 
        ZX(i-filestart+1,:,1) = rot90(round(0.8*image(y_start,:,1))); 
        ZX(i-filestart+1,:,2) = rot90(round(0.8*image(y_end,:,1))); 
        clear image file i 
    end 
    center = zeros(y_size,2); 
    center(y_start,1) = round(size(ZX,1)/2);%% 
    center(y_start,2) = round(size(ZX,2)/2);%% 
    radius = round((sqrt(center(y_start,1)^2+center(y_start,2)^2))/2); 
    answer = 'no'; 
    figure(1); 
    while ~strcmp(answer,'yes') 
        for theta = 0:2*pi()/180:2*pi() 
            x = round(radius*cos(theta))+center(y_start,2); 
            z = round(radius*sin(theta))+center(y_start,1); 
            if x < 1 
                x = 1; 
            elseif x>x_size 
                x = x_size; 
            end 
            if z<1 
                z = 1; 
            elseif z>z_size 
                z = z_size; 
            end 
            if x-font<1 
                if z-font<1 
                    ZX(z:z+2*font,x:x+2*font,1) = 2^bit_d-1; 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x:x+2*font,1) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x:x+2*font,1) = 2^bit_d-1; 
                end 
            elseif x+font>size(ZX,2) 
                if z-font<1 
                    ZX(z:z+2*font,x-2*font:x,1) = 2^bit_d-1; 
 200 
 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x-2*font:x,1) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x-2*font:x,1) = 2^bit_d-1; 
                end 
            else 
                if z-font<1 
                    ZX(z:z+2*font,x-font:x+font,1) = 2^bit_d-1; 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x-font:x+font,1) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x-font:x+font,1,1) = 2^bit_d-1; 
                end 
            end 
        end 
        subplot(1,2,1); 
        imshow(ZX(:,:,1),[0 2^bit_d-1]); 
        title('First image'); 
        subplot(1,2,2); 
        imshow(ZX(:,:,2),[0 2^bit_d-1]); 
        title('Last image'); 
        shg; 
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (center or radius): ','s'); 
            if strcmp(answer,'center') 
                disp(['Current center is: ' int2str(center(y_start,1)) ',' int2str(center(y_start,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(y_start,1) = input('Please input new row (z,1) coordinate for the center: '); 
                center(y_start,2) = input('Please input new column (y,2) coordinate for the center: '); 
            elseif strcmp(answer,'radius') 
                disp(['Current center is: ' int2str(center(y_start,1)) ',' int2str(center(y_start,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input new radius: '); 
            end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
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                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZX(i-filestart+1,:,1) = round(0.8*image(y_start,:,1)); 
                clear image file i 
            end 
             
        end 
    end 
    answer = 'no'; 
    if center(y_end,1)==0 && center(y_end,2)==0%% 
        center(:,1) = center(y_start,1);%% 
        center(:,2) = center(y_start,2);%% 
    end%% 
    while ~strcmp(answer,'yes') 
        for theta = 0:2*pi()/180:2*pi() 
            x = round(radius*cos(theta))+center(y_end,2); 
            z = round(radius*sin(theta))+center(y_end,1); 
            if x < 1 
                x = 1; 
            elseif x>x_size 
                x = x_size; 
            end 
            if z<1 
                z = 1; 
            elseif z>z_size 
                z = z_size; 
            end 
            if x-font<1 
                if z-font<1 
                    ZX(z:z+2*font,x:x+2*font,2) = 2^bit_d-1; 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x:x+2*font,2) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x:x+2*font,2) = 2^bit_d-1; 
                end 
            elseif x+font>size(ZX,2) 
                if z-font<1 
                    ZX(z:z+2*font,x-2*font:x,2) = 2^bit_d-1; 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x-2*font:x,2) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x-2*font:x,2) = 2^bit_d-1; 
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                end 
            else 
                if z-font<1 
                    ZX(z:z+2*font,x-font:x+font,2) = 2^bit_d-1; 
                elseif z+font>size(ZX,1) 
                    ZX(z-2*font:z,x-font:x+font,2) = 2^bit_d-1; 
                else 
                    ZX(z-font:z+font,x-font:x+font,2) = 2^bit_d-1; 
                end 
            end 
        end 
        subplot(1,2,2); 
        imshow(ZX(:,:,2),[0 2^bit_d-1]); 
        title('Last image'); 
        shg; 
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (center or radius): ','s'); 
            if strcmp(answer,'center') 
                disp(['Current center is: ' int2str(center(y_end,1)) ',' int2str(center(y_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(y_end,1) = input('Please input new row (z,1) coordinate for the center: '); 
                center(y_end,2) = input('Please input new column (y,2) coordinate for the center: '); 
            elseif strcmp(answer,'radius') 
                disp(['Current center is: ' int2str(center(y_end,1)) ',' int2str(center(y_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input new radius: '); 
            end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZX(i-filestart+1,:,2) = round(0.8*image(y_end,:,1)); 
                clear image file i 
            end 
        end 
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    end 
    saveas(1,[filename '_ROI1.jpg']); 
    close all 
     
    %%% Shifting ROI %%% 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        z_change = (center(y_end,1)-center(y_start,1))/(y_end-y_start); 
        x_change = (center(y_end,2)-center(y_start,2))/(y_end-y_start); 
        y_change = 1; 
        for y = 1:y_start-1 
            center(y,1) = center(y_start,1)-round(z_change*(y_start-y)); 
            center(y,2) = center(y_start,2)-round(x_change*(y_start-y)); 
        end 
        for y = y_start+1:y_end-1 
            center(y,1) = center(y_start,1)+round(z_change*(y-y_start)); 
            center(y,2) = center(y_start,2)+round(x_change*(y-y_start)); 
        end 
        for y = y_end+1:y_size 
            center(y,1) = center(y_end,1)+round(z_change*(y-y_end)); 
            center(y,2) = center(y_end,2)+round(x_change*(y-y_end)); 
        end 
        b = y_end-y_start;%% 
        a = center(y_end,2)-center(y_start,2);%% 
        c = center(y_end,1)-center(y_start,1);%% 
        count = 1; 
        figure(3); 
        for y = y_start:round((y_end-y_start)/5):y_end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZX(i-filestart+1,:,1) = round(0.8*image(y,:,1)); 
                clear image file i 
            end 
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            for x = 1:x_size 
                for z = 1:z_size 
                    yo = y-y_start;%% 
                    xo = x-center(y_start,2);%% 
                    zo = z-center(y_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        if z-font<1 
                            if y-font<1 
                                ZX(z:z+2*font,x:x+2*font) = 2^bit_d-1; 
                            elseif x+font>x_size 
                                ZX(z:z+2*font,x-2*font:x) = 2^bit_d-1; 
                            else 
                                ZX(z:z+2*font,x-font:x+font) = 2^bit_d-1; 
                            end 
                        elseif z+font>z_size 
                            if x-font<1 
                                ZX(z-2*font:z,x:x+2*font) = 2^bit_d-1; 
                            elseif x+font>x_size 
                                ZX(z-2*font:z,x-2*font:x) = 2^bit_d-1; 
                            else 
                                ZX(z-2*font:z,x-font:x+font) = 2^bit_d-1; 
                            end 
                        else 
                            if x-font<1 
                                ZX(z-font:z+font,x:x+2*font) = 2^bit_d-1; 
                            elseif x+font>x_size 
                                ZX(z-font:z+font,x-2*font:x) = 2^bit_d-1; 
                            else 
                                ZX(z-font:z+font,x-font:x+font) = 2^bit_d-1; 
                            end 
                        end 
                    end 
                end 
            end 
            subplot(2,3,count); 
            imshow(ZX(:,:,1),[0 2^bit_d-1]); 
            title(['Image ' int2str(y)]); 
            count = count+1; 
        end 
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        shg; 
        answer = input('Is this ROI correct for all images displaed (yes or no): ','s'); 
        if strcmp(answer,'no') 
            answer = input('What is wrong (radius, center): ','s'); 
            if strcmp(answer,'radius') 
                disp(['First image center is: ' int2str(center(y_start,1)) ',' int2str(center(y_start,2))]); 
                disp(['Last image center is: ' int2str(center(y_end,1)) ',' int2str(center(y_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                radius = input('Please input a new radius: '); 
            elseif strcmp(answer,'center') 
                disp(['First center is: ' int2str(center(y_start,1)) ',' int2str(center(y_start,2))]); 
                disp(['Current radius is: ' int2str(radius)]); 
                center(y_start,1) = input('Please input a new row (z,1) for the first image center: '); 
                center(y_start,2) = input('Please input a new column (x,2) for the first image center: '); 
                disp(['Last image center is: ' int2str(center(y_end,1)) ',' int2str(center(y_end,2))]); 
                disp(['Current radius is: ' int2str(radius) ' (' int2str(round(radius*voxel/1000)) ' mm)']); 
                center(y_end,1) = input('Please input a new row (z,1) for the last image center: '); 
                center(y_end,2) = input('Please input a new column (x,2) for the last image center: '); 
            end 
        elseif strcmp(answer,'yes') 
            saveas(3,[filename '_ROI2.jpg']); 
            o_start = ['x' int2str(center(y_start,2)) ',y' int2str(y_start) ',z' int2str(center(y_start,1))]; 
            o_end = ['x' int2str(center(y_end,2)) ',y' int2str(y_end) ',z' int2str(center(y_end,1))]; 
        else 
            disp('Invalid input'); 
        end 
        close all 
    end 
     
    %%% Threshold %%% 
     
    ZX = zeros(z_size,x_size,1); 
    threshold_in = zeros(1,2^bit_d); 
    threshold_all = zeros(1,2^bit_d); 
    for y = round(y_start:(y_end-y_start)/5:y_end) 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
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                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZX(i-filestart+1,:,1) = round(image(y,:,1)); 
            clear image file i 
        end 
        for x = 1:x_size 
            for z = 1:z_size 
                threshold_all(1,ZX(z,x)+1) = threshold_all(1,ZX(z,x)+1)+1; 
                 
                yo = y-y_start;%% 
                xo = x-center(y_start,2);%% 
                zo = z-center(y_start,1);%% 
                t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                 
                if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                    threshold_in(1,ZX(z,x)+1) = threshold_in(1,ZX(z,x)+1)+1; 
                end 
            end 
        end 
    end 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        figure(1); 
        subplot(1,2,1); 
        plot(0:2^bit_d-1,threshold_all) 
        title('Histogram'); 
        subplot(1,2,2); 
        plot(0:2^bit_d-1,threshold_in); 
        title('ROI histogram'); 
        threshold = input(['Please select a threshold value (0 to ' int2str(2^bit_d-1) '): ']); 
        figure(2) 
        count = 1; 
        for y = y_start:y_end-y_start:y_end 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
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                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZX(i-filestart+1,:,1) = round(image(y,:,1)); 
                clear image file i 
            end 
            subplot(2,2,count); 
            subimage(ZX,[0 2^bit_d-1]); 
            title(['ZX' int2str(y)]); 
            ZX(ZX<threshold) = 0; 
            ZX(ZX>=threshold) = 2^bit_d-1; 
            subplot(2,2,count+1); 
            subimage(ZX,[0 2^bit_d-1]); 
            title(['ZX' int2str(y) ' binary']); 
            count = count+2; 
        end 
        answer = input('Is this threshold value correct (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_threshold.jpg']); 
            saveas(2,[filename '_binary1.jpg']); 
        end 
        close all 
    end 
     
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        count = 1; 
        figure(1); 
        for y = round(y_start:(y_end-y_start)/5:y_end) 
            for i = filestart:fileend 
                if i<10 
                    file = [filename '000' int2str(i)]; 
                elseif i<100 
                    file = [filename '00' int2str(i)]; 
                elseif i<1000 
                    file = [filename '0' int2str(i)]; 
                else 
                    file = [filename int2str(i)]; 
                end 
                image = imread(file,type); 
                ZX(i-filestart+1,:,1) = round(image(y,:,1)); 
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                clear image file i 
            end 
            subplot(2,3,count); 
            ZX(ZX<threshold) = 0; 
            ZX(ZX>=threshold) = 2^bit_d-1; 
            subimage(ZX,[0 2^bit_d-1]); 
            title(['ZX' int2str(y) ' binary']); 
            count = count+1; 
        end 
        answer = input('Is this threshold value correct throughout the depth (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_binary2.jpg']); 
        elseif strcmp(answer,'no') 
            figure(2); 
            subplot(1,2,1); 
            plot(threshold_all,0:2^bit_d-1) 
            title('Histogram'); 
            subplot(1,2,2); 
            plot(threshold_in,0:2^bit_d-1); 
            title('ROI histogram'); 
            threshold = input(['Please select a threshold value (0 to ' int2str(2^bit_d-1) '): ']); 
        end 
        close all 
    end 
    clear count x ZY threshold_all threshold_in x y z xt yt zt xtt ytt ztt r d 
     
    %%% Trimming %%% 
     
    c_start = y_start; 
    c_end = y_end; 
    answer = 'no'; 
    while ~strcmp(answer,'yes') 
        YX = zeros(y_size,x_size,3); 
        ZY = zeros(z_size,y_size,3); 
        ZX = zeros(z_size,x_size,3); 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
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                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZY(i-filestart+1,:,1) = rot90(image(:,x_start,1)); 
            ZY(i-filestart+1,:,2) = rot90(image(:,round((x_start+x_end)/2),1)); 
            ZY(i-filestart+1,:,3) = rot90(image(:,x_end,1)); 
            ZX(i-filestart+1,:,1) = image(y_start,:,1); 
            ZX(i-filestart+1,:,2) = image(round((y_start+y_end)/2),:,1); 
            ZX(i-filestart+1,:,3) = image(y_end,:,1); 
            clear image file i 
        end 
        count = 1; 
        for i = round(z_start:(z_end-z_start)/2:z_end) 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            YX(:,:,count) = image(:,:,1); 
            count = count+1; 
            clear image file i 
        end 
        image = YX(:,:,2); 
        YX(:,:,2) = YX(:,:,3); 
        YX(:,:,3) = image; 
        clear count image 
         
        b = c_end-c_start; 
        a = center(c_end,2)-center(c_start,2); 
        c = center(c_end,1)-center(c_start,1); 
         
        count = 1; 
        for z = round(z_start:(z_end-z_start)/2:z_end) 
            for y = 1:y_size 
                if center(y,2)-font<1 
                    if y-font<1 
                        YX(y:y+2*font,center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                    elseif y+font>y_size 
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                        YX(y-2*font:y,center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                    else 
                        YX(y-font:y+font,center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                    end 
                elseif center(y,2)+font>x_size 
                    if y-font<1 
                        YX(y:y+2*font,center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                    elseif y+font>y_size 
                        YX(y-2*font:y,center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                    else 
                        YX(y-font:y+font,center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                    end 
                else 
                    if y-font<1 
                        YX(y:y+2*font,center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                    elseif y+font>y_size 
                        YX(y-2*font:y,center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                    else 
                        YX(y-font:y+font,center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                    end 
                end 
                for x = 1:x_size 
                     
                    yo = y-c_start;%% 
                    xo = x-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        YX(y,x,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
                        YX(y,x,count) = round(0.5*YX(y,x,count)); 
                    end 
                end 
            end 
            count = count+1; 
        end 
         
        count = 1; 
        for y = round(y_start:(y_end-y_start)/2:y_end) 
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            if center(y,1)-font<1 
                if center(y,2)-font<1 
                    ZX(center(y,1):center(y,1)+2*font,center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                elseif center(y,2)+font>x_size 
                    ZX(center(y,1):center(y,1)+2*font,center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                else 
                    ZX(center(y,1):center(y,1)+2*font,center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                end 
            elseif center(y,1)+font>z_size 
                if center(y,2)-font<1 
                    ZX(center(y,1)-2*font:center(y,1),center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                elseif center(y,2)+font>x_size 
                    ZX(center(y,1)-2*font:center(y,1),center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                else 
                    ZX(center(y,1)-2*font:center(y,1),center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                end 
            else 
                if center(y,2)-font<1 
                    ZX(center(y,1)-font:center(y,1)+font,center(y,2):center(y,2)+2*font,count) = 2^bit_d-1; 
                elseif center(y,2)+font>x_size 
                    ZX(center(y,1)-font:center(y,1)+font,center(y,2)-2*font:center(y,2),count) = 2^bit_d-1; 
                else 
                    ZX(center(y,1)-font:center(y,1)+font,center(y,2)-font:center(y,2)+font,count) = 2^bit_d-1; 
                end 
            end 
            for x = 1:x_size 
                for z = 1:z_size 
                     
                    yo = y-c_start;%% 
                    xo = x-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        ZX(z,x,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
                        ZX(z,x,count) = round(0.5*ZX(z,x,count)); 
                    end 
                end 
            end 
            count = count+1; 
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        end 
         
        count = 1; 
        for x = round(x_start:(x_end-x_start)/2:x_end) 
            for y = 1:y_size 
                if center(y,1)-font<1 
                    if y-font<1 
                        ZY(center(y,1):center(y,1)+2*font,y:y+2*font,count) = 2^bit_d-1; 
                    elseif y+font>y_size 
                        ZY(center(y,1):center(y,1)+2*font,y-2*font:y,count) = 2^bit_d-1; 
                    else 
                        ZY(center(y,1):center(y,1)+2*font,y-font:y+font,count) = 2^bit_d-1; 
                    end 
                elseif center(y,1)+font>z_size 
                    if y-font<1 
                        ZY(center(y,1)-2*font:center(y,1),y:y+2*font,count) = 2^bit_d-1; 
                    elseif y+font>y_size 
                        ZY(center(y,1)-2*font:center(y,1),y-2*font:y,count) = 2^bit_d-1; 
                    else 
                        ZY(center(y,1)-2*font:center(y,1),y-font:y+font,count) = 2^bit_d-1; 
                    end 
                else 
                    if y-font<1 
                        ZY(center(y,1)-font:center(y,1)+font,y:y+2*font,count) = 2^bit_d-1; 
                    elseif y+font>y_size 
                        ZY(center(y,1)-font:center(y,1)+font,y-2*font:y,count) = 2^bit_d-1; 
                    else 
                        ZY(center(y,1)-font:center(y,1)+font,y-font:y+font,count) = 2^bit_d-1; 
                    end 
                end 
                 
                for z = 1:z_size 
                     
                    yo = y-c_start;%% 
                    xo = x-center(c_start,2);%% 
                    zo = z-center(c_start,1);%% 
                    t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                    r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                    h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                     
                    if round(r)==radius && h>=0 && h<=sqrt(a^2+b^2+c^2) 
                        ZY(z,y,count) = 2^bit_d-1; 
                    elseif round(r)>radius || h<=0 || h>sqrt(a^2+b^2+c^2) 
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                        ZY(z,y,count) = round(0.5*ZY(z,y,count)); 
                    end 
                     
                end 
            end 
            count = count+1; 
        end 
         
        for x = x_start:x_end-x_start:x_end 
            if x-font<1 
                YX(:,x:x+2*font,:) = 2^bit_d-1; 
                ZX(:,x:x+2*font,:) = 2^bit_d-1; 
            elseif x+font>x_size 
                YX(:,x-2*font:x,:) = 2^bit_d-1; 
                ZX(:,x-2*font:x,:) = 2^bit_d-1; 
            else 
                YX(:,x-font:x+font,:) = 2^bit_d-1; 
                ZX(:,x-font:x+font,:) = 2^bit_d-1; 
            end 
        end 
        for y = y_start:y_end-y_start:y_end 
            if y-font<1 
                YX(y:y+2*font,:,:) = 2^bit_d-1; 
                ZY(:,y:y+2*font,:) = 2^bit_d-1; 
            elseif y+font>y_size 
                YX(y-2*font:y,:,:) = 2^bit_d-1; 
                ZY(:,y-2*font:y,:) = 2^bit_d-1; 
            else 
                YX(y-font:y+font,:,:) = 2^bit_d-1; 
                ZY(:,y-font:y+font,:) = 2^bit_d-1; 
            end 
        end 
        for z = z_start:z_end-z_start:z_end 
            if z-font<1 
                ZY(z:z+2*font,:,:) = 2^bit_d-1; 
                ZX(z:z+2*font,:,:) = 2^bit_d-1; 
            elseif z+font>z_size 
                ZY(z-2*font:z,:,:) = 2^bit_d-1; 
                ZX(z-2*font:z,:,:) = 2^bit_d-1; 
            else 
                ZY(z-font:z+font,:,:) = 2^bit_d-1; 
                ZX(z-font:z+font,:,:) = 2^bit_d-1; 
            end 
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        end 
         
        figure(1); 
        subplot(1,3,1); 
        subimage(ZX(:,:,1),[0 2^bit_d-1]); 
        title(['ZX ' int2str(y_start)]); 
        subplot(1,3,2); 
        subimage(ZX(:,:,2),[0 2^bit_d-1]); 
        title(['ZX ' int2str(round((y_end+y_start)/2))]); 
        subplot(1,3,3); 
        subimage(ZX(:,:,3),[0 2^bit_d-1]); 
        title(['ZX ' int2str(y_end)]); 
        figure(2); 
        subplot(1,3,1); 
        subimage(ZY(:,:,1),[0 2^bit_d-1]); 
        title(['ZY ' int2str(x_start)]); 
        subplot(1,3,2); 
        subimage(ZY(:,:,2),[0 2^bit_d-1]); 
        title(['ZY ' int2str(round((x_end+x_start)/2))]); 
        subplot(1,3,3); 
        subimage(ZY(:,:,3),[0 2^bit_d-1]); 
        title(['ZY ' int2str(x_end)]); 
        figure(3); 
        subplot(1,3,1); 
        subimage(YX(:,:,1),[0 2^bit_d-1]); 
        title(['YX ' int2str(z_start)]); 
        subplot(1,3,2); 
        subimage(YX(:,:,2),[0 2^bit_d-1]); 
        title(['YX ' int2str(round((z_end+z_start)/2))]); 
        subplot(1,3,3); 
        subimage(YX(:,:,3),[0 2^bit_d-1]); 
        title(['YX ' int2str(z_end)]); 
         
        answer = input('Is this correct (yes or no): ','s'); 
        if strcmp(answer,'yes') 
            saveas(1,[filename '_trimZX.jpg']); 
            saveas(2,[filename '_trimZY.jpg']); 
            saveas(3,[filename '_trimYX.jpg']); 
        elseif strcmp(answer,'no') 
            answer = input('Change ROI cutoff (y) (yes or no): ','s'); 
            if strcmp(answer,'yes') 
                disp(['Current ROI start (y): ' int2str(c_start)]); 
                disp(['Current ROI end (y): ' int2str(c_end)]); 
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                c_start = input(['Input a new ROI start (1 to ' int2str(y_size) '): ']); 
                c_end = input(['Input a new ROI end ' int2str(c_start+1) ' to ' int2str(y_size) '): ']); 
            end 
            answer = input('Change (x,y,z) scan ranges (yes or no): ','s'); 
            if strcmp(answer,'yes') 
                disp(['Current x start: ' int2str(x_start)]); 
                disp(['Current x end: ' int2str(x_end)]); 
                x_start = input(['Input x start (1 to ' int2str(x_size) '): ']); 
                x_end = input(['Input x end (' int2str(x_start+1) ' to ' int2str(x_size) '): ']); 
                disp(['Current y start: ' int2str(y_start)]); 
                disp(['Current y end: ' int2str(y_end)]); 
                y_start = input(['Input y start (1 to ' int2str(y_size) '): ']); 
                y_end = input(['Input y end (' int2str(y_start+1) ' to ' int2str(y_size) '): ']); 
                disp(['Current z start: ' int2str(z_start)]); 
                disp(['Current z end: ' int2str(z_end)]); 
                z_start = input(['Input z start (1 to ' int2str(z_size) '): ']); 
                z_end = input(['Input z end (' int2str(z_start+1) ' to ' int2str(z_size) '): ']); 
            end 
            answer = 'no'; 
        else 
            disp('Invalid input.'); 
        end 
    end 
    close all 
     
    %%% Data analysis %%% 
     
    disp('Starting data analysis.'); 
    b = c_end-c_start; 
    a = center(c_end,2)-center(c_start,2); 
    c = center(c_end,1)-center(c_start,1); 
    d = ceil(sqrt(a^2+b^2+c^2)); 
     
    radial_data = zeros(d+1,2*parts,4); 
    angular_data = zeros(d+1,2*angles+1,4); 
    inside_data = zeros(d+1,1,4); 
    outside_data = zeros(d+1,1,4); 
     
    stopwatch_count = 0; 
    stopwatch_sum = 0; 
     
    for y = y_start:y_end 
        stopwatch_start = clock; 
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        view = zeros(z_size,x_size,5); 
        for i = filestart:fileend 
            if i<10 
                file = [filename '000' int2str(i)]; 
            elseif i<100 
                file = [filename '00' int2str(i)]; 
            elseif i<1000 
                file = [filename '0' int2str(i)]; 
            else 
                file = [filename int2str(i)]; 
            end 
            image = imread(file,type); 
            ZX(i-filestart+1,:,1) = image(y,:,1); 
            if i==round((filestart+fileend)/2) 
                YX = image(:,:,1); 
            end 
            clear image file i 
        end 
        view(:,:,1) = ZX(:,:,1); 
        view(:,:,3) = view(:,:,3)-1; 
        for x = x_start:x_end 
            for z = z_start:z_end 
                 
                yo = y-c_start;%% 
                xo = x-center(c_start,2);%% 
                zo = z-center(c_start,1);%% 
                t = acos((a*xo+b*yo+c*zo)/sqrt(a^2+b^2+c^2)/sqrt(xo^2+yo^2+zo^2));%% 
                r = sqrt(xo^2+yo^2+zo^2)*sin(t);%% 
                h = sqrt(xo^2+yo^2+zo^2)*cos(t);%% 
                 
                p = atan2(z-center(y,1),x-center(y,2));%% 
                if p<0 
                    p = 2*pi+p; 
                end 
                 
                dd = round(h); 
                rr = ceil(r/(radius/parts)); 
                pp = ceil(p/2/pi*angles); 
                 
                if r>0 && r<=radius && h>=0 && h<=sqrt(a^2+b^2+c^2) %inside ROI 
                     
                    view(z,x,3) = dd; 
                    view(z,x,4) = 55+round(rr*200/parts); 
 217 
 
                     
                    inside_data(dd+1,1,1) = inside_data(dd+1,1,1)+ZX(z,x); 
                    inside_data(dd+1,1,2) = inside_data(dd+1,1,2)+1; 
                     
                    radial_data(dd+1,rr,1) = radial_data(dd+1,rr,1)+ZX(z,x); 
                    radial_data(dd+1,rr,2) = radial_data(dd+1,rr,2)+1; 
                     
                    if r<=radius/sqrt(angles+1) 
                        angular_data(dd+1,1,1) = angular_data(dd+1,1,1)+ZX(z,x); 
                        angular_data(dd+1,1,2) = angular_data(dd+1,1,2)+1; 
                        view(z,x,5) = 55; 
                    else  
                        angular_data(dd+1,pp+1,1) = angular_data(dd+1,pp+1,1)+ZX(z,x); 
                        angular_data(dd+1,pp+1,2) = angular_data(dd+1,pp+1,2)+1; 
                        view(z,x,5) = 55+round(pp*200/angles); 
                    end 
                     
                    if ZX(z,x)>=threshold 
                        radial_data(dd+1,rr,3) = radial_data(dd+1,rr,3)+ZX(z,x); 
                        radial_data(dd+1,rr,4) = radial_data(dd+1,rr,4)+1; 
                        inside_data(dd+1,1,4) = inside_data(dd+1,1,4)+1; 
                        inside_data(dd+1,1,3) = inside_data(dd+1,1,3)+ZX(z,x); 
                        if r<=radius/sqrt(angles+1) 
                            angular_data(dd+1,1,3) = angular_data(dd+1,1,3)+ZX(z,x); 
                            angular_data(dd+1,1,4) = angular_data(dd+1,1,4)+1; 
                        else 
                            angular_data(dd+1,pp+1,3) = angular_data(dd+1,pp+1,3)+ZX(z,x); 
                            angular_data(dd+1,pp+1,4) = angular_data(dd+1,pp+1,4)+1; 
                        end 
                        view(z,x,2) = 200; 
                    end 
                     
                    if round(r)==radius 
                        view(z,x,2) = 255; 
                    end 
                     
                elseif r>radius && h>=0 && h<=sqrt(a^2+b^2+c^2) && ceil(r/(radius/parts))<=2*parts 
                     
                    view(z,x,4) = round(ceil((r-radius)/(radius/parts))*200/parts); 
                    view(z,x,5) = round(pp*200/angles); 
                    radial_data(dd+1,rr,1) = radial_data(dd+1,rr,1)+ZX(z,x); 
                    radial_data(dd+1,rr,2) = radial_data(dd+1,rr,2)+1; 
                    outside_data(dd+1,1,1) = outside_data(dd+1,1,1)+ZX(z,x); 
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                    outside_data(dd+1,1,2) = outside_data(dd+1,1,2)+1; 
                    angular_data(dd+1,pp+angles,1) = angular_data(dd+1,pp+angles,1)+ZX(z,x); 
                    angular_data(dd+1,pp+angles,2) = angular_data(dd+1,pp+angles,2)+1; 
                     
                    if ZX(z,x)>=threshold 
                        view(z,x,2) = 100; 
                        radial_data(dd+1,rr,3) = radial_data(dd+1,rr,3)+ZX(z,x); 
                        radial_data(dd+1,rr,4) = radial_data(dd+1,rr,4)+1; 
                        outside_data(dd+1,1,3) = outside_data(dd+1,1,3)+ZX(z,x); 
                        outside_data(dd+1,1,4) = outside_data(dd+1,1,4)+1; 
                        angular_data(dd+1,pp+angles,3) = angular_data(dd+1,pp+angles,3)+ZX(z,x); 
                        angular_data(dd+1,pp+angles,4) = angular_data(dd+1,pp+angles,4)+1; 
                    else 
                        view(z,x,2) = 55; 
                    end 
                end 
            end 
        end 
         
        matrix = view(:,:,3); 
        if max(max(matrix))>=0 
            value = [min(min(matrix(matrix>-1))) max(max(matrix))]; 
            matrix = matrix-min(min(matrix(matrix>-1))); 
            matrix(matrix<0) = 0; 
            matrix = round(matrix/max(max(matrix))*200)+55; 
            view(:,:,3) = matrix; 
        else 
            view(:,:,3) = 0; 
            value = [0 0]; 
        end 
        clear matrix 
         
        if y-font<1 
            YX(y:y+2*font,:) = 2^bit_d-1; 
        elseif y+font>y_size 
            YX(y-2*font:y,:) = 2^bit_d-1; 
        else 
            YX(y-font:y+font,:) = 2^bit_d-1; 
        end 
        figure(y); 
        subplot(2,3,1); 
        subimage(YX,[0 2^bit_d-1]); 
        title(['YX ' int2str(round((filestart+fileend)/2))]); 
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        subplot(2,3,2); 
        subimage(view(:,:,1),[0 2^bit_d-1]); 
        title(['ZX ' int2str(y)]); 
        subplot(2,3,3); 
        subimage(view(:,:,2),[0 255]); 
        title(['ZX ' int2str(y) ' binary']); 
        subplot(2,3,4); 
        subimage(view(:,:,3),[0 255]); 
        title(['Depth: ' int2str(value(1)) '-' int2str(value(2))]); 
        subplot(2,3,5); 
        subimage(view(:,:,4),[0 255]); 
        title(['ZX ' int2str(y) ' angular']); 
        subplot(2,3,6); 
        subimage(view(:,:,5),[0 255]); 
        title(['ZX ' int2str(y) ' radial']); 
        saveas(y,[filename '_result' int2str(y) '.jpg']); 
        close all 
         
        stopwatch_end = clock; 
        stopwatch_sum = stopwatch_sum+stopwatch_end(6)-stopwatch_start(6)+stopwatch_end(5)*60-
stopwatch_start(5)*60+stopwatch_end(4)*3600-stopwatch_start(4)*3600; 
        stopwatch_count = stopwatch_count+1; 
        hh = floor((y_end-y)*stopwatch_sum/stopwatch_count/3600); 
        mm = floor(((y_end-y)*stopwatch_sum/stopwatch_count-hh*3600)/60); 
        ss = (y_end-y)*stopwatch_sum/stopwatch_count-hh*3600-mm*60; 
        disp(['Approximate time remaining: ' int2str(hh) 'h ' int2str(mm) 'm ' int2str(ss) 's (status: ' int2str(y-
y_start+1) '/' int2str(y_end-y_start+1) ')']) 
    end 
     
    %%% Data write %%% 
     
    disp('Generating excel file.'); 
    data_radial = cell(d+1+3,2*parts+3,3); 
    data_angular = cell(d+1+3,2*angles+1+3,3); 
     
    for k = 1:3 
        data_radial{3,3,k} = 'Depth (um):'; 
        data_angular{3,3,k} = 'Depth (um):'; 
        for j = 1:d+1 
            data_radial{j+3,3,k} = (j-1)*voxel; 
            data_angular{j+3,3,k} = (j-1)*voxel; 
        end 
    end 
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    data_radial{3,1,1} = 'Outside average intensity:'; 
    data_angular{3,1,1} = 'Outside average intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,1,1} = outside_data(j,1,1)/outside_data(j,1,2); 
        data_angular{j+3,1,1} = outside_data(j,1,1)/outside_data(j,1,2); 
    end 
     
    data_radial{3,2,1} = 'Inside average intensity:'; 
    data_angular{3,2,1} = 'Inside average intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,2,1} = inside_data(j,1,1)/inside_data(j,1,2); 
        data_angular{j+3,2,1} = inside_data(j,1,1)/inside_data(j,1,2); 
    end 
     
    data_radial{3,1,2} = 'Outside average >threshold intensity:'; 
    data_angular{3,1,2} = 'Outside average >threshold intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,1,2} = outside_data(j,1,3)/outside_data(j,1,4); 
        data_angular{j+3,1,2} = outside_data(j,1,3)/outside_data(j,1,4); 
    end 
     
    data_radial{3,2,2} = 'Inside average >threshold intensity:'; 
    data_angular{3,2,2} = 'Inside average >threshold intensity:'; 
    for j = 1:d+1 
        data_radial{j+3,2,2} = inside_data(j,1,3)/inside_data(j,1,4); 
        data_angular{j+3,2,2} = inside_data(j,1,3)/inside_data(j,1,4); 
    end 
     
    data_radial{3,1,3} = 'Outside fill fraction:'; 
    data_angular{3,1,3} = 'Outside fill fraction:'; 
    for j = 1:d+1 
        data_radial{j+3,1,3} = outside_data(j,1,4)/outside_data(j,1,2); 
        data_angular{j+3,1,3} = outside_data(j,1,4)/outside_data(j,1,2); 
    end 
     
    data_radial{3,2,3} = 'Inside fill fraction:'; 
    data_angular{3,2,3} = 'Inside fill fraction:'; 
    for j = 1:d+1 
        data_radial{j+3,2,3} = inside_data(j,1,4)/inside_data(j,1,2); 
        data_angular{j+3,2,3} = inside_data(j,1,4)/inside_data(j,1,2); 
    end 
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    for i = 1:parts 
        for k = 1:3       
            data_radial{2,i+3,k} = ['Inside partition ' int2str(i)]; 
            data_radial{3,i+3,k} = [int2str((i-1)*radius/parts*voxel) ' to ' int2str(i*radius/parts*voxel) ' um']; 
            data_radial{2,i+3+parts,k} = ['Outside partition ' int2str(i)]; 
            data_radial{3,i+3+parts,k} = [int2str((i-1)*radius/parts*voxel) ' to ' int2str(i*radius/parts*voxel) ' 
um']; 
        end 
    end 
    for i = 1:2*parts 
        for j = 1:d+1 
            data_radial{j+3,i+3,1} = radial_data(j,i,1)/radial_data(j,i,2); 
            data_radial{j+3,i+3,2} = radial_data(j,i,3)/radial_data(j,i,4); 
            data_radial{j+3,i+3,3} = radial_data(j,i,4)/radial_data(j,i,2); 
        end 
    end 
     
    for k = 1:3 
        data_angular{2,4,k} = 'Center partition:'; 
        data_angular{3,4,k} =  ['0 to ' int2str(radius/sqrt(angles+1)) ' um']; 
        for i = 1:angles 
            data_angular{2,i+4,k} = ['Inside angle ' int2str(i)]; 
            data_angular{3,i+4,k} = [int2str((i-1)*360/angles) ' to ' int2str((i)*360/angles) ' deg']; 
            data_angular{2,i+4+angles,k} = ['Outside angle ' int2str(i)]; 
            data_angular{3,i+4+angles,k} = [int2str((i-1)*360/angles) ' to ' int2str((i)*360/angles) ' deg']; 
        end 
    end 
    for j = 1:d+1 
        data_angular{j+3,4,1} = angular_data(j,1,1)/angular_data(j,1,2); 
        data_angular{j+3,4,2} = angular_data(j,1,3)/angular_data(j,1,4); 
        data_angular{j+3,4,3} = angular_data(j,1,4)/angular_data(j,1,2); 
        for i = 1:2*angles 
            data_angular{j+3,i+4,1} = angular_data(j,i+1,1)/angular_data(j,i+1,2); 
            data_angular{j+3,i+4,2} = angular_data(j,i+1,3)/angular_data(j,i+1,4); 
            data_angular{j+3,i+4,3} = angular_data(j,i+1,4)/angular_data(j,i+1,2); 
        end 
    end 
     
    data_radial{1,1,1} = 'RADIAL (average intensity)'; 
    data_radial{1,1,2} = 'RADIAL (average >threshold intensity)'; 
    data_radial{1,1,3} = 'RADIAL (fill fraction)'; 
    data_angular{1,1,1} = 'ANGULAR (average intensity)'; 
    data_angular{1,1,2} = 'ANGULAR (average >threshold intensity)'; 
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    data_angular{1,1,3} = 'ANGULAR (fill fraction)'; 
     
    history = cell(6,10,1); 
    history{1,1,1} = 'HISTORY'; 
    history{1,3,1} = 'filename: '; 
    history{1,4,1} = filename; 
    history{1,5,1} = 'filestart: '; 
    history{1,6,1} = filestart; 
    history{1,7,1} = 'fileend: '; 
    history{1,8,1} = fileend; 
    history{1,9,1} = 'version: '; 
    history{1,10,1} = version; 
     
    history{2,1,1} = 'x_start:'; 
    history{2,2,1} = x_start; 
    history{2,3,1} = 'x_end: '; 
    history{2,4,1} = x_end; 
    history{2,5,1} = 'x_change: '; 
    history{2,6,1} = x_change; 
    history{2,7,1} = 'x:[c_start,c_end]: '; 
    %         history{2,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
    history{2,9,1} = 'x_size: '; 
    history{2,10,1} = x_size; 
     
    history{3,1,1} = 'y_start: '; 
    history{3,2,1} = y_start; 
    history{3,3,1} = 'y_end: '; 
    history{3,4,1} = y_end; 
    history{3,5,1} = 'y_change: '; 
    history{3,6,1} = y_change; 
    history{3,7,1} = 'y:[c_start,c_end]: '; 
    history{3,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
    history{3,9,1} = 'y_size: '; 
    history{3,10,1} = y_size; 
     
    history{4,1,1} = 'z_start: '; 
    history{4,2,1} = z_start; 
    history{4,3,1} = 'z_end: '; 
    history{4,4,1} = z_end; 
    history{4,5,1} = 'z_change: '; 
    history{4,6,1} = z_change; 
    history{4,7,1} = 'z:[c_start,c_end]: '; 
    %         history{4,8,1} = ['[' int2str(c_start) ',' int2str(c_end) ']']; 
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    history{4,9,1} = 'z_size: '; 
    history{4,10,1} = z_size; 
     
    history{5,1,1} = 'threshold: '; 
    history{5,2,1} = threshold; 
    history{5,3,1} = 'radius: '; 
    history{5,4,1} = radius; 
    history{5,5,1} = 'type: '; 
    history{5,6,1} = type; 
    history{5,7,1} = 'parts: '; 
    history{5,8,1} = parts; 
    history{5,9,1} = 'angles: '; 
    history{5,10,1} = angles; 
     
    history{6,1,1} = 'voxel: '; 
    history{6,2,1} = voxel; 
    history{6,3,1} = 'bit depth: '; 
    history{6,4,1} = bit_d; 
    history{6,5,1} = 'plane: '; 
    history{6,6,1} = plane; 
    history{6,7,1} = 'start coordinates: '; 
    history{6,8,1} = o_start; 
    history{6,9,1} = 'end coordinates: '; 
    history{6,10,1} = o_end; 
     
    time = clock; 
    data_name = [filename(1:11) '_' int2str(time(2)) int2str(time(3)) int2str(time(1)) '_' int2str(time(4)) 
int2str(time(5))]; 
    xlswrite(data_name,data_radial(:,:,1),1); 
    xlswrite(data_name,data_radial(:,:,2),2); 
    xlswrite(data_name,data_radial(:,:,3),3); 
    xlswrite(data_name,data_angular(:,:,1),4); 
    xlswrite(data_name,data_angular(:,:,2),5); 
    xlswrite(data_name,data_angular(:,:,3),6); 
    xlswrite(data_name,history(:,:,1),7); 
     
    raw_name = [filename(1:5) '_RAWDATA_' int2str(time(2)) int2str(time(3)) int2str(time(1)) '_' 
int2str(time(4)) int2str(time(5))]; 
    xlswrite(raw_name,radial_data(:,:,1),1); 
    xlswrite(raw_name,radial_data(:,:,2),2); 
    xlswrite(raw_name,radial_data(:,:,3),3); 
    xlswrite(raw_name,radial_data(:,:,4),4); 
    xlswrite(raw_name,angular_data(:,:,1),5); 
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    xlswrite(raw_name,angular_data(:,:,2),6); 
    xlswrite(raw_name,angular_data(:,:,3),7); 
    xlswrite(raw_name,angular_data(:,:,4),8); 
    xlswrite(raw_name,[inside_data(:,:,1) inside_data(:,:,2) inside_data(:,:,3) inside_data(:,:,4)],9); 
    xlswrite(raw_name,[outside_data(:,:,1) outside_data(:,:,2) outside_data(:,:,3) outside_data(:,:,4)],10); 
end 
  
load gong; 
wavplay(y,Fs); 
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APPENDIX B 
PROCEDURES AND PROTOCOLS FOR SCAFFOLD 
FABRICATION, CHARACTERIZATION, AND CELL CULTURE 
B.1 Fabrication of Non-Mineralized Precursor Suspension  
 
B.1.1 Reference 
Yannas, I.; Lee, E.; Orgill, D.; Skrabut, E.; Murphy, G. Synthesis and characterization of a model 
extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A 
1989, 86 (3), 933-7. 
 
O’Brien, F.; Harley, B.; Yannas, I.; Gibson, L. Influence of freezing rate on pore structure in freeze-dried 
collagen-GAG scaffold. Biomaterials 2004, 25 (6), 1077-86. 
 
B.1.2 Supplies 
• Dry Collagen (Cat. No.  C9879, Sigma Aldrich) 
• Chondroitin-6-Sulfate (Cat. No.  C4384, Sigma Aldrich) 
• Glacial Acetic Acid (Cat. No. 71251, Sigma Aldrich) 
• De-Ionized Water 
 
B.1.3 Equipment 
• Balance 
• Jacketed Cooling Vessel 
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• Blender 
• Pipette 
• 25mL Conical Tube 
 
B.1.4 Procedure 
1. Setup the jacketed vessel, setting the water temperature to 4°C. 
 
2. Add 0.87 mL glacial acetic acid to 300 mL of de-ionized water to make a solution of 0.05 M 
acetic acid. 
 
3. Add 1.5g of Collagen to the jacketed vessel. Then add 250mL of the 0.05 M acetic acid solution 
to the Collagen. Set the blender to 15,000 rpm for 30min, so that the collagen is submerged prior 
to hydration. 
 
4. Measure out 0.133 g of Chondroitin-6-Sulfate and add it to 50mL of the 0.05 M acetic acid 
solution in a beaker. Then mix the buffer and the Chondroitin (GAG Solution), using a magnetic 
stirring bar, until fully dissolved. 
  
5. Set the blender to 15,000rpm and blend the Collagen made in step 3 for 60min. 
 
6. Add the GAG Solution prepared in step 4 to the Collagen Solution prepared in step 3 while 
mixing at 15,000 rpm. In between each addition, take care to prevent any clumping of the 
collagen/GAG with a spatula. With the additional volume, the slurry will mix better. 
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7. Blend this GAG / Hydrated Collagen Solution at 15,000rpm for 30min. 
 
8. Stores the slurry for 18-22hrs at 2-8°C. 
 
B.1.5 Notes 
• Solution expires 3 months after manufacture. 
• When mixing Phosphoric Acid with De-Ionized Water, never add water to acid. 
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B.2 Preparation of Phosphoric Acid-Calcium Hydroxide Buffer Solution 
 
B.2.1 Reference 
Process Record No. PR OM-001 Preparation of 0.1456M Phosphoric Acid/0.037M Calcium Hydroxide, 
BioUetikon and OrthoMimetics. 
 
B.2.2 Supplies 
• 5.904mL of 85% Phosphoric Acid (Cat. No. P5811, Sigma Aldrich) 
• 570mL De-IonizedWater 
• 1.644g Calcium Hydroxide (Cat. No. 31219, Sigma Aldrich) 
 
B.2.3 Equipment 
• Balance 
• Glass Beaker 
• pH Meter 
• Magnetic Stirrer (Recommended) 
• 0.2µm filter (For Sterilization) 
• Sterile bottle (For Sterilization) 
 
B.2.4 Procedure 
2. Add 5.904mL of 85% Phosphoric Acid to 570mL De-Ionized Water in a glass beaker and stir 
thoroughly. 
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3. Add 1.644g Calcium Hydroxide to the Phosphoric Acid solution and stir until fully dissolved and 
no visible particulates can be seen. A magnetic stirrer is recommended. 
 
4. Using De-Ionized Water, bring the Phosphoric Acid solution to the intend volume of 600mL if 
needed.  
 
5. Use a pH meter to check the final pH of the solution. It is recommended to be between 2.0-2.4. 
 
B.2.5 Notes 
• Solution expires 3 months after manufacture. 
• When mixing Phosphoric Acid with De-Ionized Water, never add water to acid. 
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B.3 Fabrication of Mineralized Precursor Suspension 
 
B.3.1 Reference 
Process Record No. PR OM-004 Preparation of Mineralized Slurry, BioUetikon and OrthoMimetics. 
 
B.3.2 Supplies 
• 0.1456M Phosphoric Acid / 0.037M Calcium Hydroxide Buffer Solution 
• Dry Collagen (Cat. No.  C9879, Sigma Aldrich) 
• Chondroitin-6-Sulfate (Cat. No.  C4384, Sigma Aldrich) 
• Calcium Hydroxide (Cat. No. 31219, Sigma Aldrich) 
• Calcium Nitrate Tetrahydrate (Cat. No. 31218, Sigma Aldrich) 
• De-Ionized Water 
 
B.3.3 Equipment 
• Balance 
• Jacketed Cooling Vessel 
• Blender 
• Pipette 
• 25mL Conical Tube 
 
B.3.4 Procedure 
9. Setup the jacketed vessel, setting the water temperature to 4°C. 
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10. Add 5.7966g of Collagen to the jacketed vessel. Then add 242.12mL of Phosphate Acid / 
Calcium Hydroxide buffer to the Collagen. Set the blender to 15,000 rpm for 30min, so that the 
collagen is submerged prior to hydration. Allow the collagen to hydrate for 18-22hrs in the cooled 
jacketed vessel at 4°C. This mixture will become very viscous and difficult to blend. 
 
11. Measure out 2.515g of Chondroitin-6-Sulfate and add it to 42.94mL of Phosphate Acid / Calcium 
Hydroxide Buffer in a beaker. Then mix the buffer and the Chondroitin (GAG Solution), using a 
magnetic stirring bar, until fully dissolved. 
 
12. Measure out 1.92g of Calcium Hydroxide and 1.17g of Calcium Nitrate Tetrahydrate and place 
both in a 25mL Conical Tube. Add 15mL of De-Ionized Water to the 25mL Conical Tube using a 
pipette. Then mix (vortex/shake) the solution to suspend the salts in the De-Ionized Water. 
 
13. Set the blender to 15,000rpm and blend the Hydrated Collagen made in step 2 for 60min. 
 
14. Add the GAG Solution prepared in step 3 to the Hydrated Collagen Solution prepared in step 3 in 
8mL steps while mixing at 15,000 rpm. In between each 8mL step, take care to prevent any 
clumping of the collagen/GAG with a spatula. With the additional volume, the slurry will mix 
better. 
 
15. Blend this GAG / Hydrated Collagen Solution at 15,000rpm for 30min. 
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16. Blend the Collagen / GAG mixture at 200-800rpm while adding the salts to maximize dispersion. 
Using a pipette, add the salt solution at a rate of 8mL/min to the Collagen / GAG mixture, 
allowing time for blending after each volume. Then blend the slurry at 15,000rpm for 30min. 
 
17. Stores the slurry for 18-22hrs at 2-8°C. 
 
 
B.3.5 Notes 
• Do not use the slurry immediately after manufacturing. 
• Prior to use, the slurry must be blended to ensure proper mixing. 
• Do not mix the GAG Solution too aggressively to prevent separation. 
• When adding the Salts Solution to the GAG / Hydrated Collagen Solution be   prepared for 
foaming. 
• Carefully wash all equipment (rotor-stator, mixing flasks, and moulds) carefully and thoroughly 
to prevent any cross contamination. 
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B.4 Hydroxyproline Assay for Collagen Content 
 
B.4.1 References 
 
Chapter 16: Determination of Collagen Content, Concentration, and Sub-types in Kidney Tissue 
Chrishan S. Samuel 
Methods in Molecular Biology, vol. 466: Kidney Research 
 
B.4.2 Materials 
 
o Chloramines T (Sigma-Aldrich, 857319-5G, $20.20) 
o Sodium Acetate Anhydrous (Sigma-Aldrich, 236500-25G, $28.80) 
o Tri-Sodium Citrate 2H2O (?) 
o Citric Acid (Sigma-Aldrich, 251275-5G, $24.10) 
o 4-(Dimethylamino)benzaldehyde (a.k.a. DMAB) (Sigma-Aldrich, 39070-50G, $46.30) 
o HCl (Sigma-Aldrich, 84428-100ML, $32.30) 
o Strong Base (NaOH) (Sigma-Aldrich, 221465-25G, $27.40) 
o DI H2O 
o Hydroxyproline (Sigma-Aldrich, H5877-250MG, $18.40) 
o Isopropanol (Sigma-Aldrich, 190764-500ML, $32.60) 
 
B.4.3 Procedure 
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1. With the exception of the Chloramine T Solution and the Acetate Citrate Buffer, all solutions 
should be prepared the day of the assay for best possible freshness. 
 
2. Prepare the Chloramines T Solution by dissolving Chloramine T in DI H2O to yield a 7g/100mL 
solution. It can be stored up to 2 week at 4oC in the dark. 
 
3. Prepare an Acetate Citrate Buffer (pH 6.0 per 100mL) by dissolving 3.44g Sodium Acetate 
Anhydrous, 3.75g Tri-Sodium Citrate 2H2O, and 0.55g Citric Acid in 38.5mL of Isopropyl 
Alcohol and DI H2O. It can be stored at 4oC for 6 months. 
 
4. Prepare an Oxidation Buffer by combining 1:4 Chloarmine T Solution with Acetate Citrate 
Buffer. It is recommened that 1mL Chloramine T solution and 4mL Acetate Citrate Buffer be 
used. 
 
5. Prepare Ehrlich’s reagent by combining 2.0g para-dimethylaminobenzaldehyde in 3.0mL 60% 
perchloric acid. This can be stored up to 2 weeks at 4oC in the dark. 
 
6. Prepare an Analytical Isopropanol agent by combining 3:13 Ehrlich’s reagent with Isopropanol. 
The solution will be yellow in color. 
 
7. Prepare a 6-8mm diameter scaffold punch. 
 
8. Accurately measure the dry weight of the sample. 
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9. Place the sample in a 1mL Reacta-Vial. A regular plastic cap can be used to seal the vial. A 
second larger glass jar can be used as secondary containment during the hydrolysis (Step 9).  
 
10. Submerge the samples in 0.4-0.5mL 6M HCl prior to being hydrolyzed at 110oC for 24hrs in the 
oven. For larger vials, 1-2mL 6M HCl can be used. 
 
11. Cool samples to 4oC in the fume hood and fridge. 
 
12. Neutralize the 6M HCl used for the hydrolysis.  
a. It is suggested to prepare and use a stock 6M NaOH solution. 
 
13. Double the volume of each sample using a stock solution of 0.2M HCl. 
 
14. Assay each sample in either duplicates, triplicates, or quadruplicates. Add 10uL sample (in 0.1M 
HCl) to 90uL DI H2O. (Total of 100uL). 
 
15. Prepare the standard curve by adding: 0uL, 2 uL, 4 uL, 6 uL, 8 uL, and 10 uL 1mg/mL 
Hydroxyproline (in 0.1M HCl) and adjusting to a total volume of 100uL with DI H2O. 
 
16. Steps 17-23 are time sensitive and should be done as soon as possible. Steps 15-17 must be done 
within 4min. Steps 18-19 need to be done within another 4min. 
 
17. Add 200uL Isopropanol to all samples. 
 
18.  Add 100uL Oxidation Buffer to all samples (total volume now 0.4mL). 
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19. Vortex all samples and allow them to stand at room temperature for 4±0.5min. 
 
20. Add 1.3mL Analytical Isopropanol reagent to all samples (total volume now 1.7mL). 
 
21. Place all samples into a water bath pre-set to 60oC for 25min. 
 
22. Cool samples at 4oC for 5-10min. 
 
23. Add 3.3mL Isopropanol to all samples (total volume 5mL). 
 
24. Pipette samples into a clear plastic 96 well plate for use in the spectrometer. 
 
25. Calibrate spectrometer using the blank sample (0uL Hydroxyproline in 0.1M HCl). Obtain 
absorbance at 558nm. From this a standard curve can be generated. 
 
B.4.4 Operation of the spectrometer 
 
1. Turn on the computer, if not already on. This seriously takes roughly 20min, if the computer is 
still running slow, you could open the task manager and close McAfee applications. 
 
2. Turn on the spectrometer, the tray will automatically eject (a second time) when it is completely 
turned on and ready to be used. 
 
3. Open the program Gen5 located on the desktop. 
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4. Under ‘Open A Recent Item’ and ‘Protocols” click on the ‘Harley_HOPro_Assay_1.prt’ or just 
select under ‘Create a New Item’ an ‘Experiment’. 
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5. On the next screen, under ‘File’ click ‘New Experiment…’. 
 
 
6. Select ‘Harley_HOPro_Assay_1.prt’ and click ‘Ok’. 
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7. Once loaded, under ‘Plate’ click ‘Read’. 
 
 
8. Enter any desired information to identify the experiment and click ‘Read’. 
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9. You will now be prompted to place the 96 well plate onto the carrier and then press ‘Ok’. 
 
 
10. The experiment will automatically start. It will take about 10min to complete. 
 
11. Upon completion, the data being displayed will default to ‘Hydroxyproline 500’ which 
corresponds to 500nm absorption measurement. 
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12. The data being displayed can be changed by using the drop down list. 
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13. This data can be exported to excel by clicking on the green excel button located next to the drop 
down list. 
 
 
14. Each wavelength (500nm, 525nm, 550nm, 558nm, 575nm, 600nm) will be exported to a separate 
excel book. It is recommended, for convenience, that you copy and paste all the data into one 
excel spread sheet and then back the data up. 
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15. The Gen5 program can then be closed. 
 
16. Do not turn off the computer, leave it on. 
 
17. Close the spectrometer carrier, and turn the spectrometer off. 
 
18. Turn off the room lights.   
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B.5 1,9-Dimethylmethylene Blue (DMMB) for Glycosaminoglycan Content 
 
B.5.1 References 
 
Barbosa, I.; Garcia, S.; Barbier-Chassefiere, V.; Caruelle, J.; Martelly, I.; Papy-Garcia, D. Improved and 
simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in 
skin and muscle tissue studies. Glycobiology 2003, 13, 647-653. 
 
B.5.2 Materials 
 
• Ethanol 
• Guanidine hydrochloride (GuHCl) (Sigma-Aldrich, G4630-1KG, $56.10) 
• Sodium Formate (Sigma-Aldrich, 247596-100G, $37.70) 
• 98% Formic Acid (Sigma-Aldrich, 94318-50ML-F, $33.20) 
• DI H2O 
• 1,9-dimethylmethylene blue (DMMB) (Sigma-Aldrich, 341088-1G, $40.50) 
• Sodium Acetate (Sigma-Aldrich, S2889-250G, $24.10) 
• propan-1-ol (Sigma-Aldrich, 279544-100ML, $30.90) 
• Chondroitin-6-Sulfate (GAG) (Sigma-Aldrich, C4384) 
 
B.5.3 Procedure 
 
1. Prepare a Formate Solution by mixing 25mL Ethanol, 100mL 1M GuHCl, 1g Sodium Formate, 
and 1mL 98% Formic Acid. Raise the total volume to 500mL using DI H2O. 
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2. Prepare the DMMB Complexation Solution: 
 
a. Dissolve 16mg DMMB into 25mL Ethanol. 
b. Filter the resulting solution through filter paper. 
c. Add 100mL 1M GuHCl, 1g Sodium Formate, and 1mL 98% Formic Acid to the DMMB-
Ethanol solution. 
d. Raise the total volume to 500mL using DI H2O. 
e. Immediately dilute this DMMB solution with the Formate Solution (1:1). This is a time 
sensitive step. 
f. This solution may be stored for 4 months at room temperature in the dark. 
 
3. Prepare a DMMB Decomplexation Solution by mixing a 50mM Sodium Acetate Solution (pH 
6.8) with 10% propan-1-ol. Then dissolve GuHCl into the Sodium Acetate Solution to make a 
final concentration of 4M. This solution may be stored for 4 months at room temperature. 
 
4. Prepare a 50ug/mL proteinase K in 100mM K2HPO4 solution. 
 
5. Digest 6-8mm scaffold punches in the 1mL of the 50ug/mL proteinase K in 100mM K2HPO4 
solution overnight at 56oC. A plastic micro centrifuge tube is sufficient in size. 
 
6. Deactivate the 50ug/mL proteinase K in 100mM K2HPO4 solution by heating it to 90oC for 10min 
in the oven or equivalent. 
 
7. Centrifuge the samples at 1400xg for 5min to separate the debris from extract. 
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8. Pipette the supernate (extract) from the precipitate (debris) carefully into a new vial. This will 
represent initially diluted sample (the scaffold was diluted in the 50ug/mL proteinase K in 
100mM K2HPO4 solution). 
 
9. Estimate the amount of gag present in the supernate (extract). For a 8mm punch from a 3”x3” 
scaffold using 24.6mL out of 300mL slurry digested in 1mL Proteinase K solution:  
 
2
6 2
2.515 _ _ _ 24.6 _ _ _ (8 / 2) _ _ 1
10 / 300 _ _ (76.2 ) _ _ 1 _ Pr _ _
g GAG in Slurry mL Slurry in Scaffold mm Punch Area
g g mL Total Slurry mm Scaffold Area mL oteinase K Solution
π
µ−
× × ×
 
 
 
10. For each sample, make 2-3 dilutions using the estimated amount of gag present in the 
supernate. Dilute the samples to 10ug/mL, 20ug/mL, and/or 30ug/mL, if the amount of gag 
should be close to the expect amount. If amount of gag estimated is not expected to be 
similar, dilute samples to 10ug/mL, 30ug/mL, and/or 60ug/mL (a broader range). Thoroughly 
mix the samples after every dilution by vortexing. 
 
11. For each of the diluted samples (10ug/mL, 20ug/mL, and/or 30ug/mL ect.) add 1mL DMMB 
complexation solution to an empty micro-centrifuge tube. 
 
12. Add 100uL of the diluted samples (10ug/mL, 20ug/mL, and/or 30ug/mL ect.) to each of the 
micro-centrifuge tubes prepared in step 11. This will result in further diluted samples (1ug, 
2ug, and/or 3ug for 10ug/mL, 20ug/mL, and/or 30ug/mL ect.) which are in the linear range 
(0-4ug). 
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13. Vortex all of the micro-centrifuge tubes for 30min. This allows adequate time for the GAG-
DMMB complex to form. 
 
14. Centrifuge all of the micro-centrifuge tubes at 14000xg for 30min. 
 
15. Pipette out and discard the supernate (unused DMMB complexation solution) while carefully 
keeping any precipitate present in all of the micro-centrifuge tubes. Note: the precipitate is 
not visible below 4ug. 
 
16. Add 1mL DMMB decomplexation solution to each of the micro-centrifuge tubes. 
 
17. Vortex the micro-centrifuge tubes for 30min. This allows adequate time for the GAG-DMMB 
complex to be separated/destroyed. 
 
18. It is recommended to pipette 0.2mL each samples into 4 wells in a 96 well plate for analysis 
with a spectrometer. 
 
19. The wavelength of interest is at 656nm. 
 
20. Standard curves are prepared in the same way as steps 9-19, the only difference being that a 
known amount of GAG was added to a 100mM K2HPO4 solution. Dilute the GAG down to 
0ug, 0.2ug, 0.4ug, 0.6ug, 0.8ug, 1.0ug, 2.0ug, 4.0ug, 6.0ug, 8.0ug, 10.0ug. This accounts for 
the entire linear region and some none linear parts (8.0ug and 10.0ug). 
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B.5.4 Operation of the Spectrometer 
 
This is identical to the operation of the spectrometer for the hydroxyproline assay, with the exception that 
the ‘Harley_DMMB_Assay_1.prt’ is used instead. Please see appendix B, section B.4, subsection B.4.4 
for operating instructions. 
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B.6 Permeability of Hydrated Collagen-Glycosaminoglycan Scaffolds 
B.6.1 Reference 
O’Brien, F., Brendan, H., Waller, A., Yannas, I., Gibson, L., Prendergast, P. The effect of pore size on 
permeability and cell attachment in collagen scaffolds for tissue engineering. Technology and Health 
Care, 2007, 15, 3-17. 
 
B.6.2 Supplies 
• De-Ionized Water 
• Food coloring 
 
B.6.3 Equipment 
• Permeability Rig 
• Assorted gaskets, grommets, and spacers 
• Container (dimensions exceeding 6”x6”x4”) 
• Ring stand 
 
B.6.4 Procedure 
1. Fill the container with De-Ionized water. The water level should be a minimum of 5.83cm or 2.3” 
(2” + 75% of sample height), the gasket/grommet being used must be completely submerged. 
This allows the samples to remain submerged and hydrated, but not float away in the event of 
poor hydration. 
 
2. Assemble the rig. It is recommended that the rig is dried prior to assembly if previously used. 
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3. Thread bolts through the top half of the rig, use tape to ensure the bolts remain fixed. 
 
4. Place desired spacers (dependent on desired compression and gasket used, the spacers must be at 
most 85% of the height of the gasket to ensure a good seal) on the bolts fixed in the top half of the 
rig. 
 
5. Center gasket over the grating on the top half of the rig, use tape to ensure the gasket maintains 
this position. 
 
6. Carefully submerge the top half of the rig (step 2), ensuring that there is no air bubbles trapped. It 
is necessary for the top half of the rig to be upside down (grating facing up) in the container filled 
with De-Ionized water (step 1). 
 
7. Carefully place the sample into the container filled with De-Ionized water (step 1). Once the 
sample and hydration of the sample has been confirmed, maneuver the sample over the grating. 
This must be done such that the sample covers the grating completely and fills the 
gasket/grommet completely. 
 
8. Carefully thread the bottom half of the rig onto the exposed bolts. It must be slowly moved down 
to prevent the bottom half of the rig from becoming stuck (due to uneven progression) and 
moving the sample out of the gasket. 
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9. Once the bottom half has been threaded onto the bolts completely (the sample should have been 
smoothly compressed into the gasket/grommet), wingnuts should be threaded onto the end of the 
bolts to secure the entire rig. 
 
10. Slowly rotate the rig onto its side. This should cause the rig to be entirely submerged. There 
should be no air bubbles in the rig. 
 
11. Remove the tap used to secure the bolts on the top of the rig. While completely submerged, use 
an adjustable wrench to tighten the bolts and wingnuts to ensure that only the spacer is separating 
top and bottom halves of the rig. 
 
12. Rotate the wingnuts (approximately 30° or 60° with respect to the sides) so that they form a rough 
circle and fit into the ring stand. 
 
13. Add the bottom cap to the permeability rig to prevent any flow of water during placement onto 
the ring stand. 
 
14. Remove the bottom cap to allow water to flow through the rig. Be prepared to immediately add 
water to prevent the pressure head and water level from deviating from either 1.2” or 3.0” 
(experiment and rig dependent). 
 
15. A pasture pipette is recommended, but in some cases this may not be sufficient enough. 
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16. Place a designated graduated cylinder under the permeability rig to collect water (10.0±0.2mL 
graduated cylinder is recommended, but the choice of graduated cylinder is dependent upon the 
permeability of the scaffold). Start the timer with the appearance of the first drop. Always stop 
the timer after the last drop. 
 
17. Due to radical changes with compression, stopping measurements after set volume or time 
increments is difficult. 
 
18. Make a note of: 
a. Volume of De-Ionized Water in graduate cylinder (mL). 
b. Time the measurement occurred over (s). 
c. Height of gasket/grommet used (mm). 
d. Height of spacers used (mm). 
e. Pressure head used (1.2” or 3.0”, experiment and rig dependent). 
f. Any other information that maybe relevant to experiment. 
 
19. Repeat step 12 twice more for each sample (for a total of three measurements per sample). 
 
20. Replace the rig in the container filled with De-Ionized water. Disassemble the rig, note carefully 
if there is an abnormality in sample hydration or placement. 
 
21. Repeat steps 2-14 for different compressions, samples, or groups (experiment dependent). 
 
22. Calculate the permeability of samples using Darcy’s Law:  
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𝑲𝑲 = 𝑸𝑸 ∙ 𝒍𝒍 ∙ 𝝁𝝁
∆𝑷𝑷 ∙ 𝑨𝑨
= 𝑽𝑽 ∙ 𝒍𝒍 ∙ 𝝁𝝁
𝒕𝒕 ∙ ∆𝑷𝑷 ∙ 𝑨𝑨
 
 
Where:  V is the volume measured. 
  𝒍𝒍 is the distance the De-Ionized water travels, in this case the     
   spacer distance. 
  𝝁𝝁 is the viscosity of water, which is 0.001 Pas. 
  𝒕𝒕 is the time the measurement occurs over. 
  𝑨𝑨 is the area through which the De-Ionized water travels. 
  ∆𝑷𝑷 = (𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑 𝒉𝒉𝒑𝒑𝒉𝒉𝒉𝒉) ∙ (𝒉𝒉𝒑𝒑𝒅𝒅𝒑𝒑𝒅𝒅𝒕𝒕𝒅𝒅 𝒐𝒐𝒐𝒐 𝒘𝒘𝒉𝒉𝒕𝒕𝒑𝒑𝒑𝒑) ∙ (𝒈𝒈𝒑𝒑𝒉𝒉𝒈𝒈𝒅𝒅𝒕𝒕𝒅𝒅) is the    
   pressure. 
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B.7 Sectioning the Embedded CG Scaffold Samples Protocol; Aniline Blue Staining 
Protocol 
 
B.7.1 Reference 
O’Brien, Harley, et al., 2004; O’Brien, Harley, et al., 2005 
 
B.7.2 Supplies 
• Aniline Blue 
o 2.5mg aniline blue (Cat. No. AC40118-0250, Fisher Scientific, Hanover Park, IL) 
o 2mL glacial acetic acid (Mallinckrodt Chemical Co., Paris, KY) 
o 100mL distilled water 
o Filter before use 
• 1% Acetic Acid 
o 1mL glacial acetic acid (Mallinckrodt Chemical Co.) 
o 99mL distilled water 
• 95%, 100% ethanol 
• Cytoseal 60 (Cat. No. NC9472256, Fisher Scientific) 
 
B.7.3 Equipment 
• Leica RM2165 microtome (Mannheim, Germany) 
 
B.7.4 Procedure 
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1. Serially section the embedded CG scaffold samples on a Leica RM2165 microtome (Mannheim, 
Germany) at a 5um thickness. Mount each section on a glass microscope slide. 
 
2. Dip the slides in the Aniline Blue solution for 2-4 minutes. 
 
3. Place the slides into a 1% acetic acid solution for 1 minute. 
 
4. Dip each slide 5-10 times in 95% alcohol until most of background staining goes away. 
 
5. Dip each slide 5-10 times 100% alcohol to complete the rinsing process. 
 
6. Mount each sample with 4 drops of Cytoseal 60 (Fisher Scientific) and coverslip. Try to not 
introduce air bubbles when placing the coverslip onto the sample. 
 
7. Dry the coverslipped samples laying flat in a chemical fume hood for at minimum 1 hour.  
 
8. Continue to dry the coverslipped samples while laying flat for an additional 2 days on the bench 
top or in the chemical fume hood. 
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B.8 Complete α-MEM Media for MC3T3 Pre-Osteoblasts 
 
B.8.1 Supplies 
• 440mL of α-MEM Media without Ascorbic Acid (SCS CMF, RAL 491, UIUC) 
• 50mL Fetal Bovine Serum, Qualified, Heat-Inactivated (16140-71, Invitrogen) 
• 5mL Penicillin-Streptomycin, Liquid (15140-122, Invitrogen) 
• 5mL L-Glutamine, 200 mM (25030-081, Invitrogen) 
 
B.8.2 Equipment 
• Automatic Pipette 
• 2x 25mL Sterile Pipette Tips 
• 2x 5mL Sterile Pipette Tips 
• Sterile 500mL Sealable Bottle 
• 37°C Water Bath 
• Bio Safety Cabinet 
• 70% Ethanol (30% DI H2O) 
 
B.8.3 Procedure 
1. The Fetal Bovine Serum (FBS), Penicillin-Streptomycin (Pen-Strep), and L-Glutamine (L-Glu) 
are stored at -20°C. It is necessary to thaw these using a 37°C Water Bath. After thawing, make 
sure they are adequately mixed, vortexing or shaking is recommended. 
 
2. Turn on the Bio Safety Cabinet (BSC). Allow adequate time for it to properly turn on. 
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3. Spray with 70% Ethanol two 25mL Pipette Tips, two 5mL Pipette Tips, the Sterile 500mL Bottle, 
the Automatic Pipette, the α-MEM Media without Ascorbic Acid, FBS, Pen-Strep, and L-Glu. 
After spraying each item, place them into the ready BSC. 
 
4. Carefully Pipette 440mL (88%) of the α-MEM without Ascorbic Acid into the empty 500mL 
Sterile Bottle using a 25mL Pipette Tip. This will take 16x25mL+2x20mL. 
 
5. Carefully Pipette 50mL (10%) FBS into the 500mL Sterile Bottle. 
 
6. Carefully pipette, using a 5mL Pipette Tip, 5mL (1%) Pen-Strep into the 500mL Sterile Bottle. 
 
7. Carefully pipette, using a 5mL Pipette Tip, 5mL (1%) L-Glu into the 500mL Sterile Bottle. 
 
8. Mix all the components together by gently shaking the 500mL Sterile Bottle. This is the 
“Complete α-MEM Media.” Store this at 4°C when not in use. 
 
9. Clean up the BSC by removing any Pipette Tips and/or empty containers. These should be placed 
in the Biowaste. 
 
B.8.4 Notes 
• Once open, if any of the Pipette Tips touch any surface within the BSC, they should be replaced 
to avoid contaminating any of the solutions in use. 
• If any of the FBS or Anti-Anti remains, they should be placed at -20°C for storage. 
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B.9 Complete Mesenchymal Stem Cell Media for Human Mesenchymal Stem Cell 
Culture 
 
B.9.1 Supplies 
• 450 mL of d-MEM Media (SCS CMF, RAL 491, UIUC) 
• 50 mL Fetal Bovine Serum, Mesenchymal Stem Cell-Qualified (12662-029, Invitrogen) 
• 5 mL Antibiotic-Antimycotic, 100X (15240-062, Invitrogen) 
 
B.9.2 Equipment 
• Automatic Pipette 
• 2x 25mL Sterile Pipette Tips 
• 1x 5mL Sterile Pipette Tips 
• Sterile 500mL Sealable Bottle 
• 37°C Water Bath 
• Bio Safety Cabinet 
• 70% Ethanol (30% DI H2O) 
 
B.9.3 Procedure 
1. The Fetal Bovine Serum (FBS) and Antibiotic-Antimycotic (Anti-Anti) are stored at -20°C. It is 
necessary to thaw these using a 37°C Water Bath. After thawing, make sure they are adequately 
mixed, vortexing or shaking is recommended. 
 
2. Turn on the Bio Safety Cabinet (BSC). Allow adequate time for it to properly turn on. 
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3. Spray with 70% Ethanol two 25mL Pipette Tips, one 5mL Pipette Tips, the Sterile 500mL Bottle, 
the Automatic Pipette, the d-MEM Media without Ascorbic Acid, FBS, and Anti-Anti. After 
spraying each item, place them into the ready BSC. 
 
4. Carefully Pipette 450mL (90%) of the d-MEM into the empty 500mL Sterile Bottle using a 25mL 
Pipette Tip. This will take 18x25mL. 
 
5. Carefully Pipette 50mL (10%) FBS into the 500mL Sterile Bottle. 
 
6. Carefully pipette, using a 5mL Pipette Tip, 5mL Anti-Anti into the 500mL Sterile Bottle. 
 
7. Mix all the components together by gently shaking the 500mL Sterile Bottle. This is the 
“Complete d-MEM Media.” Store this at 4°C when not in use. 
 
8. Clean up the BSC by removing any Pipette Tips and/or empty containers. These should be placed 
in the Biowaste. 
 
B.9.4 Notes 
• Once open, if any of the Pipette Tips touch any surface within the BSC, they should be replaced 
to avoid contaminating any of the solutions in use. 
• If any of the FBS, Pen-Strep, or L-Glue remains, they should be placed at -20°C for storage. 
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B.10 Passaging MC3T3 Pre-Osteoblasts Cell Culture 
 
B.10.1 Supplies 
• Complete α-MEM Media for MC3T3 Pre-Osteoblasts 
• 3mL per flask Trypsin, 0.05% (1X) with EDTA 4Na, liquid (925300-062, Invitrogen) 
• 10mL per flask Sterile Phosphate Buffered Saline without Calcium and Magnesium (CLSL Stock 
Room, CLSL C107, UIUC) 
 
B.10.2 Equipment 
• 1 BD Falcon 50mL Conical Centrifuge Tubes per 4 flasks (14-432-22, Fisher Scientific) 
• Centrifuge capable of 1200rpm 
• 75mL Polystyrene Cell Culture Flasks (CLSL Stock Room, CLSL C107, UIUC) 
• Glass Beaker (for waste) 
• Automatic Pipette 
• 3x 10mL Sterile Pipette Tips 
• 1x 5mL Sterile Pipette Tip 
• 1x 25mL Sterile Pipette Tip 
• Hemocytometer or other equivalent device and capable microscope 
• 37°C Water Bath 
• 70% Ethanol (30% DI H2O) 
• Sterile Cell Incubator 
• Micro-Pipette and associated Micro Pipette Tips 
 
B.10.3 Procedure 
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1. Trypsin is normally stored at -20°C. It is necessary to thaw it using a 37°C Water Bath prior to 
use. After thawing, make sure the Trypsin is adequately mixed either by vortexing or shaking. 
 
2. Because the Complete α-MEM Media is stored at 4°C, it is necessary to bring warm it up to 37°C 
prior to use. Again, this can be done using the 37°C Water Bath. 
 
3. In the same manner as the Complete α-MEM Media, warm up the Sterile Phosphate Buffered 
Saline without Calcium and Magnesium (PBS) to 37°C. 
 
4. Turn on the Bio Safety Cabinet (BSC) and allow adequate time for it to become ready prior to 
putting things in it. 
 
5. Spray with 70% Ethanol the thawed Trypsin, the warmed up Complete α-MEM Media, the 50mL 
Conical Centrifuge Tubes, the Glass Beaker (for waste), three 10mL Sterile Pipette Tips, one 
5mL Steril Pipette Tip, one 25mL Sterile Pipette Tip, the Automatic Pipette, and any new Cell 
Culture Flasks. After spraying each item, place them into the ready BSC. 
 
6. Begin by using one 10mL Sterile Pipette Tip to remove any old media from the flasks. Pipette 
this media into the Glass Beaker (for waste). Cap each flask after the removal of the media. Be 
careful not to disturb the bottom of the flask (where the cells reside) with the pipette tip. 
 
7. Using a clean 10mL Sterile Pipette, pipette 10mL PBS into the now empty flasks. Cap all the 
flasks and gently swish the PBS around inside. Then using the same 10mL Sterile Pipette Tip, 
pipette remove the 10mL PBS from each flask and pipette into the Glass Beaker. 
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8. Using a clean 5mL Sterile Pipette, pipette 3mL Trypsin into each of the Cell Culture Flasks. 
Afterwards, cap each flask and place into the cell incubator for 4min. Remember to spray each 
flask with 70% Ethanol prior to placing them into the Sterile Incubator. 
 
9. After 4min, remove the flasks from the sterile incubator. Gently tap the sides of each flask to 
loosen any cells that are still attached. Using a microscope, verify that the cells are detached and 
floating. Then, after being sprayed with 70% Ethanol, the flasks can be placed back into the BSC. 
 
10. Using a 10mL Sterile Pipette Tip, immediately add 6mL Complete α-MEM Media to each flask. 
Cap the flasks and gently swish any Media and Trypsin around inside. This deactivates the 
Trypsin. 
 
11. Using the same 10mL Sterile Pipette Tip, pipette a majority of the 9mL Media and Trypsin in 
each flask up and then over the bottom of the flask. This washes any cells that are yet attached on 
the bottom of the flask. After repeating this twice, pipette all 9mL into a 50mL conical tube. Each 
conical tube will hold up to 45mL (or five flasks). 
 
12. Thoroughly mix each cell solution using either a 10mL or 25mL Sterile Pipette. Remove 20µL of 
this mixed cell solution into a micro-centrifuge tube using a micro-pipette. 
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B.11 Operation of the DXA for Bone Mineral Density Analysis 
 
B.11.1 Equipment 
• Hologic QDR 4500A 
 
B.11.2 Procedure 
 
1. If you are the first user of the day, select “Daily OC” (green box), no other option will be 
available. This starts the daily calibration. If the instrument has already been calibrated, choose 
the “Perform Exam” (red box). 
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2. If you are performing the “Daily OC” follow the on screen instructions. When prompted for the 
calibration spine phantom, it is located in the wood box on the side of the room. CAREFULLY 
handle and maneuver it onto the bench and align it with the laser. To align: (1) have the crosshair 
centered on the circle within the black dot; (2)  orient the phantom so that the spine is extending 
to the right of the crosshair; (3) position the right (as opposed to left, top, bottom) crosshair line 
such that while maintaining (1), so the line is situated in the center of the text. Place the phantom 
back in its case following completion of the scan. 
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3.  If the crosshair disappears during calibration or sample positioning, you may reactivate by 
pressing the laser button on the console next to the apparatus. 
 
4. After pressing the “preform exam” button, select “new patient,” input your sample name, then 
click ok. Additional information is not necessary and maybe skipped. 
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5. Ensure that after creation you have your sample (patient) selected and press ok. You will be 
prompted for additional information, skip this as it does not apply and click ok. 
 
6. You will then be prompted to select your scan type. Select “small animal” (at the bottom of the 
list) and click next. Then select “regional high resolution.” If your sample is too large, you can 
select “rat whole body.” However, for best results use the “regional high resolution.” 
7. You may now place the appropriate absorbent material on top of the bedding. It is recommended: 
(1) several paper towels; (2) two layers of bench paper (absorbent side face up); (3) more paper 
towels.  
 
 267 
 
Remember, this apparatus is for human usage, ensure that there is no chance of chemical or 
biological contamination. Adequate preparation will allow for simple clean up once data 
collection is complete. 
  
8. Place the sample to the right of the crosshair prior to starting the scan by hitting “start scan.” 
 
9. The scan will then commence. For a scan distance of 5.8cm, the total scan time was 
approximately 1.5-2min. 
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10. Following completion of the scan, select “analyze scan,” then select the analysis method of 
“subregion hi-res.” 
 
11. Analysis of the scan then consisted of selecting the global region of interest (ROI) by dragging 
the vertical and horizontal cutoff lines to outline the sample. Following this, ensure the “bone 
map” has properly highlighted all of the bone sample. 
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12. The next step in data analysis involved the selection of a sub region. Select the “sub region” step 
with “point mode.” The ROI sub-region will appear as a box, this box maybe selected and 
dragged to the center of your defect. With the sub-region selected, click the “+” button to add 
additional inflection points to the sub-region, for creating an octagon this requires four additional 
sub regions. Drag the corners to extend the sub-region to the approximation of an octagon. Once 
properly outlined, click on the “results” tab to access the scan output. 
 
13. After analyzing the scan, click “close” to select “report.” Uncheck the rate of change option, then 
click print. The default printer should be the printer next to the computer, check the make and 
model to ensure that it is. 
14. Select “perform exam” to scan another example. 
 
Note: analysis can be performed a second time or retroactively, or printed, by selecting “scans” and 
locating the correct sample (patient) name within the database. 
  
 270 
 
REFERENCES 
1. Clarke, B., Normal bone anatomy and physiology. Clinical journal of the American Society of 
Nephrology : CJASN, 2008. 3 Suppl 3: p. S131-9. 
2. Wang, X. and Q. Ni, Determination of cortical bone porosity and pore size distribution using a 
low field pulsed NMR approach. Journal of orthopaedic research : official publication of the 
Orthopaedic Research Society, 2003. 21(2): p. 312-9. 
3. Kragstrup, J. and F. Melsen, Three-dimensional morphology of trabecular bone osteons 
reconstructed from serial sections. Metabolic bone disease & related research, 1983. 5(3): p. 127-
30. 
4. Gilbert, S.F., Developmental Biology. 6th ed2000, Sunderland (MA): Sinauer Associates. 
5. Mohsin, S., F.J. O'Brien, and T.C. Lee, Microcracks in compact bone: a three-dimensional view. 
Journal of anatomy, 2006. 209(1): p. 119-24. 
6. Marsell, R. and T.A. Einhorn, The biology of fracture healing. Injury, 2011. 42(6): p. 551-5. 
7. Einhorn, T.A. and L.C. Gerstenfeld, Fracture healing: mechanisms and interventions. Nature 
reviews. Rheumatology, 2015. 11(1): p. 45-54. 
8. Gaston, M.S. and A.H. Simpson, Inhibition of fracture healing. The Journal of bone and joint 
surgery. British volume, 2007. 89(12): p. 1553-60. 
9. Ponseti, I.V., History of Orthopaedic Surgery. The Iowa Orthopaedic Journal, 1991. 11: p. 59-64. 
10. Pollak, A.N., Watkins-Castillo, S.I. BMUS: The Burden of Musculoskeletal Diseases in the 
United States. 2014  [cited 2015 10/1/2015]; Available from: 
http://www.boneandjointburden.org/2014-report/vi0/injuries. 
11. Yelin, E.H., Watkins-Castillo, S.I. Economic Cost of Musculoskeletal Injuries. 2014  [cited 2015 
10/1/2015]; Available from: http://www.boneandjointburden.org/2014-report/vif0/economic-cost-
musculoskeletal-injuries. 
12. Parker, S.E., et al., Updated National Birth Prevalence estimates for selected birth defects in the 
United States, 2004-2006. Birth defects research. Part A, Clinical and molecular teratology, 2010. 
88(12): p. 1008-16. 
13. (NBDPN), T.C.f.D.C.a.P.C.N.B.D.P.N. Prevalence (Number of Cases) of Cleft Lip and Cleft 
Palate. 2014  [cited 2015 10/1/2015]; Available from: 
http://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/CraniofacialBirthDefects/PrevalenceC
left%20LipCleftPalate.htm. 
14. Kraft, A., et al., Craniomaxillofacial trauma: synopsis of 14,654 cases with 35,129 injuries in 15 
years. Craniomaxillofacial trauma & reconstruction, 2012. 5(1): p. 41-50. 
15. Handoll, H.H. and R. Madhok, Closed reduction methods for treating distal radial fractures in 
adults. The Cochrane database of systematic reviews, 2003(1): p. CD003763. 
16. Fan, K., et al., Top five craniofacial techniques for training in plastic surgery residency. Plastic 
and reconstructive surgery, 2012. 129(3): p. 477e-487e. 
17. Burwell, R.G., Studies in the Transplantation of Bone. Vii. The Fresh Composite Homograft-
Autograft of Cancellous Bone; an Analysis of Factors Leading to Osteogenesis in Marrow 
Transplants and in Marrow-Containing Bone Grafts. The Journal of bone and joint surgery. 
British volume, 1964. 46: p. 110-40. 
18. Boyne, P.J., Autogenous cancellous bone and marrow transplants. Clinical orthopaedics and 
related research, 1970. 73: p. 199-209. 
19. Nade, S. and R.G. Burwell, Decalcified bone as a substrate for osteogenesis. An appraisal of the 
interrelation of bone and marrow in combined grafts. The Journal of bone and joint surgery. 
British volume, 1977. 59(2): p. 189-96. 
 271 
 
20. Nade, S., Clinical implications of cell function in osteogenesis. A reappraisal of bone-graft 
surgery. Annals of the Royal College of Surgeons of England, 1979. 61(3): p. 189-94. 
21. Langer, R. and J.P. Vacanti, Tissue engineering. Science, 1993. 260(5110): p. 920-6. 
22. Mitragotri, S. and J. Lahann, Physical approaches to biomaterial design. Nature materials, 2009. 
8(1): p. 15-23. 
23. Kohn, J., New approaches to biomaterials design. Nature materials, 2004. 3(11): p. 745-7. 
24. Drogset, J.O., et al., Autologous patellar tendon and quadrupled hamstring grafts in anterior 
cruciate ligament reconstruction: a prospective randomized multicenter review of different 
fixation methods. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 
2010. 18(8): p. 1085-93. 
25. Timmer, M.D., et al., Fabrication of poly(propylene fumarate)-based orthopaedic implants by 
photo-crosslinking through transparent silicone molds. Biomaterials, 2003. 24(25): p. 4707-14. 
26. Khiste, S.V., V. Ranganath, and A.S. Nichani, Evaluation of tensile strength of surgical synthetic 
absorbable suture materials: an in vitro study. Journal of periodontal & implant science, 2013. 
43(3): p. 130-5. 
27. Chou, S.Y., C.M. Cheng, and P.R. LeDuc, Composite polymer systems with control of local 
substrate elasticity and their effect on cytoskeletal and morphological characteristics of adherent 
cells. Biomaterials, 2009. 30(18): p. 3136-42. 
28. Engler, A.J., et al., Matrix elasticity directs stem cell lineage specification. Cell, 2006. 126(4): p. 
677-89. 
29. Pamula, E., et al., The influence of pore size on colonization of poly(L-lactide-glycolide) scaffolds 
with human osteoblast-like MG 63 cells in vitro. Journal of materials science. Materials in 
medicine, 2008. 19(1): p. 425-35. 
30. Hallab, N.J., et al., Evaluation of metallic and polymeric biomaterial surface energy and surface 
roughness characteristics for directed cell adhesion. Tissue engineering, 2001. 7(1): p. 55-71. 
31. Lutolf, M.P. and J.A. Hubbell, Synthetic biomaterials as instructive extracellular 
microenvironments for morphogenesis in tissue engineering. Nature Biotechnology, 2005. 23(1): 
p. 47-55. 
32. Tocce, E.J., et al., Functionalization of reactive polymer multilayers with RGD and an antifouling 
motif: RGD density provides control over human corneal epithelial cell-substrate interactions. 
Journal of biomedical materials research. Part A, 2012. 100(1): p. 84-93. 
33. Wei, G. and P.X. Ma, Structure and properties of nano-hydroxyapatite/polymer composite 
scaffolds for bone tissue engineering. Biomaterials, 2004. 25(19): p. 4749-57. 
34. Lee, K., E.A. Silva, and D.J. Mooney, Growth factor delivery-based tissue engineering: general 
approaches and a review of recent developments. Journal of the Royal Society, Interface / the 
Royal Society, 2011. 8(55): p. 153-70. 
35. Uchida, A., et al., The use of ceramics for bone replacement. A comparative study of three 
different porous ceramics. The Journal of bone and joint surgery. British volume, 1984. 66(2): p. 
269-75. 
36. Kitsugi, T., et al., Four calcium phosphate ceramics as bone substitutes for non-weight-bearing. 
Biomaterials, 1993. 14(3): p. 216-24. 
37. Yuan, H., et al., Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. 
Proceedings of the National Academy of Sciences of the United States of America, 2010. 
107(31): p. 13614-9. 
38. Combes, C. and C. Rey, Amorphous calcium phosphates: synthesis, properties and uses in 
biomaterials. Acta biomaterialia, 2010. 6(9): p. 3362-78. 
39. Samavedi, S., A.R. Whittington, and A.S. Goldstein, Calcium phosphate ceramics in bone tissue 
engineering: a review of properties and their influence on cell behavior. Acta biomaterialia, 
2013. 9(9): p. 8037-45. 
 272 
 
40. Suzawa, Y., et al., Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal 
Stem Cells with Osteogenic Capability. International journal of molecular sciences, 2015. 16(6): 
p. 14245-58. 
41. Wang, Y., et al., [Effect of staining method and sintering temperature on the color of porcelain-
fused-to-metal restorations]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 
2004. 13(6): p. 553-6. 
42. Flauder, S., R. Sajzew, and F.A. Muller, Mechanical properties of porous beta-tricalcium 
phosphate composites prepared by ice-templating and poly(epsilon-caprolactone) impregnation. 
ACS applied materials & interfaces, 2015. 7(1): p. 845-51. 
43. Rogina, A., et al., In Situ Hydroxyapatite Content Affects the Cell Differentiation on Porous 
Chitosan/Hydroxyapatite Scaffolds. Annals of biomedical engineering, 2015. 
44. Mottaghitalab, F., et al., Silk as a potential candidate for bone tissue engineering. Journal of 
controlled release : official journal of the Controlled Release Society, 2015. 215: p. 112-28. 
45. Villa, M.M., et al., Improving the permeability of lyophilized collagen-hydroxyapatite scaffolds 
for cell-based bone regeneration with a gelatin porogen. Journal of biomedical materials 
research. Part B, Applied biomaterials, 2015. 
46. Furth, M.E., A. Atala, and M.E. Van Dyke, Smart biomaterials design for tissue engineering and 
regenerative medicine. Biomaterials, 2007. 28(34): p. 5068-73. 
47. Banerjee, A., et al., The influence of hydrogel modulus on the proliferation and differentiation of 
encapsulated neural stem cells. Biomaterials, 2009. 30(27): p. 4695-9. 
48. Weisgerber, D.W., et al., The impact of discrete compartments of a multi-compartment collagen-
GAG scaffold on overall construct biophysical properties. Journal of the mechanical behavior of 
biomedical materials, 2013. 28: p. 26-36. 
49. Hannink, G. and J.J. Arts, Bioresorbability, porosity and mechanical strength of bone substitutes: 
what is optimal for bone regeneration? Injury, 2011. 42 Suppl 2: p. S22-5. 
50. Rho, J.Y., R.B. Ashman, and C.H. Turner, Young's modulus of trabecular and cortical bone 
material: ultrasonic and microtensile measurements. Journal of biomechanics, 1993. 26(2): p. 
111-9. 
51. Reddi, A.H., Regulation of cartilage and bone differentiation by bone morphogenetic proteins. 
Current opinion in cell biology, 1992. 4(5): p. 850-5. 
52. Kirker-Head, C.A., Potential applications and delivery strategies for bone morphogenetic 
proteins. Advanced drug delivery reviews, 2000. 43(1): p. 65-92. 
53. Warnke, P.H., et al., Growth and transplantation of a custom vascularised bone graft in a man. 
Lancet, 2004. 364(9436): p. 766-70. 
54. Urist, M.R., Bone: formation by autoinduction. Science, 1965. 150(3698): p. 893-9. 
55. Johnson, E.E. and M.R. Urist, One-stage lengthening of femoral nonunion augmented with 
human bone morphogenetic protein. Clinical orthopaedics and related research, 1998(347): p. 
105-16. 
56. Quinlan, E., et al., Development of collagen-hydroxyapatite scaffolds incorporating PLGA and 
alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering. 
Journal of controlled release : official journal of the Controlled Release Society, 2015. 198: p. 71-
9. 
57. Epstein, N.E., Pros, cons, and costs of INFUSE in spinal surgery. Surgical neurology 
international, 2011. 2: p. 10. 
58. Epstein, N.E., Complications due to the use of BMP/INFUSE in spine surgery: The evidence 
continues to mount. Surgical neurology international, 2013. 4(Suppl 5): p. S343-52. 
59. Brouillet, F., et al., Biomimetic apatite-based composite materials obtained by spark plasma 
sintering (SPS): physicochemical and mechanical characterizations. Journal of materials science. 
Materials in medicine, 2015. 26(8): p. 223. 
 273 
 
60. Przekora, A., K. Palka, and G. Ginalska, Chitosan/beta-1,3-glucan/calcium phosphate ceramics 
composites--novel cell scaffolds for bone tissue engineering application. Journal of 
biotechnology, 2014. 182-183: p. 46-53. 
61. Jin, Y., et al., Bio-inspired mineralization of hydroxyapatite in 3D silk fibroin hydrogel for bone 
tissue engineering. Colloids and surfaces. B, Biointerfaces, 2015. 134: p. 339-45. 
62. Palazzo, B., et al., Fabrication, characterization and cell cultures on a novel composite chitosan-
nano-hydroxyapatite scaffold. International journal of immunopathology and pharmacology, 
2011. 24(1 Suppl 2): p. 73-8. 
63. Kanungo, I., et al., Influence of PCL on the material properties of collagen based biocomposites 
and in vitro evaluation of drug release. Materials science & engineering. C, Materials for 
biological applications, 2013. 33(8): p. 4651-9. 
64. Patel, J.J., et al., Dual Delivery of EPO and BMP2 from a Novel Modular Poly-varepsilon-
Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps. Tissue 
engineering. Part C, Methods, 2015. 21(9): p. 889-97. 
65. Chwalek, K., et al., In vitro bioengineered model of cortical brain tissue. Nature protocols, 2015. 
10(9): p. 1362-73. 
66. Cerri, F., et al., Peripheral nerve morphogenesis induced by scaffold micropatterning. 
Biomaterials, 2014. 35(13): p. 4035-45. 
67. Arora, A., A. Kothari, and D.S. Katti, Pore orientation mediated control of mechanical behavior 
of scaffolds and its application in cartilage-mimetic scaffold design. Journal of the mechanical 
behavior of biomedical materials, 2015. 51: p. 169-83. 
68. Zhao, X., et al., Conditions for seeding and promoting neo-auricular cartilage formation in a 
fibrous collagen scaffold. Journal of cranio-maxillo-facial surgery : official publication of the 
European Association for Cranio-Maxillo-Facial Surgery, 2015. 43(3): p. 382-9. 
69. Mullen, L.M., et al., Bioactive IGF-1 release from collagen-GAG scaffold to enhance cartilage 
repair in vitro. Journal of materials science. Materials in medicine, 2015. 26(1): p. 5325. 
70. Pang, Y., et al., The temporal and spatial dynamics of microscale collagen scaffold remodeling 
by smooth muscle cells. Biomaterials, 2009. 30(11): p. 2023-31. 
71. Zhao, W., et al., Diaphragmatic muscle reconstruction with an aligned electrospun poly(epsilon-
caprolactone)/collagen hybrid scaffold. Biomaterials, 2013. 34(33): p. 8235-40. 
72. Serena, E., et al., Electrophysiologic stimulation improves myogenic potential of muscle 
precursor cells grown in a 3D collagen scaffold. Neurological research, 2008. 30(2): p. 207-14. 
73. Villa, M.M., et al., Bone tissue engineering with a collagen-hydroxyapatite scaffold and culture 
expanded bone marrow stromal cells. Journal of biomedical materials research. Part B, Applied 
biomaterials, 2015. 103(2): p. 243-53. 
74. Xia, Z., M.M. Villa, and M. Wei, A Biomimetic Collagen-Apatite Scaffold with a Multi-Level 
Lamellar Structure for Bone Tissue Engineering. Journal of materials chemistry. B, Materials for 
biology and medicine, 2014. 2(14): p. 1998-2007. 
75. Long, T., et al., Fabrication of three-dimensional porous scaffold based on collagen fiber and 
bioglass for bone tissue engineering. Journal of biomedical materials research. Part B, Applied 
biomaterials, 2015. 103(7): p. 1455-64. 
76. Williams, D., Collagen: ubiquitous in nature, multifunctional in devices. Medical device 
technology, 1998. 9(6): p. 10-3. 
77. Di Lullo, G.A., et al., Mapping the ligand-binding sites and disease-associated mutations on the 
most abundant protein in the human, type I collagen. The Journal of biological chemistry, 2002. 
277(6): p. 4223-31. 
78. Yannas, I.V., et al., Synthesis and characterization of a model extracellular matrix that induces 
partial regeneration of adult mammalian skin. Proceedings of the National Academy of Sciences 
of the United States of America, 1989. 86(3): p. 933-7. 
 274 
 
79. Burke, J.F., et al., Successful use of a physiologically acceptable artificial skin in the treatment of 
extensive burn injury. Annals of surgery, 1981. 194(4): p. 413-28. 
80. Yannas, I.V. and J.F. Burke, Design of an artificial skin. I. Basic design principles. Journal of 
biomedical materials research, 1980. 14(1): p. 65-81. 
81. Yannas, I.V., et al., Design of an artificial skin. II. Control of chemical composition. Journal of 
biomedical materials research, 1980. 14(2): p. 107-32. 
82. Dagalakis, N., et al., Design of an artificial skin. Part III. Control of pore structure. Journal of 
biomedical materials research, 1980. 14(4): p. 511-28. 
83. Chamberlain, L.J., et al., Collagen-GAG substrate enhances the quality of nerve regeneration 
through collagen tubes up to level of autograft. Experimental neurology, 1998. 154(2): p. 315-29. 
84. Chamberlain, L.J., et al., Near-terminus axonal structure and function following rat sciatic nerve 
regeneration through a collagen-GAG matrix in a ten-millimeter gap. Journal of neuroscience 
research, 2000. 60(5): p. 666-77. 
85. Spilker, M.H., et al., Contraction of collagen-glycosaminoglycan matrices by peripheral nerve 
cells in vitro. Biomaterials, 2001. 22(10): p. 1085-93. 
86. Farrell, E., et al., A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem 
cell differentiation along osteogenic and chondrogenic routes. Tissue engineering, 2006. 12(3): p. 
459-68. 
87. Lynn, A.K., et al., Design of a multiphase osteochondral scaffold. I. Control of chemical 
composition. Journal of biomedical materials research. Part A, 2010. 92(3): p. 1057-65. 
88. Harley, B.A., et al., Design of a multiphase osteochondral scaffold. II. Fabrication of a 
mineralized collagen-glycosaminoglycan scaffold. Journal of biomedical materials research. Part 
A, 2010. 92(3): p. 1066-77. 
89. Harley, B.A., et al., Design of a multiphase osteochondral scaffold III: Fabrication of layered 
scaffolds with continuous interfaces. Journal of biomedical materials research. Part A, 2010. 
92(3): p. 1078-93. 
90. Getgood, A.M., et al., Evaluation of early-stage osteochondral defect repair using a biphasic 
scaffold based on a collagen-glycosaminoglycan biopolymer in a caprine model. The Knee, 2012. 
19(4): p. 422-30. 
91. O'Brien, F.J., et al., Influence of freezing rate on pore structure in freeze-dried collagen-GAG 
scaffolds. Biomaterials, 2004. 25(6): p. 1077-86. 
92. O'Brien, F.J., et al., The effect of pore size on cell adhesion in collagen-GAG scaffolds. 
Biomaterials, 2005. 26(4): p. 433-41. 
93. O'Brien, F.J., et al., The effect of pore size on permeability and cell attachment in collagen 
scaffolds for tissue engineering. Technology and health care : official journal of the European 
Society for Engineering and Medicine, 2007. 15(1): p. 3-17. 
94. Harley, B.A., et al., Mechanical characterization of collagen-glycosaminoglycan scaffolds. Acta 
biomaterialia, 2007. 3(4): p. 463-74. 
95. Harley, B.A., et al., A new technique for calculating individual dermal fibroblast contractile 
forces generated within collagen-GAG scaffolds. Biophysical journal, 2007. 93(8): p. 2911-22. 
96. Harley, B.A., et al., Fabricating tubular scaffolds with a radial pore size gradient by a spinning 
technique. Biomaterials, 2006. 27(6): p. 866-74. 
97. Caliari, S.R. and B.A. Harley, The effect of anisotropic collagen-GAG scaffolds and growth 
factor supplementation on tendon cell recruitment, alignment, and metabolic activity. 
Biomaterials, 2011. 32(23): p. 5330-40. 
98. Harley, B.A., et al., Optimal degradation rate for collagen chambers used for regeneration of 
peripheral nerves over long gaps. Cells, tissues, organs, 2004. 176(1-3): p. 153-65. 
99. Lynn, A.K., I.V. Yannas, and W. Bonfield, Antigenicity and immunogenicity of collagen. Journal 
of biomedical materials research. Part B, Applied biomaterials, 2004. 71(2): p. 343-54. 
 275 
 
100. Gonnerman, E.A., et al., The promotion of HL-1 cardiomyocyte beating using anisotropic 
collagen-GAG scaffolds. Biomaterials, 2012. 33(34): p. 8812-21. 
101. Caliari, S.R., et al., The influence of collagen-glycosaminoglycan scaffold relative density and 
microstructural anisotropy on tenocyte bioactivity and transcriptomic stability. Journal of the 
mechanical behavior of biomedical materials, 2012. 11: p. 27-40. 
102. Martin, T.A., et al., The generation of biomolecular patterns in highly porous collagen-GAG 
scaffolds using direct photolithography. Biomaterials, 2011. 32(16): p. 3949-57. 
103. Pence, J.C., et al., Strategies to balance covalent and non-covalent biomolecule attachment within 
collagen-GAG biomaterials. Biomaterials science, 2014. 2(9): p. 1296-1304. 
104. Alsop, A.T., et al., Photopatterning of vascular endothelial growth factor within collagen-
glycosaminoglycan scaffolds can induce a spatially confined response in human umbilical vein 
endothelial cells. Acta biomaterialia, 2014. 10(11): p. 4715-22. 
105. Pence, J.C., K.B. Clancy, and B.A. Harley, The induction of pro-angiogenic processes within a 
collagen scaffold via exogenous estradiol and endometrial epithelial cells. Biotechnology and 
bioengineering, 2015. 112(10): p. 2185-94. 
106. Hortensius, R.A., et al., The effect of glycosaminoglycan content on polyethylenimine-based gene 
delivery within three-dimensional collagen-GAG scaffolds. Biomaterials science, 2015. 3(4): p. 
645-54. 
107. Lynn, A.K. and W. Bonfield, A novel method for the simultaneous, titrant-free control of pH and 
calcium phosphate mass yield. Accounts of chemical research, 2005. 38(3): p. 202-7. 
108. Kanungo, B.P., et al., Characterization of mineralized collagen-glycosaminoglycan scaffolds for 
bone regeneration. Acta biomaterialia, 2008. 4(3): p. 490-503. 
109. Bloebaum, R.D., et al., Determining mineral content variations in bone using backscattered 
electron imaging. Bone, 1997. 20(5): p. 485-90. 
110. Pietrzak, W.S. and J. Woodell-May, The composition of human cortical allograft bone derived 
from FDA/AATB-screened donors. The Journal of craniofacial surgery, 2005. 16(4): p. 579-85. 
111. Sierpowska, J., et al., Effect of human trabecular bone composition on its electrical properties. 
Medical engineering & physics, 2007. 29(8): p. 845-52. 
112. Yeni, Y.N., C.U. Brown, and T.L. Norman, Influence of bone composition and apparent density 
on fracture toughness of the human femur and tibia. Bone, 1998. 22(1): p. 79-84. 
113. Al-Munajjed, A.A., J.P. Gleeson, and F.J. O'Brien, Development of a collagen calcium-phosphate 
scaffold as a novel bone graft substitute. Studies in health technology and informatics, 2008. 133: 
p. 11-20. 
114. Al-Munajjed, A.A., et al., Development of a biomimetic collagen-hydroxyapatite scaffold for 
bone tissue engineering using a SBF immersion technique. Journal of biomedical materials 
research. Part B, Applied biomaterials, 2009. 90(2): p. 584-91. 
115. Gleeson, J.P., N.A. Plunkett, and F.J. O'Brien, Addition of hydroxyapatite improves stiffness, 
interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone 
tissue regeneration. European cells & materials, 2010. 20: p. 218-30. 
116. Curtin, C.M., et al., Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient 
non-viral gene delivery platform for stem cell-mediated bone formation. Advanced materials, 
2012. 24(6): p. 749-54. 
117. Curtin, C.M., et al., Combinatorial gene therapy accelerates bone regeneration: non-viral dual 
delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold. Advanced healthcare 
materials, 2015. 4(2): p. 223-7. 
118. Murphy, C.M., et al., A collagen-hydroxyapatite scaffold allows for binding and co-delivery of 
recombinant bone morphogenetic proteins and bisphosphonates. Acta biomaterialia, 2014. 10(5): 
p. 2250-8. 
 276 
 
119. Quinlan, E., et al., Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite 
scaffolds for superior bone tissue regeneration. Journal of controlled release : official journal of 
the Controlled Release Society, 2015. 207: p. 112-9. 
120. Quinlan, E., et al., Controlled release of vascular endothelial growth factor from spray-dried 
alginate microparticles in collagen-hydroxyapatite scaffolds for promoting vascularization and 
bone repair. Journal of tissue engineering and regenerative medicine, 2015. 
121. Lopez-Noriega, A., et al., Thermally triggered release of a pro-osteogenic peptide from a 
functionalized collagen-based scaffold using thermosensitive liposomes. Journal of controlled 
release : official journal of the Controlled Release Society, 2014. 187: p. 158-66. 
122. Weisgerber, D.W., S.R. Caliari, and B.A. Harley, Mineralized collagen scaffolds induce hMSC 
osteogenesis and matrix remodeling. Biomaterials science, 2015. 3(3): p. 533-42. 
123. Weisgerber, D.W., K. Erning, C. Flanagan, S. Hollister, B.A.C. Harley, Adaptation of the 
mineralized collagen-glycosaminoglycan scaffold for in vivo implantation: formation of a multi-
scale biomaterial composite. In preparation, 2015. 
124. Weisgerber, D.W., R.A. Hortensius, Milner D., Rubessa M., Lopez-Lake H., M. Wheeler, B.A.C. 
Harley, In vivo implantation of the mineral polycaprolactone-collagen-glycosaminoglycan 
composite into a subcritical porcine mandibular ramus defect: assessment of in vivo efficacy. In 
preparation, 2015. 
125. Weisgerber, D.W., R.A. Hortensius, B.A.C. Harley, Alterations in mineralized collagen-
glycosaminoglycan scaffold composition: effect of mineral addition and protein constituents. In 
preparation, 2015. 
126. Siemionow, M., et al., Near-total human face transplantation for a severely disfigured patient in 
the USA. Lancet, 2009. 374(9685): p. 203-9. 
127. Nade, S., Osteogenesis after bone and bone marrow transplantation. II. The initial cellular events 
following transplantation of decalcified allografts of cancellous bone. Acta orthopaedica 
Scandinavica, 1977. 48(6): p. 572-9. 
128. Miller, M.J., et al., Guided bone growth in sheep: a model for tissue-engineered bone flaps. 
Tissue engineering, 1996. 2(1): p. 51-9. 
129. Christenson, E.M., et al., Nanobiomaterial applications in orthopedics. Journal of orthopaedic 
research : official publication of the Orthopaedic Research Society, 2007. 25(1): p. 11-22. 
130. Mountziaris, P.M. and A.G. Mikos, Modulation of the inflammatory response for enhanced bone 
tissue regeneration. Tissue engineering. Part B, Reviews, 2008. 14(2): p. 179-86. 
131. Krishnan, L., N.J. Willett, and R.E. Guldberg, Vascularization strategies for bone regeneration. 
Annals of biomedical engineering, 2014. 42(2): p. 432-44. 
132. DiCarlo, E.F. and P.G. Bullough, The biologic responses to orthopedic implants and their wear 
debris. Clinical materials, 1992. 9(3-4): p. 235-60. 
133. Landgraeber, S., et al., The pathology of orthopedic implant failure is mediated by innate immune 
system cytokines. Mediators of inflammation, 2014. 2014: p. 185150. 
134. Thomas, P., [Allergic reactions to implant materials]. Der Orthopade, 2003. 32(1): p. 60-4. 
135. Kanungo, B.P. and L.J. Gibson, Density-property relationships in mineralized collagen-
glycosaminoglycan scaffolds. Acta biomaterialia, 2009. 5(4): p. 1006-18. 
136. Dhankhar, P., Homogenization Fundamentals. IOSR Journal of Engineering, 2014. 4(5): p. 1-8. 
137. Kasper, J.C. and W. Friess, The freezing step in lyophilization: physico-chemical fundamentals, 
freezing methods and consequences on process performance and quality attributes of 
biopharmaceuticals. European journal of pharmaceutics and biopharmaceutics : official journal 
of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011. 78(2): p. 248-63. 
138. Yannas, I.V. and A.V. Tobolsky, Cross-linking of gelatine by dehydration. Nature, 1967. 
215(5100): p. 509-10. 
139. Samuel, C.S., Methods in Molecular Biology. Vol. 466. 2009, Totowa, NJ: Kidney Research. 
Humana Press. 
 277 
 
140. Barbosa, I., et al., Improved and simple micro assay for sulfated glycosaminoglycans 
quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology, 
2003. 13(9): p. 647-53. 
141. Haugh, M.G., C.M. Murphy, and F.J. O'Brien, Novel freeze-drying methods to produce a range of 
collagen-glycosaminoglycan scaffolds with tailored mean pore sizes. Tissue engineering. Part C, 
Methods, 2010. 16(5): p. 887-94. 
142. Gibson, L.J., Ashby, M.F., Harley, B.A., Cellular materials in nature and medicine2010, 
Cambridge, UK: Cambridge University Press. 
143. Dodson, T.B., et al., Cranial bone graft to reconstruct the mandibular condyle in Macaca 
mulatta. Journal of oral and maxillofacial surgery : official journal of the American Association 
of Oral and Maxillofacial Surgeons, 1997. 55(3): p. 260-7. 
144. Smith, M.H., et al., Computed tomography-based tissue-engineered scaffolds in 
craniomaxillofacial surgery. The international journal of medical robotics + computer assisted 
surgery : MRCAS, 2007. 3(3): p. 207-16. 
145. Zimmermann, G. and A. Moghaddam, Allograft bone matrix versus synthetic bone graft 
substitutes. Injury, 2011. 42 Suppl 2: p. S16-21. 
146. Laurencin, C., Y. Khan, and S.F. El-Amin, Bone graft substitutes. Expert review of medical 
devices, 2006. 3(1): p. 49-57. 
147. Lyons, F.G., et al., Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone 
void filler? Clinical orthopaedics and related research, 2014. 472(4): p. 1318-28. 
148. Hutmacher, D.W., Scaffold design and fabrication technologies for engineering tissues--state of 
the art and future perspectives. Journal of biomaterials science. Polymer edition, 2001. 12(1): p. 
107-24. 
149. Xu, X.L., et al., Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue 
engineering. Journal of biomedical materials research. Part B, Applied biomaterials, 2005. 75(2): 
p. 289-303. 
150. Place, E.S., N.D. Evans, and M.M. Stevens, Complexity in biomaterials for tissue engineering. 
Nature materials, 2009. 8(6): p. 457-70. 
151. Grayson, W.L., et al., Engineering anatomically shaped human bone grafts. Proceedings of the 
National Academy of Sciences of the United States of America, 2010. 107(8): p. 3299-304. 
152. Muller, P., et al., Calcium phosphate surfaces promote osteogenic differentiation of mesenchymal 
stem cells. Journal of cellular and molecular medicine, 2008. 12(1): p. 281-91. 
153. Nakamura, S., et al., Effect of calcium ion concentrations on osteogenic differentiation and 
hematopoietic stem cell niche-related protein expression in osteoblasts. Tissue engineering. Part 
A, 2010. 16(8): p. 2467-73. 
154. Hu, J., et al., Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials, 
2010. 31(31): p. 7971-7. 
155. Musah, S., et al., Glycosaminoglycan-binding hydrogels enable mechanical control of human 
pluripotent stem cell self-renewal. ACS nano, 2012. 6(11): p. 10168-77. 
156. Liao, S.S., et al., Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA 
composite. Journal of biomedical materials research. Part B, Applied biomaterials, 2004. 69(2): p. 
158-65. 
157. Kim, H.W., J.H. Song, and H.E. Kim, Bioactive glass nanofiber-collagen nanocomposite as a 
novel bone regeneration matrix. Journal of biomedical materials research. Part A, 2006. 79(3): p. 
698-705. 
158. Massumi, M., et al., The effect of topography on differentiation fates of matrigel-coated mouse 
embryonic stem cells cultured on PLGA nanofibrous scaffolds. Tissue engineering. Part A, 2012. 
18(5-6): p. 609-20. 
159. Sun, Y., et al., Mechanics regulates fate decisions of human embryonic stem cells. Plos One, 
2012. 7(5): p. e37178. 
 278 
 
160. Pountos, I., et al., The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, 
parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic 
differentiation of mesenchymal stem cells derived from osteoporotic bone. Journal of orthopaedic 
trauma, 2010. 24(9): p. 552-6. 
161. Shen, W., et al., The effect of incorporation of exogenous stromal cell-derived factor-1 alpha 
within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials, 2010. 
31(28): p. 7239-49. 
162. Lee, J.H., et al., Osteogenic differentiation of human adipose tissue-derived stromal cells (hASCs) 
in a porous three-dimensional scaffold. Biochemical and biophysical research communications, 
2008. 370(3): p. 456-60. 
163. Shen, Y.H., M.S. Shoichet, and M. Radisic, Vascular endothelial growth factor immobilized in 
collagen scaffold promotes penetration and proliferation of endothelial cells. Acta biomaterialia, 
2008. 4(3): p. 477-89. 
164. Caliari, S.R. and B.A. Harley, Composite growth factor supplementation strategies to enhance 
tenocyte bioactivity in aligned collagen-GAG scaffolds. Tissue engineering. Part A, 2013. 19(9-
10): p. 1100-12. 
165. Caliari, S.R. and B.A. Harley, Structural and biochemical modification of a collagen scaffold to 
selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation. Advanced 
healthcare materials, 2014. 3(7): p. 1086-96. 
166. Wang, H., et al., Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy, 
2012. 14(4): p. 423-30. 
167. Thomopoulos, S., et al., Effect of several growth factors on canine flexor tendon fibroblast 
proliferation and collagen synthesis in vitro. The Journal of hand surgery, 2005. 30(3): p. 441-7. 
168. Malladi, P., et al., Effect of reduced oxygen tension on chondrogenesis and osteogenesis in 
adipose-derived mesenchymal cells. American journal of physiology. Cell physiology, 2006. 
290(4): p. C1139-46. 
169. Ren, X., et al., Osteogenesis on nanoparticulate mineralized collagen scaffolds via autogenous 
activation of the canonical BMP receptor signaling pathway. Biomaterials, 2015. 50: p. 107-14. 
170. Lee, J.C., et al., Optimizing Collagen Scaffolds for Bone Engineering: Effects of Cross-linking 
and Mineral Content on Structural Contraction and Osteogenesis. The Journal of craniofacial 
surgery, 2015. 26(6): p. 1992-6. 
171. Zhou, J., et al., In vitro generation of osteochondral differentiation of human marrow 
mesenchymal stem cells in novel collagen-hydroxyapatite layered scaffolds. Acta biomaterialia, 
2011. 7(11): p. 3999-4006. 
172. Tseng, P.C., et al., Resveratrol promotes osteogenesis of human mesenchymal stem cells by 
upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. Journal of bone and mineral 
research : the official journal of the American Society for Bone and Mineral Research, 2011. 
26(10): p. 2552-63. 
173. Frank, O., et al., Real-time quantitative RT-PCR analysis of human bone marrow stromal cells 
during osteogenic differentiation in vitro. Journal of Cellular Biochemistry, 2002. 85(4): p. 737-
46. 
174. Pauly, S., et al., Characterization of tendon cell cultures of the human rotator cuff. European cells 
& materials, 2010. 20: p. 84-97. 
175. Brydone, A.S., D. Meek, and S. Maclaine, Bone grafting, orthopaedic biomaterials, and the 
clinical need for bone engineering. Proceedings of the Institution of Mechanical Engineers. Part 
H, Journal of engineering in medicine, 2010. 224(12): p. 1329-43. 
176. Langer, R. and D.A. Tirrell, Designing materials for biology and medicine. Nature, 2004. 
428(6982): p. 487-92. 
177. Agrawal, C.M. and R.B. Ray, Biodegradable polymeric scaffolds for musculoskeletal tissue 
engineering. Journal of biomedical materials research, 2001. 55(2): p. 141-50. 
 279 
 
178. Wettergreen, M.A., et al., Computer-aided tissue engineering of a human vertebral body. Annals 
of biomedical engineering, 2005. 33(10): p. 1333-43. 
179. Lipner, J., et al., The mechanics of PLGA nanofiber scaffolds with biomimetic gradients in 
mineral for tendon-to-bone repair. Journal of the mechanical behavior of biomedical materials, 
2014. 40: p. 59-68. 
180. Temple, J.P., et al., Engineering anatomically shaped vascularized bone grafts with hASCs and 
3D-printed PCL scaffolds. Journal of biomedical materials research. Part A, 2014. 102(12): p. 
4317-25. 
181. Przekora, A. and G. Ginalska, Addition of 1,3-beta-D-glucan to chitosan-based composites 
enhances osteoblast adhesion, growth, and proliferation. International journal of biological 
macromolecules, 2014. 70: p. 474-81. 
182. Chen, L., et al., Preparation and evaluation of an Arg-Gly-Asp-modified chitosan/hydroxyapatite 
scaffold for application in bone tissue engineering. Molecular medicine reports, 2015. 
183. Xie, J., et al., Osteogenic differentiation and bone regeneration of the iPSC-MSCs supported by a 
biomimetic nanofibrous scaffold. Acta biomaterialia, 2015. 
184. Mobasseri, S.A., G. Terenghi, and S. Downes, Micro-structural geometry of thin films intended 
for the inner lumen of nerve conduits affects nerve repair. Journal of materials science. Materials 
in medicine, 2013. 24(7): p. 1639-47. 
185. O'Brien, F.J., et al., The effect of pore size on permeability and cell attachment in collagen 
scaffolds for tissue engineering. Technol Health Care, 2007. 15(1): p. 3-17. 
186. Woodard, J.R., et al., The mechanical properties and osteoconductivity of hydroxyapatite bone 
scaffolds with multi-scale porosity. Biomaterials, 2007. 28(1): p. 45-54. 
187. Suarez-Gonzalez, D., et al., Controllable mineral coatings on PCL scaffolds as carriers for 
growth factor release. Biomaterials, 2012. 33(2): p. 713-21. 
188. Patel, J.J., C.L. Flanagan, and S.J. Hollister, Bone Morphogenetic Protein-2 Adsorption onto 
Poly-varepsilon-caprolactone Better Preserves Bioactivity In Vitro and Produces More Bone In 
Vivo than Conjugation Under Clinically Relevant Loading Scenarios. Tissue engineering. Part C, 
Methods, 2015. 21(5): p. 489-98. 
189. Hu, W.W., et al., The use of reactive polymer coatings to facilitate gene delivery from poly 
(epsilon-caprolactone) scaffolds. Biomaterials, 2009. 30(29): p. 5785-92. 
190. Jeong, C.G., H. Zhang, and S.J. Hollister, Three-dimensional poly(1,8-octanediol-co-citrate) 
scaffold pore shape and permeability effects on sub-cutaneous in vivo chondrogenesis using 
primary chondrocytes. Acta biomaterialia, 2011. 7(2): p. 505-14. 
191. Patel, J.J., et al., Dual Delivery of EPO and BMP2 from a Novel Modular Poly-varepsilon-
Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps. Tissue 
engineering. Part C, Methods, 2015. 
192. Smith, M.H., et al., Computed tomography-based tissue-engineered scaffolds in 
craniomaxillofacial surgery. Int J Med Robot, 2007. 3(3): p. 207-16. 
193. Hollister, S.J., et al., Engineering craniofacial scaffolds. Orthod Craniofac Res, 2005. 8(3): p. 
162-73. 
194. Kuhne, J.H., et al., Bone formation in coralline hydroxyapatite. Effects of pore size studied in 
rabbits. Acta Orthop Scand, 1994. 65(3): p. 246-52. 
195. Hulbert, S.F., et al., Potential of ceramic materials as permanently implantable skeletal 
prostheses. J Biomed Mater Res, 1970. 4(3): p. 433-456. 
196. Lipowiecki, M., et al., Permeability of rapid prototyped artificial bone scaffold structures. 
Journal of biomedical materials research. Part A, 2014. 102(11): p. 4127-35. 
197. Karam, G.N. and L.J. Gibson, Biomimicking of animal quills and plant stems - natural 
cylindrical-shells with foam cores. Mater. Sci. Eng. C Biomim. Mater. Sens. Syst., 1994. 2(1-2): 
p. 113-132. 
 280 
 
198. Olde Damink, L.H., et al., Cross-linking of dermal sheep collagen using a water-soluble 
carbodiimide. Biomaterials, 1996. 17(8): p. 765-73. 
199. Pontius, J.S., Estimation of the mean in line intercept sampling. Environmental and Ecological 
Statistics, 1998. 5(4): p. 371-379. 
200. Tierney, C.M., M.J. Jaasma, and F.J. O'Brien, Osteoblast activity on collagen-GAG scaffolds is 
affected by collagen and GAG concentrations. Journal of biomedical materials research. Part A, 
2009. 91(1): p. 92-101. 
201. Hannink, G. and J.J.C. Arts, Bioresorbability, porosity and mechanical strength of bone 
substitutes: What is optimal for bone regeneration? Injury-International Journal of the Care of the 
Injured, 2011. 42: p. S22-S25. 
202. Harley, B.A.C. and L.J. Gibson, In vivo and in vitro applications of collagen-GAG scaffolds. 
Chem Eng J, 2008. 137(1): p. 102-121. 
203. Caliari, S.R., et al., Collagen Scaffolds Incorporating Coincident Gradations of Instructive 
Structural and Biochemical Cues for Osteotendinous Junction Engineering. Advanced healthcare 
materials, 2015. 4(6): p. 831-7. 
204. Caliari, S.R. and B.A. Harley, Collagen-GAG scaffold biophysical properties bias MSC lineage 
choice in the presence of mixed soluble signals. Tissue engineering. Part A, 2014. 20(17-18): p. 
2463-72. 
205. Kurtz, S.M. and J.N. Devine, PEEK biomaterials in trauma, orthopedic, and spinal implants. 
Biomaterials, 2007. 28(32): p. 4845-69. 
206. Bonfield, W., Composites for bone replacement. Journal of biomedical engineering, 1988. 10(6): 
p. 522-6. 
207. Jungreuthmayer, C., et al., A comparative study of shear stresses in collagen-glycosaminoglycan 
and calcium phosphate scaffolds in bone tissue-engineering bioreactors. Tissue engineering. Part 
A, 2009. 15(5): p. 1141-9. 
208. Amoroso, N.J., et al., Microstructural manipulation of electrospun scaffolds for specific bending 
stiffness for heart valve tissue engineering. Acta biomaterialia, 2012. 8(12): p. 4268-77. 
209. Argento, G., et al., Multi-scale mechanical characterization of scaffolds for heart valve tissue 
engineering. Journal of biomechanics, 2012. 45(16): p. 2893-8. 
210. Wust, S., R. Muller, and S. Hofmann, 3D Bioprinting of complex channels-Effects of material, 
orientation, geometry, and cell embedding. Journal of biomedical materials research. Part A, 
2015. 103(8): p. 2558-70. 
211. Yodmuang, S., et al., Silk microfiber-reinforced silk hydrogel composites for functional cartilage 
tissue repair. Acta biomaterialia, 2015. 11: p. 27-36. 
212. Rizkalla, A.S. and D.W. Jones, Indentation fracture toughness and dynamic elastic moduli for 
commercial feldspathic dental porcelain materials. Dental materials : official publication of the 
Academy of Dental Materials, 2004. 20(2): p. 198-206. 
213. Tarafder, S. and S. Bose, Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for 
bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo 
osteogenesis. ACS applied materials & interfaces, 2014. 6(13): p. 9955-65. 
214. Hak, D.J., et al., Use of carbon-fiber-reinforced composite implants in orthopedic surgery. 
Orthopedics, 2014. 37(12): p. 825-30. 
215. Nganga, S., et al., Multi-layer porous fiber-reinforced composites for implants: in vitro calcium 
phosphate formation in the presence of bioactive glass. Dental materials : official publication of 
the Academy of Dental Materials, 2012. 28(11): p. 1134-45. 
216. Alberti, K., et al., Functional immobilization of signaling proteins enables control of stem cell 
fate. Nature methods, 2008. 5(7): p. 645-50. 
217. Watarai, A., et al., TGFbeta functionalized starPEG-heparin hydrogels modulate human dermal 
fibroblast growth and differentiation. Acta biomaterialia, 2015. 25: p. 65-75. 
 281 
 
218. Sakiyama-Elbert, S.E. and J.A. Hubbell, Development of fibrin derivatives for controlled release 
of heparin-binding growth factors. Journal of controlled release : official journal of the 
Controlled Release Society, 2000. 65(3): p. 389-402. 
219. Sakiyama-Elbert, S.E. and J.A. Hubbell, Controlled release of nerve growth factor from a 
heparin-containing fibrin-based cell ingrowth matrix. Journal of controlled release : official 
journal of the Controlled Release Society, 2000. 69(1): p. 149-58. 
220. Hudalla, G.A., et al., Harnessing endogenous growth factor activity modulates stem cell 
behavior. Integrative biology : quantitative biosciences from nano to macro, 2011. 3(8): p. 832-
42. 
221. Paschoa, A.F., Heparin: 100 years of pleiotropic effects. Journal of thrombosis and thrombolysis, 
2015. 
222. Gama, C.I., et al., Sulfation patterns of glycosaminoglycans encode molecular recognition and 
activity. Nature chemical biology, 2006. 2(9): p. 467-73. 
223. Raman, R., V. Sasisekharan, and R. Sasisekharan, Structural insights into biological roles of 
protein-glycosaminoglycan interactions. Chemistry & Biology, 2005. 12(3): p. 267-77. 
224. Kisiel, M., et al., Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan 
gel for improved bone formation. Plos One, 2013. 8(10): p. e78551. 
225. Kanzaki, S., et al., Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and 
BMP receptor. Journal of cellular physiology, 2008. 216(3): p. 844-50. 
226. Hortensius, R.A. and B.A. Harley, The use of bioinspired alterations in the glycosaminoglycan 
content of collagen-GAG scaffolds to regulate cell activity. Biomaterials, 2013. 34(31): p. 7645-
52. 
227. Thomopoulos, S., G.M. Genin, and L.M. Galatz, The development and morphogenesis of the 
tendon-to-bone insertion - what development can teach us about healing. Journal of 
musculoskeletal & neuronal interactions, 2010. 10(1): p. 35-45. 
228. Cimino, F., B.S. Volk, and D. Setter, Anterior cruciate ligament injury: diagnosis, management, 
and prevention. American family physician, 2010. 82(8): p. 917-22. 
229. Buckwalter, J.A., H.J. Mankin, and A.J. Grodzinsky, Articular cartilage and osteoarthritis. 
Instructional course lectures, 2005. 54: p. 465-80. 
230. Genin, G.M., et al., Functional grading of mineral and collagen in the attachment of tendon to 
bone. Biophysical journal, 2009. 97(4): p. 976-85. 
231. Woo, S.L., et al., Injury and repair of ligaments and tendons. Annual review of biomedical 
engineering, 2000. 2: p. 83-118. 
232. Wopenka, B., et al., The tendon-to-bone transition of the rotator cuff: a preliminary Raman 
spectroscopic study documenting the gradual mineralization across the insertion in rat tissue 
samples. Applied spectroscopy, 2008. 62(12): p. 1285-94. 
233. Butler, D.L., et al., Functional tissue engineering for tendon repair: A multidisciplinary strategy 
using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. Journal of orthopaedic 
research : official publication of the Orthopaedic Research Society, 2008. 26(1): p. 1-9. 
234. Vitale, M.A., et al., Rotator cuff repair: an analysis of utility scores and cost-effectiveness. 
Journal of shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.], 2007. 
16(2): p. 181-7. 
235. Boileau, P., et al., Arthroscopic repair of full-thickness tears of the supraspinatus: does the 
tendon really heal? The Journal of bone and joint surgery. American volume, 2005. 87(6): p. 
1229-40. 
236. Galatz, L., et al., Development of the supraspinatus tendon-to-bone insertion: localized 
expression of extracellular matrix and growth factor genes. Journal of orthopaedic research : 
official publication of the Orthopaedic Research Society, 2007. 25(12): p. 1621-8. 
237. Klepps, S., et al., Prospective evaluation of the effect of rotator cuff integrity on the outcome of 
open rotator cuff repairs. The American journal of sports medicine, 2004. 32(7): p. 1716-22. 
 282 
 
238. Millar, N.L., et al., Open versus two forms of arthroscopic rotator cuff repair. Clinical 
orthopaedics and related research, 2009. 467(4): p. 966-78. 
239. Li, X., et al., Nanofiber scaffolds with gradations in mineral content for mimicking the tendon-to-
bone insertion site. Nano letters, 2009. 9(7): p. 2763-8. 
240. Chan, V., et al., Three-dimensional photopatterning of hydrogels using stereolithography for 
long-term cell encapsulation. Lab on a chip, 2010. 10(16): p. 2062-70. 
241. Feinberg, S.E., et al., Image-based biomimetic approach to reconstruction of the 
temporomandibular joint. Cells, tissues, organs, 2001. 169(3): p. 309-21. 
242. Khanarian, N.T., et al., A functional agarose-hydroxyapatite scaffold for osteochondral interface 
regeneration. Biomaterials, 2012. 33(21): p. 5247-58. 
243. Moffat, K.L., et al., Orthopedic interface tissue engineering for the biological fixation of soft 
tissue grafts. Clinics in sports medicine, 2009. 28(1): p. 157-76. 
 
 
